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Abstract
The Bcl-2 family of proteins are critical regulators of mitochondrial function and 
deregulation during apoptosis. To this effect, the ‘BH3-only’ members of this family 
play an important role in initiating many of the apoptotic signalling pathways. This 
thesis focuses on the BH3-only protein Bid. We have used the active form of Bid, 
tBid, as bait in a yeast two-hybrid assay to identify novel interaction partners for this 
protein. In combination with a GST pull-down assay we identified two novel 
interaction partners for tBid. The proteins identified were Mcl-1 and EID-1.
Mcl-1 is an anti-apoptotic Bcl-2 family member, although its role in apoptosis has not 
been as extensively studied as other anti-apoptotic proteins such as Bcl-2 and Bcl-XL. 
EID-1 was first identified as a pRb interacting protein that has been shown to inhibit 
differentiation of myoblasts. However, there is no data to suggest that EID-1 may 
have a role in apoptosis, and to date all data suggests that the protein has a nuclear 
function rather than a cytoplasmic one.
During the course of this work, we observed that Mcl-1 is cleaved during apoptosis of 
Jurkat T cells. We have characterised this cleavage and found it to be as a result of 
caspase cleavage. There are two caspase cleavage sites in Mcl-1. These occur at 
Asp127 and Asp157. Many Bcl-2 family members are cleaved by caspases during 
apoptosis. In particular, anti-apoptotic family members cleaved by caspases are 
converted into pro-apoptotic proteins. In contrast to this we did not observe any pro- 
apoptotic activity associated with the cleavage fragments. We also found that the 
PEST region in Mcl-1 did not regulate its half-life in FDCP-1 cells, confirming results 
already observed in U937 cells.
While further work needs to be carried out, the results presented here provide a 
number of important observations that may help to further the understanding of how 
both Bid and Mcl-1 contribute to apoptosis.
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1 - Introduction
Tissue homeostasis requires that many aspects of cell growth and proliferation be 
carefully controlled. Normal growth is controlled at a number of different levels 
within cells and when problems arise they can be dealt with in a number of different 
ways. One way in which this control is exerted is through programmed cell death or 
apoptosis. This is a genetically controlled cell suicide that has proven to be very 
complex in terms of both its regulation and execution. Regulation of tissue 
development in this manner has proven to be vital for normal development and tissue 
homeostasis as well as being an important response to various cellular stresses.
1.1 -  Apoptosis
Apoptosis as we know it today was first observed by Kerr, Wylie and Currie in 1972 
(Kerr et al., 1972). The process has very distinctive morphological changes 
associated with it. Cells initially condense and the cytoplasm becomes quite 
concentrated and thick, the nuclear membrane breaks down and the cell’s DNA 
condenses and becomes fragmented, with the cell membrane blebbing into apoptotic 
bodies.
These macroscopic features of apoptosis are controlled very carefully at a molecular 
level. Cells constantly receive signals that promote cell survival and growth. As well 
as signals that promote apoptosis directly, removal or withdrawal of such survival 
signals can initiate apoptosis. Death receptors expressed on the cell surface transduce 
signals from outside the cell and administer a direct signal to initiate apoptosis 
(Locksley et al., 2001), while checkpoint proteins such as p53 can control and initiate 
signals frxom internal stresses by upregulating pro-apoptotic genes that initiate 
apoptosis (Fridman and Lowe, 2003).
The result of these initiation signals is ultimately the activation of a family of 
proteases known as caspases.
15
1.1.1 -  Caspases
Caspases (cysteinyl aspartate-specific proteases) are the main workhorses of 
apoptosis (Eamshaw et al., 1999). Once activated they carry out much of the work 
required for successful completion of the apoptotic program. As well as having the 
ability to cleave and activate other caspases, they cleave and activate other molecules 
within the cell. This converts neutral or anti-apoptotic proteins into strong pro- 
apoptotic proteins with specific roles in apoptosis (Nicholson, 1999).
There is now a large number of mammalian caspases identified and these can be 
placed into two main groups -  initiator caspases or effector caspases. Initiator 
caspases are upstream caspases and initiate the caspase cascade (Eamshaw et al., 
1999). This group includes caspase-8, -2 and -10, which are the first caspases 
activated in the extrinsic pathway at the DISC (Peter and Krammer, 2003). Caspase-9 
is also an initiator caspase, being the initial caspase activated after mitochondrial 
deregulation (Adrain and Martin, 2001). The effector caspases, also known as 
executioner caspases, are downstream caspases that cleave a very broad range of 
cellular substrates (Earnshaw et al., 1999). Caspases in this group include caspase-3, 
-6, and -7.
All caspases cleave after an aspartic acid residue (termed PI), with the amino acids at 
positions P2, P3 and P4 preceding PI at the cleavage site also being important in 
determining what constitutes a cleavage site (Rano et al., 1997; Thornberry et al., 
1997). Caspase-3 and -7 cleavage sites generally have the consensus sequence 
DXXD. Although this is the most common caspase cleavage motif there are many 
caspase-3 and -7 cleavage sites that do not share this motif (Nicholson, 1999). 
Consensus cleavage sites for other caspases can differ from that of caspase-3 although 
they all share the requirement for an aspartic acid residue at position PI and often a 
number of different caspases can cleave at the same site.
Regulation of caspases and caspase activity is critical to normal cellular homeostasis. 
To leave such proteases unchecked can have dire consequences for the cell.
16
1.2 -  Apoptosis in Development and Disease
Apoptosis plays an important role in development of all multicellular organisms. It is 
a highly conserved process that is shared by simple organisms such as the nematode 
worm Caenorhabditis elegans, and the more complex fruit-fly Drosophila 
melanogaster as well as vertebrates (Fig. 1-1). During normal development of C. 
elegans 1090 cells are generated. The same 131 of these cells die in a specific and 
reproducible manner to generate the mature worm. Studies of death in these cells 
have identified a simple apoptotic pathway that appears to be a basic, primitive model 
of what happens in higher organisms. Apoptosis in Drosophila is a more complex 
event and includes a number of genes (rpr, grim, and hid) that have little homology to 
apoptotic genes identified in either the worm or mammals. Interestingly apoptosis in 
both C. elegans and Drosophila appears to be limited to early life and does not appear 
to have a role beyond development of the mature organism. In contrast, the process 
of programmed cell death in mammals is not only important during embryonic and 
foetal development but it has a functional importance for many biological processes 
throughout the lifetime of the mammal. Apoptosis is a vital tool for proper 
homeostasis and maintenance of biological systems such as the nervous and immune 
systems (Becker and Bonni, 2004; Opferman and Korsmeyer, 2003; Zahir and 
Weaver, 2004).
Throughout an organism’s life span its cells accumulate damage to their genome.
This may be as a result of exposure to various genotoxic agents as well as the normal 
process of ageing. Over time, such damage may lead to impairment of control 
mechanisms within cells. Disruption in the balance of molecules that control 
apoptosis can have adverse consequences for the cell and contribute to the 
pathogenesis of a number of disease types. Such changes that lead to the promotion 
of cell survival can be a major stepping stone to the development of cancer (Hanahan 
and Weinberg, 2000), while changes that promote apoptosis can contribute to the 
pathogenesis of many neurodegenerative diseases (Mattson, 2000).
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Figure 1-1: Conserved components of the cell-death machinery. The diagram 
above shows conserved pathways in C. elegans, Drosophila and mammals that are 
key to caspase activation. Analogous colours represent homologus proteins between 
species. The pathway in C. elegans is a much simpler version of the pathway found 
in both Drosophila and mammals.
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1.3 -  Apoptotic pathways
Execution of apoptosis is signalled through two main pathways. One is an extrinsic 
pathway, whereby external signals are transduced across the cell membrane by a 
family of receptors known as death receptors. These death receptors belong to the 
tumour necrosis factor receptor (TNFR) family. There are now a large number of 
these receptors identified. One of best-characterised death receptor pathways is that 
of the CD95 or Fas receptor. The other main apoptotic pathway is an intrinsic 
pathway mediated by signals that are generated within the cell. These signals 
converge on the mitochondria and result in release of mitochondrial proteins required 
for apoptosis. Ultimately these pathways result in caspase activation and subsequent 
demolition of the cell.
1.3.1 -  The extrinsic pathway
The death receptor family, or TNFR family, now consists of at least 29 receptors 
(Locksley et al., 2001). These receptors are found on the surface of cells with some 
of these receptors being tissue specific (e.g. the neuronal specific p75 neurotrophic 
receptor) and others more ubiquitous (e.g. the Fas receptor). All death receptors have 
the same basic structure (Locksley et al., 2001). They contain a cysteine-rich 
extracellular domain, and usually have a death domain (DD) in their cytoplasmic 
regions. Generally there is also good homology between cytoplasmic domains of 
these receptors. Ligation of a death ligand to its corresponding death receptor results 
in oligomerisation of the receptor. Internally this results in the formation of a death 
induced signalling complex (DISC) (Peter and Krammer, 2003). This DISC allows 
for the activation of initiator caspases that then go on to activate downstream 
executioner caspases (Locksley et al., 2001; Peter and Krammer, 2003).
The Fas (CD95) receptor has been one of the best studied death receptors to date and 
is a good example of how these receptors signal apoptosis (Krammer, 2000; Nagata, 
1999). This pathway is outlined in Figure 1-2. Binding of Fas ligand (FasL) to the 
receptor results in trimerisation of the receptor. This brings the Fas receptor DDs into 
close contact with each other and acts as a platform for the assembly of the DISC
19
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Figure 1-2: Extrinsic signalling via the CD95 (Fas) receptor pathway. This 
figure outlines the events that occur during Fas mediated apoptosis. Binding of the 
Fas ligand to its receptor results in the formation of the DISC at the membrane. This 
allows for activation of pro-caspase-8 to its active form. The signal can then take one 
of two pathways. Large amounts of caspase-8 activated at the DISC results in direct 
activation of effector caspases (e.g. caspase-3) and is independent of the mitochondria 
(Type I pathway). Small amounts of caspase-8 activated at the DISC require 
mitochondrial amplification of the apoptotic signal that is mediated through cleavage 
of Bid. The figure is taken from Nagata, 2000.
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(Peter and Krammer, 2003). An adaptor protein known as the Fas associated death 
domain (FADD) is recruited to the DD and allows for binding of other DISC 
components such as the imitator caspase pro-caspase-8. This allows for activation of 
caspase-8 (Peter and Krammer, 2003). Once caspase-8 has been activated it can go 
on to cleave and activate executioner caspases directly or may cleave other substrates 
that can amplify the signal through the mitochondrial pathway (Fig. 1-2). One or 
other of these signalling pathway options is used preferentially, giving two types of 
cells known as Type I or Type II (Barnhart et al., 2003; Scaffidi et al., 1998; Scaffidi 
et al., 1999).
In some cell types lots of caspase-8 is activated at the DISC. This results in the direct 
activation of the executioner caspase caspase-3, thus signalling apoptosis independent 
of the mitochondrial pathway. These are Type I cells and include the B cell line 
SKW6.4 and T cell line H9, as well as primary thymocytes (Scaffidi et al., 1999; Yin 
et al., 1999). However, in other cells there is little caspase-8 activated at the DISC 
resulting in small amounts of active caspase-3 within the cell. In these cases the weak 
signal needs to be amplified to ensure that apoptosis progresses efficiently. In such 
cells the Bcl-2 family member Bid is cleaved by caspase-8 to generate an active C- 
terminal fragment known as tBid (Li et al., 1998b; Luo et al., 1998). This active form 
of Bid translocates to the mitochondria, making a connection with the intrinsic death 
pathway and allows for amplification of the apoptotic signal (Fig. 1-2). These are 
Type II cells and include the T cell lines CEM and Jurkat, as well as primary 
hepatocytes (Scaffidi et al., 1999; Yin et al., 1999).
There are also a number of proteins that act as inhibitors of the extrinsic pathway. 
Within the TNFR family itself are a number of decoy receptors. Expression of decoy 
receptors can antagonise apoptotic signalling via the extrinsic pathway (Dempsey et 
al., 2003). There are also a number of adapter proteins that act as inhibitors of 
apoptotic signalling from the death receptors. Silencer of death domain (SODD) was 
identified as a protein that inhibited apoptotic signalling from TNF-R1 (TNF receptor 
1) by inhibiting the binding of TNF receptor associated death domain (TRADD) and 
DISC formation (Jiang et al., 1999). In addition, cellular FADD-like interleukin-1(3- 
converting enzyme (FLICE)-inhibitory protein (cFLIP) can also be recruited to the
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DISC in Fas signalling. It is homologous to caspase-8 but lacks any caspase activity 
and can prevent caspase-8 activation (Irmler et al., 1997).
While these receptors appear to function primarily in signalling apoptosis this is not 
their only function. In a similar way to the formation of the DISC, the recruitment of 
TNF receptor associated factors (TRAFs) to the receptor results in signalling via a 
number of pathways (Dempsey et al., 2003). This includes signalling via NF-kB, PI- 
3K, and p38 ERK/MAPK signalling pathways. Signalling via these pathways 
regulates many survival, proliferation and differentiation pathways. Thus these ‘death 
receptors’ also have roles other than signalling apoptosis.
1.3.2 -  The intrinsic pathway
The second predominant apoptotic pathway controlling apoptosis involves the 
mitochondria. Mitochondria are traditionally known as the powerhouse of the cell 
and generate the ATP required for normal cellular functioning. However, they also 
contain a pool of proteins vital for inducing apoptosis. Intrinsic signals that arise 
within the cell as a result of stress or genotoxic damage converge on the mitochondria 
to induce apoptosis. Disruption and deregulation of the mitochondria results in the 
release of these proteins, which promote apoptosis and activation of caspases (Fig. 1- 
3).
In terms of apoptosis, the Bcl-2 family of proteins regulate mitochondrial integrity 
(Cory and Adams, 2002; Desagher and Martinou, 2000). Bcl-2 proteins are discussed 
in greater depth in section 1.4 below. Bax and Bak are two pro-apoptotic members of 
this family and are instrumental in co-ordinating the release of apoptotic 
mitochondrial proteins (Wei et al., 2001). Apoptotic signals result in activation of 
these pro-apoptotic members of the Bcl-2 family and subsequent disruption of the 
mitochondrial membrane. This allows release of mitochondrial proteins into the 
cytoplasm, where they function to initiate and promote apoptosis (Desagher and 
Martinou, 2000). While there is now much known about Bcl-2 family proteins, 
exactly how they co-ordinate mitochondrial deregulation is not fully understood.
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Figure 1-3: Apoptotic signalling via the intrinsic (mitochondrial) pathway.
Many apoptotic pathways converge on the mitochondria to induce the release of 
cytochrome c and subsequent activation of caspase-9. Many of these signals activate 
BH3-only proteins (e.g. Bid or Bad) that then translocate to the mitochondria and 
result in activation of the pro-apoptotic Bcl-2 family members to induce cytochrome c 
release. Figure taken from Desagher and Martineau, 2000.
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Cytochrome c is an essential component of the electron transport chain responsible 
for generation of ATP. During apoptosis it takes on a very different role, one that is 
critical to signalling apoptosis in the intrinsic death pathway. Deregulation of the 
mitochondria results in the release of cytochrome c into the cytoplasm (Liu et al., 
1996). Once in the cytoplasm, cytochrome c promotes oligomerisation of apoptotic 
protease activating factor-1 (Apaf-1) (Zou et al., 1997). Apaf-1 contains a caspase 
activation and recruitment domain (CARD) that interacts with a similar domain in the 
initiator caspase pro-caspase-9 (Shiozaki et al., 2002). The complex formed between 
cytochrome c, Apaf-1 and pro-caspase-9, in the presence of dATP, is known as the 
apoptosome (Zou et al., 1999). Formation of the apoptosome acts as a platform for 
activation of caspase-9 (Adrain and Martin, 2001; Zou et al., 1999). Caspase-9 is an 
initiator caspase that then goes on to activate the executioner caspases caspase-3 and 
-7. Although the release of cytochrome c from the mitochondria is an extremely 
important event there are also a number of other important proteins that are released 
from the mitochondria. Apoptosis inducing factor (AIF), endonuclease G (EndoG), 
Smac/Diablo and HtrA2/Omi are just a number of these.
Once EndoG and AIF have been released into the cytoplasm they both translocate to 
the nucleus (Li et al., 2001; Susin et al., 1999). AIF has a role in chromatin 
condensation and EndoG is an endonuclease that cleaves DNA inter-nucleosomally. 
However while they can carry out these functions independent of one another, when 
expressed together both functions appear to be enhanced (Cregan et al., 2004). In this 
way they can induce a caspase independent chromatin condensation and nucleosomal 
cleavage similar to that observed when caspase activated DNase (CAD) is activated 
(Sakahira et al., 1998).
Proteins such as second mitochondrial activator of caspases (Smac)/DIABLO and 
HtrA2/Omi also contribute to the activation of caspases (Du et al., 2000; Faccio et al., 
2000; Suzuki et al., 2001; Verhagen et al., 2000). They act as inhibitors of the 
inhibitors of apoptosis (IAP) family of proteins. IAP proteins are endogenous and 
specific inhibitors of caspases.
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IAPs are molecules that bind specifically to caspases and inhibit their activation 
(Deveraux and Reed, 1999). The first IAP gene was identified in baculovirus where it 
prevented the infected cell from dying (Crook et al., 1993). All IAPs have one to 
three baculovirus IAP repeat (BIR) domains and it is these BIR domains that are 
responsible for the proteins ability to inhibit caspases (Deveraux and Reed, 1999). 
There are five known mammalian IAP proteins -  XIAP, c-IAPl, C-IAP2, NIAP and 
survivin. XIAP, c-IAPl and C-IAP2 directly inhibit active caspase-3 and -7 and 
procaspase-9 with XIAP being the most potent of these inhibitors (Deveraux and 
Reed, 1999). As well as having a role in inhibiting caspase activity IAPs appear to 
have other roles in cellular function. In particular, survivin is known to bind 
microtubules during mitosis, although its BIR domain does not appear to be required 
for this activity (Li et al., 1998a). Normal cellular functioning has IAPs present in the 
cytoplasm free to interact with appropriate caspases. Disruption of the mitochondria 
however results in the release of molecules like SMAC/Diablo and HtrA2/Omi (Du et 
al., 2000; Faccio et al., 2000; Suzuki et al., 2001; Verhagen et al., 2000). These 
proteins interact specifically with IAP molecules to relieve inhibition of the caspase 
proteins allowing them to carry out the function to their full potential.
As the mitochondria represent a key point in the intrinsic pathway of apoptosis its 
regulation is of key importance. It is likely that there are other mitochondrial proteins 
that also have roles to play in apoptosis similar to those already discovered. 
Particularly in the case of the intrinsic pathway, apoptotic signals that converge on the 
mitochondria arise from various checkpoint proteins that monitor cell growth and 
viability. Many of these signals require de novo expression of proteins and thus 
transcription and translation of proteins is often required for apoptosis to proceed. 
Thus there are a number of proteins that direct transcription in order to signal 
apoptosis to the mitochondria (Kumar and Cakouros, 2004).
1.3.3 -  Transcriptional control and activation
Apoptosis is a genetically controlled programmed cell death and as such many 
apoptotic pathways require changes in gene expression for proper execution of the 
death program. In particular many of the intrinsic death signals are initiated through 
changes to gene expression, while signalling from the extrinsic cell death pathway can
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also lead to changes in gene expression. Developmental signals, cytokine withdrawal 
and cytotoxic damage (e.g. UV damage or stress) all elicit a stimulus that requires 
changes to gene expression.
There are now many transcription factors identified that are known to induce 
expression of genes involved in protection and activation of apoptosis. These include 
p53, pRb, E2F-1, c-Jun and NF-kB (Kumar and Cakouros, 2004). These transcription 
factors do not function to signal apoptosis exclusively but play many roles in the 
control and regulation of cell growth and proliferation in response to many different 
stimuli. Through their ability to manipulate the apoptotic program, they are able to 
orchestrate an appropriate response to eliminate any cells that pose a threat to the 
organism.
1.3.3.1 -  E2F-1 and pRb in apoptosis
The E2F family of proteins (of which E2F-1 is the best studied) and the tumour 
suppresser protein pRb play important roles in regulation of cell cycle (Cam and 
Dynlacht, 2003; Stevaux and Dyson, 2002). E2F proteins are known to promote cell 
growth and proliferation and are controlled through a number of mechanisms 
including interaction with the tumour suppresser pRb (Dyson, 1998). Overexpression 
of E2F-1 in cell lines and mouse models can result in apoptosis. E2F-1 can influence 
apoptosis in a number of ways including inhibition of anti-apoptotic signalling, direct 
transcriptional activation of p53, or through p53 stabilisation mediated by p l4ARF 
(Phillips and Vousden, 2001). Mice deficient for the pRb gene die during 
embryogenesis (between days E13.5 -  E16.5) with extensive apoptosis being one of 
the causes of death (Lee et al., 1992). This suggests that pRb contributes to survival 
in normal cells and that loss of the protein results in a death signal. Much of the work 
in trying to elucidate the molecular mechanism of how the loss of pRb induces 
apoptosis has focused on pRbs ability to interact with E2F. The interaction of pRb 
with E2F-1 allows for the sequestration of E2F-1, thus preventing it from inducing 
expression of its target genes. Loss of pRb frees E2F-1 and allows it to transactivate 
its target genes, inducing apoptosis through either the p53 pathway or through direct 
induction of genes such as apafl that are directly involved in apoptosis (Phillips and 
Vousden, 2001). E2F-1 can also transactivate the p73 gene, a member of the p53
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family (Irwin et al., 2000). The p73 protein shares some transcriptional targets with 
the p53 protein and also plays a role in apoptosis (Melino et al., 2003). As well as 
inducing expression of pro-apoptotic proteins, E2F-1 is known to repress expression 
of the anti-apoptotic mcl-1 gene (Croxton et al., 2002). Thus the pRb and E2F can 
make a significant contribution to apoptosis in a variety of ways.
1.3.3.2 -  p53 signalling in apoptosis
As outlined above, E2F and pRb signal through the p53 protein to induce apoptosis. 
p53 functions as a critical checkpoint protein, monitoring genome stability and acting 
as a key decision maker when things go wrong (Okorokov, 2003). Damage to the 
genome results in a signalling cascade that activates p53 (Pluquet and Hainaut, 2001). 
Once activated in this manner p53 induces a G1 cell cycle arrest through induction of 
the cyclin-dependent kinase inhibitor p21 (Dulic et al., 1994). If the damage can be 
repaired the cell re-enters cell cycle, otherwise p53 can induce a permanent G1 arrest 
known as premature senescence preventing the cell from dividing any further or it can 
induce apoptosis. Apoptosis mediated by p53 primarily involves transcription of 
genes directly involved in apoptosis (Fridman and Lowe, 2003). There are a wide 
variety of apoptotic genes that can be induced by p53. These include the pro- 
apoptotic Bcl-2 family members Bax, PUMA and NOXA as well as a host of other 
proteins including PIG3, p53AIP (p53 apoptosis inducing protein), APAF1 and the 
CD95 Fas receptor amongst others (Kumar and Cakouros, 2004). The p53 family 
member p73 has also been found to play a similar role to p53 in apoptosis (Melino et 
al., 2003). p73 and p53 share activate transcription of number of common targets 
including Bax, APAF1 and PUMA (Melino et al., 2003). There is also a body of 
evidence to suggest that some forms of p53 can localise to the mitochondria and may 
have an apoptotic function that is independent of its transactivation capabilities (Leu 
et al., 2004; Mihara et al., 2003). p53 that is localised to the mitochondria has been 
shown to be able to interact with pro-apoptotic Bak resulting in its oligomerisation. 
This leads to release of cytochrome c and activation of pro-caspase-9 allowing 
apoptosis to proceed (Leu et al., 2004).
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1.3.3.3 -  NF-kB and its role in apoptosis
Rel/NF-KB transcription factors play important roles in controlling cell growth and 
differentiation as well as having a role in apoptosis (Pahl, 1999). There are a number 
of proteins in the NF-kB family and they bind to their DNA target sites (kB sites) as 
homodimers or heterodimers. Most of the work on NF-kB relates to its pro-survival 
function and through its transcriptional activation abilities NF-kB is known to induce 
expression of many anti-apoptotic proteins including cIAPl, cIAP2, A l, Bcl-XL and 
TRAF proteins (Pahl, 1999). However it is clear that NF-kB can also mediate an 
apoptotic response (Barkett and Gilmore, 1999). Activation-induced cell death 
(AICD) is an important mechanism for immune cell homeostasis with binding of 
FasL to its receptor being an important initiation event for AICD. Studies have 
shown that engagement of the T cell receptor results in upregulation of FasL, 
mediated by NF-kB suggesting a pro-apoptotic role for NF-kB in AICD (Kasibhatla 
et al., 1999; Matsui et al., 1998). As well as being able to induce expression of FasL 
NF-kB is known to induce expression of the Fas receptor (CD95), p53 and the NF-kB 
inhibitor IkBcx which all have a role in inducing apoptosis (Barkett and Gilmore,
1999).
1.3.3.4 -  Apoptosis in response to growth factor withdrawal
Cells are constantly receiving survival signals from their environment in the form of 
cytokines and growth factors. These signals often stimulate expression of anti- 
apoptotic proteins. For example in haematopoietic cells interleukin-3 (IL-3) 
stimulates mcl-1 expression through binding of CREB to a CRE-2 binding site in the 
mcl-1 promoter, thus promoting survival of these cells (Wang et al., 1999). 
Withdrawal of IL-3 results in reduced expression of Mcl-1 and contributes to 
programmed cell death. Deprivation of IL-3 in pro-B and T cells also results in 
dephosphorylation of the forkhead transcription factor FKHRL1 and its translocation 
to the nucleus and transcription of the pro-apoptotic bim gene (Dijkers et al., 2000), 
an important gene required for T cell development (Bouillet et al., 2002; Davey et al., 
2002; Hildeman et al., 2002; Villunger et al., 2004). Transcriptional control of bim 
also plays a role in neuronal apoptosis. Sympathetic neurons are dependent on nerve 
growth factor (NGF) for survival. Removal of NGF results in a signalling cascade
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that results activation of c-Jun by increasing levels and phosphorylation of the protein 
(Ham et al., 1995; Ham et al., 2000). This increase in c-Jun is essential for NGF 
withdrawal mediated apoptosis and, along with FHKRL1, can activate transcription of 
the bim gene to induce apoptosis (Gilley et al., 2003).
The above examples highlight the importance of controlling transcription during 
apoptosis. Many of the control and checkpoint proteins that monitor stress within the 
cell signal apoptosis through proteins such as p53 and activate the intrinsic cell death 
pathway in this manner. This also emphasises the complexity of programmed cell 
death in mammals. There are many levels of control required both to initiate 
apoptosis and also to prevent inappropriate apoptosis.
1 .4 - The Bcl-2 family
One of the most important protein families that regulate apoptosis is the Bcl-2 family 
of proteins. The B cell lymphoma-2 {bcl-2) gene was first identified as a potential 
oncogene as a result of a chromosomal translocation involved in some B-cell 
lymphomas (Pegoraro et al., 1984). This t(14;18) translocation couples the 
immunoglobulin heavy chain locus on chromosome 14 to the bcl-2 locus on 
chromosome 18, resulting in overexpression of Bcl-2 (Chen-Levy et al., 1989). Initial 
studies on the function of Bcl-2 identified it as important for cell survival, as distinct 
from proliferation (Vaux et al., 1988). There have since been a large number of these 
proteins in this family identified (Fig. 1-4).
The Bcl-2 family of proteins are critical regulators of mitochondrial deregulation 
during apoptosis (Cory and Adams, 2002; Desagher and Martinou, 2000). Many of 
the physiological signals and signals arising from intracellular damage that result in 
apoptosis induce changes to the balance of pro- and anti-apoptotic Bcl-2 family
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Figure 1-4: Members of the mammalian Bcl-2 family. Bcl-2 proteins represent a 
large family of proteins that can regulate mitochondrial function during apoptosis.
The role of many of these proteins remains to be further clarified from a physiological 
point of view. Figure taken from Cory et al., 2003.
30
members at the mitochondria. Once the pro-apoptotic members take control 
cytochrome c is released from the mitochondria and apoptosis progresses.
1.4.1 -  Characteristics of Bcl-2 proteins
As mentioned already Bcl-2 proteins can be divided into two main groups, pro- and 
anti-apoptotic family members. The defining feature of all Bcl-2 proteins is that they 
contain at least one of four Bcl-2 homology domains (BH1-4) (Fig. 1-4). The number 
and type of BH domains that a Bcl-2 protein has determines whether it is an anti- 
apoptotic or pro-apoptotic protein (Cory and Adams, 2002). Many of the anti- 
apoptotic members of this family (e.g. Bcl-2 and Bcl-XL) contain all four BH 
domains. The pro-apoptotic members of the family can be further sub-divided into 
two groups. Those such as Bax and Bak that contain BH1, BH2 and BH3 domains 
(multi-domain pro-apoptotic Bcl-2 proteins), or those such as Bid, Bim, Bad, etc that 
contain only a BH3 domain (BH3-only proteins). The BH domains are critical for 
correct functioning of these proteins. The BH1, BH2 and BH3 domains of the multi­
domain Bcl-2 family members form a hydrophobic cleft that acts as an acceptor for 
BH3 domains (Sattler et al., 1997). Many of these proteins contain a C-terminal 
hydrophobic transmembrane domain that allows for insertion into intracellular 
membranes, in particular to the outer membrane of the mitochondria (Goping et al., 
1998). The C-terminal domain of Bax also affects its conformation and dimerisation 
properties (Suzuki et al., 2000). It is interesting to note that there is high homology 
between the pro- and anti-apoptotic multi-domain members of the Bcl-2 family. 
However, the BH3-only proteins share little homology with other Bcl-2 proteins apart 
from their BH3 domain (Kelekar and Thompson, 1998).
1.4.2 -  Bcl-2 proteins and the mitochondrion
The manner in which Bcl-2 family members co-ordinate mitochondrial deregulation 
and cytochrome c release is not very well understood. Overexpression of the anti- 
apoptotic Bcl-2 protein can completely block cytochrome c release in some cell types 
(Kluck et al., 1997; Yang et al., 1997) and cell-free systems suggest that Bcl-2 must 
be associated with the mitochondria to prevent cytochrome c release (Kluck et al.,
1997). Conversely, the overexpression of Bax in some cells is sufficient to initiate
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apoptosis in the absence of a death stimulus (Jurgensmeier et al., 1998; Rosse et al.,
1998). However the mechanism by which Bcl-2 family members control this is 
poorly understood. There are a number of possible models for how cytochrome c is 
released from mitochondria during apoptosis (Desagher and Martinou, 2000). Some 
of these models are based on swelling of the mitochondrial matrix during early 
apoptosis resulting in rupture and release of mitochondrial proteins into the 
cytoplasm. Evidence for such models is scant and as there appears to be a selective 
release of mitochondrial proteins into the cytoplasm this does not fit with these 
models.
A more attractive model is the release of cytochrome c from the mitochondria through 
pore formation in the outer membrane. The three dimensional structures of Bcl-2 
family members have been shown to be similar to the pore forming domains of 
diphtheria toxin and some bacterial colicins (Muchmore et al., 1996). Many of the 
Bcl-2 family proteins have also been shown to form pores in synthetic lipid vesicles 
and planar lipid bilayers (Schendel et al., 1999; Schendel et al., 1998). Although the 
helical domains of Bcl-2 family members are not large enough themselves to span the 
outer mitochondrial membrane, Bax and Bak oligomerise during apoptosis and hence 
could potentially form much larger channels through which mitochondrial proteins 
may be exported into the cytoplasm. Indeed this oligomerisation of these pro- 
apoptotic proteins appears to be required for cytochrome c release and is inhibited by 
anti-apoptotic proteins such Bcl-2 and Bcl-XL. While the Bax or Bak may themselves 
have channel forming capabilities there is also the possibility that they may interact 
with other channel proteins present in the outer mitochondrial membrane to release 
cytochrome c. Bax is known to interact with the voltage dependent anion channel 
(VDAC) and may co-ordinate cytochrome c release by controlling this channel in 
some manner (Cheng et al., 2003). Finally there is also the possibility that the Bcl-2 
family of proteins may form a lipidic pore or protein-lipid complex to allow 
mitochondrial proteins to diffuse into the cytosol. Much of the evidence for the 
ability of Bcl-2 proteins to form pores and channels comes from in vitro studies and 
so it is difficult to know if they could form such pores and channels in vivo (Desagher 
and Martinou, 2000).
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1.4.3 -  BH3-only proteins
The number of BH3-only members of the Bcl-2 family represents a large proportion 
of the members of this family. Apart from their ~9 amino acid BH3 domain, they 
share little homology with each other or with other members of the Bcl-2 family 
(Kelekar and Thompson, 1998). Many of these BH3-only proteins sequestered within 
the cytoplasm in an inactive form and are activated quickly in response to an 
apoptotic stimulus. Once activated they translocate to the mitochondria where they 
interact with other Bcl-2 proteins to promote apoptosis through Bax and Bak 
activation. These proteins are often the first Bcl-2 proteins activated in response to 
specific apoptotic signals. Studies of BH3 domain peptides have identified two 
mechanisms through which these BH3-only proteins appear to work (Chittenden, 
2002; Letai et al., 2002). These mechanisms are based on the observation that BH3 
domain peptides derived from different BH3-only proteins have different specificities 
for the multi-domain Bcl-2 family members. BH3 peptides derived from Bid or Bim 
BH3 domains can bind to both the pro-apoptotic Bax and Bak, and to anti-apoptotic 
Bcl-2 (Letai et al., 2002). On the other hand, BH3 peptides derived from Bad and Bik 
appear to only bind to anti-apoptotic Bcl-2 (Letai et al., 2002). Thus Bid or Bim may 
act as “activator” proteins, by directly activating Bax and Bak. In this setting anti- 
apoptotic proteins such as Bcl-2 and Bcl-XL act like decoy receptors sequestering the 
BH3-only protein and suppressing the signal. Bad and Bik may act as “enabler” 
proteins, interacting with anti-apoptotic Bcl-2, and allowing for easy activation of Bax 
and Bak (Chittenden, 2002; Letai et al., 2002). This is illustrated in Figure 1-5.
1.4.4 -  Regulation of BH3-only proteins
Some BH3-only proteins are regulated at a transcriptional level and are quickly 
upregulated in response to a death stimulus (Kumar and Cakouros, 2004). However 
most of the BH3-only proteins exist in inactive forms within the cell with activation 
of these proteins carried out through various post-translational modifications (Kelekar 
and Thompson, 1998).
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Figure 1-5: A model for the control of apoptosis by BH3-only proteins. The pro- 
apoptotic multi-domain proteins Bax and Bak normally exist in an inactive state at the 
mitochondria (1). Some BH3-only proteins may contain an activating (or effector) 
BH3 domain (e.g. Bid and Bim) that can directly activate and induce oligomerisation 
of Bax/Bak (2). In this case Bcl-2 anti-apoptotic proteins function to sequester the 
activating BH3-only protein and prevent activation of Bax/Bak (3). Other BH3-only 
proteins may contain a sensitizing (or enabler) BH3 domain that interacts with anti- 
apoptotic Bcl-2 proteins and sensitizing the cell to the effects of activating BH3-only 
proteins (4). Over-expression of anti-apoptotic Bcl-2 family members can lead to the 
sequestration of both types of BH3-only proteins, thus blocking apoptosis completely 
(5). Figure taken from Chittenden, 2002.
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The BH3-only proteins PUMA and Noxa have been shown to be direct transcriptional 
targets of the p53 protein (Nakano and Vousden, 2001; Oda et al., 2000). Gene 
targeting studies in mice have shown these proteins to be important mediators of the 
p53 apoptotic signalling cascade (Jeffers et al., 2003; Shibue et al., 2003). Another 
transcriptionally regulated BH3-only protein is the neuronal specific DP5/Hrk 
(Imaizumi et al., 1997; Inohara et al., 1997). Expression of the human homologue of 
this protein is primarily in lymphoid tissue while DP5, the rodent homologue, is 
highly specific to the nervous system and contributes to apoptosis in the absence of 
nerve growth factor.
As mentioned earlier most BH3 only proteins exist in an inactive form within the cell 
and are regulated through post-translational modification. The Bad protein is 
regulated through phosphorylation on multiple sites through signalling from various 
growth factors (Datta et al., 1997; del Peso et al., 1997). Phospho-Bad is sequestered 
by the 14-3-3 scaffold proteins and so does not come into contact with other Bcl-2 
family members at the mitochondria (Zha et al., 1996). Bim is also sequestered in the 
cell although through binding to the dynein light chain LC8, which is part of the 
motor dynein complex (Zha et al., 1996). In response to lack of survival signals or 
apoptotic signals Bad and Bim are released from their sequestration partners and 
translocate to the mitochondria where they induce cytochrome c release (Kelekar and 
Thompson, 1998). Bid, a molecule we are particularly interested in, also exists in an 
inactive form (p22) within the cell. Signalling via death receptors results in activation 
of caspase-8, which goes on to cleave Bid to generate an active C terminal fragment 
(pl5) known as truncated Bid (tBid) (Li et al., 1998b; Luo et al., 1998). This active 
form of the Bid protein then translocates to the mitochondria to induce mitochondrial 
deregulation (Korsmeyer et al., 2000; Wei et al., 2000).
Thus it is likely that these BH3-only proteins act as sensors within the cell to detect 
damage and signals that requires apoptosis and are critical initiators of mitochondrial 
deregulation and cytochrome c release.
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1 .5 .- B id
1.5.1 -  Identification of Bid
Bid (BH3 interacting domain death agonist) was initially cloned through an 
interactive cloning technique that identified proteins that interact with both Bcl-2 and 
Bax (Wang et al., 1996). A cDNA encoding the Bid protein was identified in a 
number of clones and a BLAST search identified a region sharing high homology 
with a BH3 domain. Apart from its BH3 domain Bid did not appear to share any 
homology with any other Bcl-2 family member. The protein was found to be 
expressed in adult mouse brain, spleen, liver and testis with a very high expression 
level in kidney. There appeared to be little expression of the protein in heart or 
skeletal muscle. There did not appear to be any hydrophobic transmembrane domain 
in the protein as is the case with other Bcl-2 family members and cell fractionation 
experiments confirmed the proteins mainly cytosolic localisation (Wang et al., 1996).
1.5.2 -  Regulation of Bid
Upon induction of apoptosis via the death receptor pathway, formation of a death 
induced signalling complex results in activation of initiator caspases such as caspase- 
8 (Peter and Krammer, 2003). Two studies examining how caspase-8 mediates 
mitochondrial damage identified Bid as a substrate for the enzyme (Li et al., 1998b; 
Luo et al., 1998). Cleavage of Bid by caspase-8 generates a truncated active C 
terminal fragment called tBid. This active tBid fragment translocates to the 
mitochondria where it induces cytochrome c release resulting in formation of the 
apoptosome and subsequent caspse-9 activation (Adrain and Martin, 2001; 
Korsmeyer et al., 2000). Thus tBid acts to amplify the signal from the death receptor. 
As well as being cleaved by caspase-8 Bid is also cleaved by granzyme B to generate 
gtBid, a 14-kDa fragment similar to that generated by caspase-8 cleavage (Barry et 
al., 2000; Heibein et al., 2000). Granzyme B is a serine protease that cleaves 
substrates after aspartate residues and is involved in death induced by cytotoxic T 
lymphocytes (CTL) (Lord et al., 2003). CTLs can kill target cells through the release 
of granules containing the pore forming protein perforin and granzymes.
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Figure 1-6: The BH3-only protein Bid. The schematic shows the caspase-8 and granzyme B cleavage sites at Asp60 and Asp75 
respectively for human Bid. Also highlighted is the BH3 domain. This is a 9 amino acid stretch from Leu90 to Asp98. Sites of major 
phosphorylation are in red, with likely minor sites of phosphorylation in blue.
Once inside the target cell granzyme B can cleave caspase-3, caspase-8 and Bid. It 
has been shown that Bid cleavage by granzyme B is required for granzyme B- 
mediated cytochrome c release (Heibein et al., 2000). Once cleaved by granzyme B 
gtBid translocates to the mitochondria where it mediates cytochrome c release in a 
manner similar to that for caspase cleaved tBid. This mechanism of apoptotic 
initiation by granzyme B represents an important pathway by which CTLs can induce 
apoptosis via the mitochondria without the initial activation of caspases (Lord et al., 
2003).
Bid is also regulated through phosphorylation (Desagher et al., 2001). It is 
phosphorylated by casein kinases I and II. There appears to be a number of 
phosphorylation sites in mouse Bid at T58, S61 and S64. Other phosphorylation sites 
may also exist close to this region. This phosphorylation of Bid is likely to be 
sequential and can prevent cleavage by caspase-8 (Desagher et al., 2001). Bid has 
also been reported to be regulated through p53 (Sax et al., 2002). In this situation bid 
acts as a p53-responsive ‘chemosensitivity gene’ that may enhance the cell death 
response to chemotherapy.
1.5.3 -  tBid and the mitochondrion
How tBid targets the mitochondria is unclear. A post-translational N-myristoylation 
of the p 15 tBid fragment appears to be a factor in the rapid targeting of the protein to 
the mitochondria (Zha et al., 2000). There is also evidence that tBid translocation to 
the mitochondria is mediated by the mitochondrial lipid cardiolipin (Lutter et al.,
2000). Cardiolipin is only found in the mitochondrial inner membrane and at inter­
membrane contact points (McMillin and Dowhan, 2002). The binding of tBid to the 
mitochondria appears to be dependent on the amount of cardiolipin in the membrane 
as tBid does not interact directly with cardiolipin in vitro (Lutter et al., 2000). Thus it 
is thought that cardiolipin may effect mitochondrial membrane structure allowing 
tBid to bind and integrate into the membrane (McMillin and Dowhan, 2002).
Once it has translocated to the mitochondria tBid carries out its apoptotic function. 
The BH3 domain of Bid is known to interact with other pro- and anti-apoptotic Bcl-2 
proteins (Letai et al., 2002). In particular Bid is thought to have an ‘activating’
38
function through its ability to induce homo-oligomerisation, and hence activation, of 
Bax and Bak (Desagher et al., 1999; Eskes et al., 2000; Korsmeyer et al., 2000; 
Roucou et al., 2002; Wei et al., 2000). As Bid can also interact with anti-apoptotic 
Bcl-2 family members it is thought that they function to sequester tBid and prevent it 
from activating the pro-apoptotic Bax and Bak (Cheng et al., 2001). Although tBid 
has been shown to be capable of forming ion channels in vitro it is not clear if this 
happens in vivo (Schendel et al., 1999). It has also been shown that Bax and tBid can 
decrease the stability of planar phospholipid bilayers and thus suggesting that perhaps 
these pro-apoptotic proteins may destabilise the outer mitochondrial membrane 
(Basanez et al., 1999; Kudla et al., 2000). In this way they could perhaps induce 
release of mitochondrial proteins through the through the formation of a lipidic pore 
or protein lipid complex (Desagher and Martinou, 2000). However, exactly how tBid 
activates and induces mitochondrial deregulation and cytochrome c release through 
Bax and Bak is unclear, although it is critical for its function. Bid mediated 
cytochrome c release results in formation of the apoptosome and activation of 
caspase-9 (Adrain and Martin, 2001). This is an important mechanism for 
amplification of apoptotic signals to ensure efficient and complete apoptosis.
1.5.4 -  The physiological significance of Bid
Gene targeting studies to generate Bid-deficient mice showed no apparent 
developmental abnormalities with mice born completely normal and at the normal 
mendelian frequency (Yin et al., 1999). As Bid is cleaved in response to DISC 
formation, mice were injected with the activating anti-Fas (Jo2) antibody to activate 
this pathway in mice. Most of the wild-type mice injected with the antibody died 
quickly from massive hepatic apoptosis and haemorrhaging of the liver. Of the Bid- 
deficient mice injected with the antibody most survived the insult and had no apparent 
damage to the liver (Yin et al., 1999). Culturing of mouse embryo fibroblasts (MEF) 
and thymocytes from targeted mice showed an impaired apoptotic response to (Bid 
mediated) Fas signalling and little effect from other stimuli (Yin et al., 1999). Thus 
while some cellular systems may depend on Bid to signal apoptosis in response to Fas 
signalling many cellular systems are not dependent on Bid for progression of 
apoptosis, but use the ability of Bid to amplify the apoptotic signal through 
cytochrome c release. Follow-up studies on the Bid deficient mice showed an altered
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myeloid homeostasis with an elevated absolute neutrophil count accompanied by mild 
hepatosplenomegaly (Zinkel et al., 2003). While haematopoietic cell populations in 
Bid-/- mice of under 12 months of age appeared normal the bone marrow of young (6 
to 12 weeks of age) mice demonstrated increased colony-forming units of 
macrophage and mixed colonies in methylcellulose (Zinkel et al., 2003). As the Bid- 
/- mice age they spontaneously develop a myeloproliferative disorder, which 
progresses from myeloid hyperplasia to a clonal malignancy resembling chronic 
myelomonocytic leukemia (CMML). This shows that Bid plays an important role in a 
number of tissues. It is of critical importance for Fas induced apoptosis in 
hepatocytes and an important amplifier of this signal in other cell types. In addition it 
is critical in the regulation of normal myeloid homeostasis and for suppression of 
leukaemias of this lineage.
1.6 -  Project aims
The initial aim of this project were to identify novel interactions with the pro- 
apoptotic tBid protein in order to further elucidate and clarify how the protein carries 
out its function. We decided to carry out a yeast two-hybrid assay to identify such 
novel interactions.
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2 - Materials and Methods
2.1 -  Materials
2.1.1 -  Reagents
All media and cell culture reagents were obtained from Gibco. All other reagents 
were purchased from Sigma unless otherwise stated. All primers for PCR reactions 
are given in Appendix I.
2.1.2 -  E.coli strains used
BL21(DE3) F  ompT gal [dcm] [Ion] hsdSB (rBmB ; an E. coli B strain) with DE3, a 
X prophage carrying the T7 RNA polymerase gene
DH10B F  mcrA A(mrr-hsdRMS-mcrBC) (j)80/«cZAM15 AlacLlA deoK recAl 
endAl araA\39 bdara, leu)1691 galU galK X rpsL (StrR)
2.1.3 -  Yeast strain used
Y190 {MATa, ura3-52, his3-A200, ade2-101, lys2-801, trpl-901, leu2-3, 112, gal4A, 
gal80A, URA3::GALuas-GAL1 TATA-lacZ, cyhr2, LYS2::GAL1 uas-HIS3tata-HIS3)
2 .1 .4 - Cell lines
Jurkat human T-cell line (ECACC)
LinXE virus packaging cell line
FDCP-1 murine myeloid progenitor cell lines (ATCC)
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2.1.5 -  Antibodies
Name Source Isotype Working
Concentration
Origin
Bax, NT Rabbit IgG WB -  1:1000 Upstate
Bid (M-20) Rabbit IgG WB -  1:1000 Santa Cruz
Bid Goat IgG WB -  1:1000 RnD Systems
Gal-4 (Gal4-8) Mouse IgGiK WB -  1:1000 Zymed
HA (3F10) Rat IgGt WB -  1:1500 Roche
Mcl-1 (sc-19) Rabbit IgG WB -  1:500 Santa Cruz
PARP Mouse IgG! WB -  1:1000 BD Pharmingen
Tubulin (YL1/2) Rat IgG2a WB -  1:5000 Serotec
For Western blotting (WB) all antibodies were diluted in TBS-T containing 5% non­
fat milk (Marvel).
2.1.6 -  Media for culture of E. coli bacteria
LB broth 1.0% (w/v) tryptone, 0.5% (w/v) yeast extract,
1.0% (w/v) NaCl (pH 7.0)
LB agar LB broth medium plus 15 g/1 agar
Psi broth 2% (w/v) tryptone, 0.5% (w/v) yeast extract,
0.4% (w/v) M gS04, 10 mM KC1, adjust pH to 
7.6 with 1 M KOH
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2.1.7 -  Media for culture of Y190 yeast
YEP 10 g/1 yeast extract (Difco), 20 g/1 Bacto 
Peptone (Difco)
YPD YEP with 4% (w/v) glucose
-WHAUL Dropout Broth 0.12 mM L-arginine, 0.8 mM L-aspartic acid, 
0.7 mM L-glutamic acid, 0.14 mM L- 
lysine»HCl, 0.14 mM L-methionine, 0.3 mM L- 
phenylalanine, 3.65 mM L-serine, 1.7 mM L- 
threonine, 0.17 mM L-tyrosine, and 1.3 mM L- 
valine to pH 5.4 with NaOH
-WHAUL Agar -WHAUL broth with 23.2 g/1 agar (Difco)
40 % Glucose 400 g/1 D-glucose filter-sterilised
10 x Yeast Nitrogen Base (YNB) 67 g/1 yeast nitrogen base (Difco) filter sterilised
-UW media -WHAUL broth/agar with 0.23 mM L-histidine, 
0.8 mM L-leucine, 1 mM adenine, 2% (w/v) 
glucose and 1 x YNB
-WL media -WHAUL broth/agar with 0.23 mM L-histidine, 
0.32 mM uracil, 1 mM adenine, 2% (w/v) 
glucose and 1 x YNB
-HWL + 3AT media -WHAUL broth/agar with 0.32 mM uracil, 1 
mM adenine, 17.5 mM 3-amino triazole (3-AT), 
2% (w/v) glucose and 1 x YNB
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2.1.8 -  Buffers and solutions
DNA loading buffer (6 x)
Fixing solution
10 x Lithium Acetate
Lysis Buffer
PIPES Buffer
Protein running Buffer
Protein Transfer Buffer
Sample Buffer (2 x)
TAE
0.25% (w/v) bromophenol blue, 0.25% (w/v) 
xylene cyanol FF and 30% (w/v) glycerol in 
water
50% (v/v) methanol, 10% (v/v) glacial acetic 
acid
1 M lithium acetate to pH 7.5 with dilute acetic 
acid
50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% 
SDS, 0.5% sodium deoxycholate, 1% Nonidet 
P-40. To this was added 1 tablet of complete 
inhibitors (Roche) per 10 ml buffer just prior to 
use
50 mM PIPES/KOH (pH 6.5), 2 mM EDTA, 
0.1% (w/v) CHAPS and 1 tablet of complete 
inhibitors (Roche) per 10 ml of buffer
25 mM Tris-HCl (pH 8.3), 192 mM glycine, 
0.1% (w/v) SDS
12 mM Tris-HCl (pH 8.3), 96 mM glycine, 20% 
(v/v) methanol
100 mM Tris-HCl pH 6.8, 4% (w/v) SDS, 1% 
(w/v) bromophenol blue, 20% (w/v) glycerol, 
200 mM DTT
40 mM Tris acetate, 1 mM EDTA
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TBS 20 mM Tris-HCl pH 7.5, 150 mM NaCl
TBS-T TBS with 0.1% (v/v) Tween
TE 10 mM Tris-HCl, 1 mM EDTA to pH 7.5
10 x TE 100 mM Tris-HCl, 10 mM EDTA to pH 7.5
TFBI 100 mM RbCl2, 50 mM MnCl2, 30 mM KOAc, 
10 mM CaCl2, 15% (v/v) glycerol, pH to 5.8 
with 0.2 M AcOH
TFBII 10 mM MOPS pH 7.0 (adjust with NaOH), 10 
mM RbCl2, 75 mM CaCl2, 15% (v/v) glycerol
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2.2 -  Methods
2.2.1 -  Molecular biology
2.2.1.1 -  Polymerase chain reaction (PCR)
PCR was used to amplify up many of the cDNAs before cloning them into the 
appropriate vectors. Unless otherwise stated, the reaction mixtures used contained lx 
Pfu polymerase buffer (containing 1.5 mM MgCl2) (Promega), 200 pM dNTPs 
(Promega), 100 ng of appropriate primers and 5 units of Pfu polymerase (Promega). 
Water was added to bring the final volume to 50 pi. Conditions used for PCR were: 1 
cycle of 94°C for 1 min 30 sec; 30 cycles of 94°C 1 min, 57 - 62°C (depending on the 
cDNA being amplified) for 1 min, 72°C for 2 min; 1 cycle of 72°C for 5 min. PCR 
products were analysed by gel electrophoresis using a 1% (w/v) TAE-agarose gel 
containing 0.5 pg/ml ethidium bromide and viewed using a UV transilluminator.
2.2.1.2 -  RT-PCR analysis of Mcl-1 constructs
RNA was prepared from 3xl06 cells for each of non-transduced FDCP-1 cells, or 
FDCP-1 cells transduced with pMSCV- HA-Mcl-l-IRES-huCD2, pMSCV-HA-A127- 
Mcl-1 -IRES-huCD2, or pMSCV-HA-A157-Mcl-l-IRES-huCD2 using a Qiagen 
RNeasy mini kit, as per the manufacturers instructions. Reverse transcription was 
carried out using an oligo-dT primer and Superscript II reverse transcriptase 
(Invitrogen) according to the manufacturers instructions. The resulting cDNA was 
used for PCR to amplify |3-Actin using the primer pair Actin F3 and Actin B3; while a 
C-terminal region from overexpressed Mcl-1 constructs was amplified using the 
primer pair Mcl-1-3F and pcDNA3.1-R.
2.2.1.3 -  Constructs for yeast two-hybrid assay
A mouse tbid cDNA was amplified by PCR from a murine pcDNA3-Bid template 
(gift from Dr. S. Korsmeyer). The primers used for PCR were 5'mtBid-EcoR I and
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3'mBid-BamU I. The PCR product was cleaned up using a Qiagen PCR clean-up kit 
as per the manufacturers instructions. This was then digested using EcoR I and BamU 
I and again cleaned up using a Qiagen PCR clean-up kit. The bait vector pGBKT7 
(Clontech) was prepared by digesting it with EcoR I and BamU I, and subsequently 
treating it with calf intestinal phosphatase (CIP) (Roche) according to manufacturers 
instructions. The vector DNA was cleaned up using a Qiagen PCR clean-up kit. The 
tbid insert was ligated into the pGBKT7 vector in a molar ratio of 1:5 (vector:insert). 
Ligation reactions were carried out in 10 pi volumes using T4 DNA ligase (Promega) 
according to the manufactures instructions.
Mouse baxa lacking the C terminal hydrophobic domain (bajcA21) was cloned by 
PCR from a pcDNA3-Baxa template. The primers used for PCR were 5'BaxA21- 
EcoR I and 3'BaxA21-C/a I. The PCR product was cleaned up using a Qiagen PCR 
clean-up kit as per the manufacturers instructions. This was then digested using EcoR 
I and Cla I and again cleaned up using a Qiagen PCR clean-up kit. The prey vector 
pGADT7 (Clontech) was prepared by digesting it with EcoR I and Cla I, and 
subsequently treating it with CIP according to manufacturers instructions. The vector 
DNA was cleaned up using a Qiagen PCR clean-up kit. Ligations were carried out as 
outlined above.
The mouse cDNA library used for the yeast two-hybrid assay was a kind gift from Dr. 
Gabriel Gil-Gomez. Briefly, mouse (FVB) thymocytes were irradiated with 5 Gy and 
cultured for 5 hours. The RNA was then purified from these cells. A cDNA library 
was generated by random priming and was directionally cloned in the EcoR I -  Xho I 
sites of the prey vector pAD-Gal4-2.1 (Stratagene). The library was amplified once 
and found to have over 90% recombinants with an average insert size of 1.5 kb.
2.2.1.4 -  Generation of a pcDNA3.1-HA vector
The plasmid vector pcDNA3.1-HA was used for all in vitro translation assays and 
transient transfection experiments. This was generated by first annealing the two 
oligos 5 '-
T CG AG ACC AT GGCTT AT CCTT AT G ACGT GCCT G ACT AT GCC AGCCT GG-3'
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and 5'-
AATT CCAGGCTGGC AT AGT CAGGCACGT CAT A AGG AT AAGCCAT GGT C-3 
This generates the following double stranded oligo -
5"TCGAGACCATGGCTTATCCTTATGACGTGCCTGACTATGCCAGCCTGG 3"
11111111111111111111111111II1111II1111111111
3 ' CTGGTACCGAATAGGAATACTGCACGGACTGATACGGTCGGACCTTAA 5 '
with Xho I and ZscoRI overhangs, which was then ligated into the Xho I and EcoRl 
sites of pcDNA3.1/myc-HIS®(-)B (Invitrogen).
2.2.1.5 -  Cloning of human cDNAs into pcDNA3.1 vectors
A pUC18-bcl2 (Clonexpress) construct was used to clone the human bcl-2 cDNA.
This construct was digested with EcoR I and Hind III to release the bcl-2 cDNA. This 
was purified by running the sample out on a 1% agarose gel and extracting the cDNA 
from the gel using a Qiagen gel-extraction kit, according to the manufacturers 
instructions. The cDNA was ligated into pcDNA3.1/myc-HIS®(-)B that had been pre­
digested EcoR I and Hind III.
All of the remaining human cDNA constructs were cloned into the EcoR I -  BamH I 
sites of pcDNA3.1-HA such that they were in the same open reading frame as the HA 
epitope tag.
Human bid and tbid cDNA was generated by PCR from oligo-dT primed cDNA 
obtained from Jurkat T cells (gift from Dr. J. Zhuang). The primers used to amplify 
bid were 5'hBid-EcoR I and 3'hBid-ZtamH I. For amplification of tbid the primers 
5'htBid-ZscoR I and 3'hBid-J5araH I were used.
The human ndpk-b cDNA was amplified by PCR from Jurkat cDNA as above. The 
primers used were 5"hNM23B-£’coR I and 3'hNM23B-ZtamH I.
The human eid-1 cDNA was amplified by PCR from a pcDNA3-T7-EID-l template 
(a gift from Dr. W.G. Kaelin Jr.). The primers used were 5'hEID-l-EcoR I and 
3'hEID-l-ZtamH I.
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Human cdc37 cDNA was amplified from a pcDNA3-CDC37 template (a gift from Dr. 
J.W. Harper) using the primers 5'hCDC37-£coR I and 3"CDC37-ZtaraH I.
Both mouse and human mcl-1 were amplified by PCR from pcDNA3-EAT (gift from 
Dr. J. Hata) and pBluescript-Mcl-1 (gift from Dr. S. Edwards) respectively. The 
primers used for PCR were 5 "Mcl-1-EcoR I and 3"Mcl-l-ZtamH I. The caspase 
cleavage fragments of Mcl-1 were also cloned by PCR into the EcoRI and BamYLl 
sites of pcDNA3.1-HA. 127-Mcl-l was amplified using the primer pair 5'M cl-l- 
EcoR I and 3"Mcl-127-R, A127-Mcl-1 was amplified with 5"Mcl-A127-F and 3'Mcl- 
1-BamHl, and A157-Mcl-1 was amplified using the primers 5"Mcl-A157-F and 3'Mcl- 
1-BamH I.
2.2.1.6 -  Site directed mutagenesis
Mutant mcl-1 constructs D127A-Mcl-1 and D157A-Mcl-1 were generated by site 
directed mutagenesis using the GeneTailor™ Site-Directed Mutagenesis System from 
Invitrogen, according to the manufacturers instructions. The primer pairs used for 
D127A-Mcl-1 were D127A-F and D127A-R. The primer pairs used for D157A- 
MCL-1 were D157A-F and D157A-R. A double mutant molecule (DblMut-Mcl-1) 
was generated using the D127A-Mcl-1 as a template and mutating Asp157 to Ala using 
the primers D157A-F and D157A-R as before.
2.2.1.7 -  Constructs for production of GST-fusion proteins
The vector used to generate GST-fusion proteins was pGEX-6P-2 (Amersham). Both 
bid and tbid cDNAs were cloned by PCR into the EcoR I and Xho I sites of the 
multiple cloning site, while mcl-1 and eid-1 cDNAs were cloned into the BamW I and 
EcoR I sites in the multiple cloning site. All cDNAs were cloned so as to be in the 
same open reading frame as the upstream GST protein.
49
Using pcDNA3.1-HA-Bid as a template, the primers 5'GST-Bid-EcoR I and 3'GST- 
Bid-Xho I were used to PCR the bid cDNA for cloning. For tbid the primers used 
were 5'GST-tBid-EcoR I and 3'GST-Bid-X/zo I.
Primers used to amplify mcl-1 from pcDNA3.1-HA-Mcl-l were 5'GST-Mcl-l-ZtaraH 
I and 3'GST-Mcl-l-EcoR I. For eid-1 primers used were 5'GST-EID-l- BamH I and 
3'GST-EID-l- EcoR I, and again the template used was pcDAN3.1-HA-EID-l.
2.2.1.8 -  Constructs used for retroviral infection
For retroviral infection of FDCP-1 cells a modified pMSCVneo vector, pMSCV- 
IRES-huCD2 tailless was used (a gift from Dr. Owen Williams). This vector was 
generated by digesting the parental pMSCVneo with EcoR I and BamH I and 
inserting a linker PCR fragment containing an IRES followed by a human CD2 gene 
lacking most of its cytoplasmic tail. This allows for detection of infected cells by 
expression of human CD2 on the surface of infected cells. HA-Mcl-1, HA-127-Mcl- 
1, HA-A127-Mcl-1, HA-A157-Mcl-1 and HA-DblMut-Mcl-1 were all cloned by 
digesting the appropriate pcDNA3.1-HA constructs with Xbal, blunt ending these 
inserts, and then cloning them into a blunt ended EcoRI site of pMSCV-IRES-huCD2.
2.2.1.9 -  DNA Sequencing
All cloned cDNAs were sequenced after cloning to ensure no detrimental mutations 
had been introduced to the cDNA during cloning. To 6 pi Ready Mix reaction mix 
(Perkin Elmer) was added 1 pi (3.2 pmol/pl) of an appropriate sequencing primer and 
300 -  500 ng plasmid DNA. The reaction volume was adjusted to 15 pi with sterile 
water. Conditions used for PCR were: 25 cycles of 96°C for 30 sec, 50°C for 30 sec, 
60°C for 4 min. Reactions were cleaned up by precipitating with 3 pi of 3 M sodium 
acetate pH 5.5 in 50 pi of 100% ethanol for at least 1 hour at -20°C. This was 
followed by two washes with 70% ethanol. Pellets were then dried and run on an ABI 
PRISM 377 DNA Sequencer (Perkin Elmer). Sequencing was analysed using 
EditView™ Automated DNA Sequence Viewer version 1.0.1 (Perkin Elmer) and 
MacVector version 6.5 (Oxford Molecular Ltd.).
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2.2.1.10 -  Preparation of competent cells
A single colony of E. coli was picked into 5 ml of psi broth and grown overnight at 
37°C. This was then added to 100 ml of psi broth prewarmed to 37°C and incubated 
at 37°C with vigorous shaking until OD550 = 0.48. The culture was then transferred to 
pre-chilled Falcon tubes and allowed to cool on ice for 10 min. Cells were pelleted by 
centrifugation at 4°C and 3,000 x g for 10 min. Pellets were very gently resuspended 
in 30 ml ice-cold TFBI and kept on ice for 20 min. Cells were again pelleted as 
before and then gently resuspended in 4 ml ice-cold TFBII. Competent bacteria were 
dispensed into 100 pi aliquots in 1.5 ml microfuge tubes, snap-frozen in an 
ethanol/dry-ice bath and stored at -80°C.
2.2.1.11 -  Transformation of competent bacteria
50 ng of DNA or 2.5 pi of ligation mix were placed in a pre-chilled 14 ml Falcon 
tube. This was placed on ice and 50 pi of competent cells added and incubated on ice 
for 30 min. Cells were incubated at 42°C for 90 sec and immediately placed on ice 
for 2 min. 400 pi of LB broth was added to the transformation mix and this was then 
incubated at 37°C for 45 min. A 200 pi aliquot of this culture was then plated out on 
LB agar plates supplemented with appropriate antibiotic.
2.2.1.12 -  Small scale DNA preparation
This was carried out using a Qiagen mini-prep kit available from Qiagen, following 
instructions as supplied by the manufacturer.
2.2.1.13 -  Large scale DNA preparation
This was carried out using a Qiagen HiSpeed Maxi kit available from Qiagen, 
following instructions as supplied by the manufacturer.
2.2.2 -  Protein
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2.2.2.1 - SDS-PAGE analysis
Resolving gels contained 1 0 -  12% acrylamide (Protogel, National Diagnostics) in 
375 mM Tris-HCl pH 8.8 and 0.1% (w/v) SDS. Stacking gels were poured on top of 
resolving gels and contained 4% (w/v) acrylamide in 125 mM Tris-HCl pH 6.8. Gels 
were polymerised using 0.1% (w/v) ammonuim persulphate and 0.1% (v/v) TEMED. 
Cells were harvested at 107 cells/ml of lysis buffer and an equal volume of 2x sample 
buffer added. Samples were boiled at 100°C for 5 min and subsequently kept on ice. 
For each sample 20 pi lysate, equivalent to 105 cells, was loaded per lane. Gels were 
run at a constant voltage of 85 V until just before the dye ran off the gel.
2.2.2.2 -  Coomassie staining of SDS-PAGE gels
Coomassie brilliant blue (250 mg/1) was dissolved in an aqueous solution containing 
40% (v/v) methanol and 10% (v/v) acetic acid. SDS-PAGE gels were stained for 2 -  
4 hours before destaining with an aqueous solution containing 10% (v/v) methanol 
and 5% acetic acid (v/v). Gels were then vacuum dried onto 3MM paper (Whatman).
2.2.2.3 -  Protein transfer to nitrocellulose membrane
SDS-PAGE gels were incubated in transfer buffer for 5 min and proteins transferred 
to Hybond-C nitrocellulose membrane (Amersham) using a BioRad Mini Trans-Blot 
Electrophoretic Transfer system according to the manufacturers instructions. Gels 
were transferred for 45 min -  1 hour at a constant voltage of 85 V.
2.2.2.4 -  Western blotting
Nitrocellulose membranes containing transferred protein were blocked for 2 hours at 
room temperature in TBS-T containing 5% (w/v) non-fat milk powder (Marvel).
Blots were incubated with the appropriate primary antibody, diluted in 5% (w/v) non­
fat milk powder in TBS-T, for 2 hours at room temperature or overnight at 4°C. 
Membranes were then washed 3 times (10 min/wash) in TBS-T and then incubated 
with horse-radish peroxidase (HRP) conjugated secondary antibody diluted 1/1000 in 
5% (w/v) non-fat milk powder in TBS-T. Membranes were again washed 3 times (10 
min/wash) in TBS-T and then incubated for 1 min with Enhanced
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ChemiLuminescence (ECL) reagent (Amersham). Blots were wrapped in saranwrap 
and exposed to autoradiography film for between 1 second and 2 hours to detect 
protein bands.
2.2.2.5 -  In vitro translation and radioactive labelling of proteins
In vitro translated proteins were generated using the TNT® T7 Quick Coupled 
Transcription/Translation System from Promega, according to the manufacturers 
instructions. The pcDNA3.1-HA constructs were used as a template as the vector 
contains a T7 transcriptional start site up-stream of the initiation codon. Proteins 
were radioactively labeled by translating in the presence of [35S]-methionine 
(Amersham).
2.2.2.6 -  GST-fusion protein production
BL21 E. coli cells containing the appropriate plasmid were grown overnight in LB 
broth supplemented with 100 pg/ml ampicillin. Cultures were then diluted 1/100 and 
grown to log phase (O D ^  = 0.5). Expression of the GST-fusion protein was then 
induced by the addition of isopropyl p-D-thiogalactoside (IPTG) (Insight 
Biotechnology). Induced cultures were grown for 2 -  3 hours at 32°C. Bacterial 
pellets were then pelleted by centrifugation at 2000 x g for 10 min. Pellets were 
washed once in ice-cold PBS. Washed pellets were then resuspended in PBS and 
cells lysed by sonication. A solution of 10% (v/v) Triton X-100 was added to a final 
concentration of 1% and then mixed. The lysate was centrifuged at 10,000 x g for 5 
min to remove insoluble material and intact cells. The supernatant was added to 1 ml 
of a 50% slurry of glutathione-sepharose beads (Amersham) and mixed gently at 
room temperature for 5 min. Beads were washed by adding 50 ml of ice-cold PBS, 
mixing and centrifuging for 1 min at 500 x g.  This wash was repeated twice and the 
beads resuspended in 1 ml of PBS, transferred to a 1.5-ml microcentrifuge tube and 
stored at 4°C. Protein production was analysed by SDS-PAGE gel electrophoresis 
(Section 2.2.2.1) followed by Coomassie staining (Section 2.2.2.2).
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2.2.2.7 -  GST fusion protein-affinity purification assay
In vitro translated prey proteins radiolabelled with [35S]-methionine were prepared as 
outlined in Section 2.1.2.5. 1 pi of the recombinant protein was added to 200 pi of 
bead binding buffer and spun in a microfuge at maximum speed for 15 min at 4°C. 
The supernatant was transferred to a clean tube and incubated on ice. 200 pi bead 
binding buffer was added to 20 pi of GST or GST-fusion protein bound to 
glutathionine sepharose beads. The sepharose beads mix was added to the 
recombinant prey protein and incubated for 2 hours with rotation at 4°C. Beads were 
pelleted by centrifugation at 200 x g for 1 min and the supernatant discarded. Pellets 
were washed 5 times with ice-cold bead binding buffer. Finally beads were 
resuspended in 25 pi of lx  sample buffer and analysed by SDS-PAGE gel 
electrophoresis (Section 2.2.2.1). Gels were fixed and stained by Coomassie staining 
(Section 2.2.2.2) to ensure equal loading of GST and GST-fusion. Gels were then 
vacuum dried onto 3MM paper and exposed to a phosphorimager screen.
2.2.3 -  Yeast two-hybrid protocols
2.2.3.1 -  Small scale transformation of Y190
Y 190 yeast was streaked out on a YPD plate containing extra adenine. A single clone 
was picked from this and cultured in 5 ml YPD overnight at 30°C. 20 ml of fresh 
media was then inoculated with 0.5 ml of the overnight culture and again incubated 
overnight. The overnight culture was then diluted in fresh media such that the O D ^  
of the culture was 0.15. Culture was grown for another 4 hours until the O D ^  was 
0.6. The cells were then pelleted by centrifugation at 3,000 x g for 10 min and the 
media removed. To generate competent yeast pellets were washed once in ice-cold 
sterile water and then washed twice in sterile 1 x lithium acetate/TE. After the final 
wash the pellet was resuspended in 0.5 ml of 1 x lithium acetate/TE and kept on ice at 
all times. 100 pg of denatured salmon sperm DNA (Clontech) was added to 0.5 pg of 
plasmid DNA, to a volume of 50 pi, and mixed. To this DNA mix was added 100 pi 
of competent yeast cells. Following this, 600 pi of lithium acetate/TE/PEG was 
added and the mixture briefly vortexed. This was then incubated at 30°C for 30
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minutes followed by the addition of 70 pi of DMSO. The cells were then mixed 
gently by inversion and given a heat shock at 42°C for 15 minutes. Cells were cooled 
on ice for 2 minutes and then the spun briefly (10 seconds at maximum speed in 
microfuge) to pellet cells. The pellets were resuspended in 100 pJ of TE and plated 
onto appropriate minimal media plates. These were incubated at 30°C for 2 -  3 days 
until colonies appeared.
2.2.3.2 -  Library transformation of Yeast
A single colony of Y 190-tBid was picked from a fresh streak-plate. This was used to 
inoculate 10 ml of minimal broth lacking tryptophan and the culture grown overnight 
at 30°C. This culture was used to inoculate 50 ml of fresh minimal media lacking 
tryptophan and again incubated overnight at 30°C. This was then diluted into ~450 
ml of fresh and complete media such that the O D ^  was 0.25. The culture was grown 
for a further 4 hours until the O D ^  reached 1.0. The culture was then centrifuged at 
3000 x g for 10 min to pellet cells and the media removed. The pellets were washed 
twice with 10 volumes of ice-cold sterile water followed by two washes with 10 
volumes of ice-cold lithium acetate/TE. Competent cells were resuspended in a total 
volume of 4 ml and kept on ice at all times. The DNA mix was prepared by adding 4 
mg of denatured salmon sperm DNA (Clontech) to 100 pg of library DNA. To this 
was added 75 pi of 10 x Lithium Acetate and 10 x TE and the total volume made up 
to 750 pi with sterile water. The DNA mix was then added to the competent cells and 
mixed gently by inversion. Next, 24 ml of lithium acetate/TE/PEG was added and 
mixed gently. The transformation mix was incubated at 30°C for 30 minutes with 
slow shaking at 60 rpm. Cells were then heat shocked at 42°C for 20 minutes and 
cooled on ice for a further 2 minutes. The cells were then pelleted by centrifugation 
at 3000 x g for 10 minutes the supernatant removed and the pellet resuspended to a 
total volume of 10 ml with sterile water. Transformation efficiency was measured by 
taking 1 pi and 5 pi aliquots and plating onto minimal media plates lacking 
tryptophan and leucine. The rest of the library transformation was plated out onto 
large Nunc plates containing minimal media lacking histidine, tryptophan and leucine 
and containing 17 mM 3-AT. Plates were wrapped loosely to prevent drying and 
incubated for up to 15 days at 30°C.
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2.2.3.3 -  Titration with 3-amino-1,2,4-triazole (3-AT)
As the HIS3 reporter gene is slightly leaky in Y 190, incorporation of 3-AT, a specific 
inhibitor of the gene product, is included in the media to inhibit the leaky HIS3. Thus 
only when the reporter is fully switched on can the yeast grow and this helps reduce 
the number of false positives from the yeast two-hybrid screen. A titration of 3-AT is 
required to identify the best concentration of the compound to use. Appropriate 
dropout media was prepared and petri dishes containing 0 mM, 5 mM, 10 mM, 15 
mM, 20 mM, 25 mM, 30 mM, 40 mM, 50 mM or 60 mM 3-AT were poured. A 
Y 190-tBid colony was picked from a fresh streak and grown overnight in 5 ml 
dropout broth lacking both tryptophan and uracil. This was diluted 1/40 and 200 pJ of 
this culture was spread on each plate. Plates were incubated for 7 days at 30°C. After 
this colony growth was observed and colonies were counted to determine the 
optimum concentration of 3-AT to use. Filter lift assays (Section 2.1.3.3) were also 
carried out to check for autoactivation of the bait construct.
2.2.3.4 -  Filter lift assay
3MM filter paper (Whatman) was cut to size and orientated with respect to the plate 
to be lifted. The filter paper was placed on the surface of the plate, pressed down 
firmly and removed swiftly. This was then used to replica plate colonies onto a 
similar plate with fresh media. Filters were frozen in liquid nitrogen for 5 seconds, 
removed and allowed to thaw. Following a second freeze thaw step filters were 
incubated in Z-buffer (20 ml for large plates, and 2 ml for petri dishes) for up to 8 
hours at room temperature to allow the blue colour to develop. These filters were 
used to identify corresponding positive colonies on the replica plates.
2.2.3.5 -  PCR from whole Yeast
Prey inserts from the yeast two-hybrid assay were initially amplified directly from 
yeast by PCR. A stock mix was prepared containing lx  Sigma KEDTaq buffer, 200 
[iM dNTPs, 100 ng of both GADF1 (5'-ATGAAGATACCCCACCAAACCC-30 and 
GADR1 (5 '-TGCACAGTTGAAGTGAACTTGC-3') primers, 0.05 Ul\i\ of
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JumpStart REDTaq DNA polymerase in sterile water. Aliquots of 50 pi were placed 
in 0.2 ml PCR tubes. Using a p200 pipette tip a tiny amount of a yeast colony was 
picked and smeared to the inside of the PCR tube. Tubes were vortexed to mix and 
then spun briefly. Conditions used for PCR were: 1 cycle of 94°C for 15 min to break 
open the yeast; 30 cycles of 94°C 1 min, 56°C for 1 min, 72°C for 5 min; 1 cycle of 
72°C for 5 min. PCR products were analyzed on a 1.0% agarose gel and were 
cleaned up using a Qiagen PCR clean-up kit according to the manufacturer’s 
instructions and eluted in 30 pi of elution buffer.
2.2.3.6 -  Sequencing of PCR products
Sequencing PCR products from yeast was carried out in as described in Section 
2.1.1.9 using 8 pi of cleaned-up PCR product as a template. Reactions were cleaned 
up and analysed as above.
2.2.3.7 - Extraction of library plasmid from yeast
Positive clones identified in the yeast two-hybrid assay were picked and grown 
overnight at 30°C in 5 ml of dropout broth lacking tryptophan and leucine. An 
aliquot of 1.5 ml was taken from this culture and centrifuged at 13,000 x g for 5 min 
and the supernatant removed. The pellet was then resuspended in 200 pi of Zymolase 
buffer and incubated at 37°C for 2 hours. Lysis of the cells was then carried out using 
a Qiagen miniprep kit, according to the manufacturers instructions, and eluted in 30 
pi of elution buffer.
2.2.3.8 -  Generation of yeast protein extracts
A single colony of yeast was picked into 5 ml of appropriate drop-out media and 
grown at 30°C overnight. Cultures were diluted 1/100 in 100 ml of fresh media until 
they had reached a density of O D ^  0.4 -  0.6. Cells were pelleted by centrifugation at
3,000 x g for 10 min. Pellets were then washed twice with ice-cold sterile water to 
remove all media. All samples were kept on ice from this point on. The pellet was 
resuspended in one volume of 2x sample buffer and the made up to five volumes with 
3 volumes of lx  sample buffer. To this was added 100 pi of acid washed glass beads
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and the samples then vortexed for 5 min in the cold-room. Samples were then boiled 
at 100°C for 10 min, cooled on ice for 2 min, and then spun at top speed in a 
microcentrifuge for 10 min. The supernatant was removed to a fresh tube and 15 pi 
analysed by SDS-PAGE gel electrophoresis (Section 2.1.2.1) and western blotting 
(Section 2.1.2.4). The remainder was stored at -70°C.
2.2.4 -  Cell biology
2.2.4.1 -  Cell lines and culture
Jurkat T-cells were grown in RPMI 1640 and supplemented with 10% FCS, 2 mM 
glutamine, 0.5 U/ml penicillin and 0.5 pg/ml streptomycin. FDCP-1 cells (ATCC) 
were grown in RPMI 1640 and supplemented with 10% FCS, 2 mM glutamine, 0.5 
U/ml penicillin, 0.5 pg/ml streptomycin, 1 mM HEPES, 0.0004% (3-mercaptoethanol 
and 10% IL-3 conditioned media from WEHI-3B cells. The 293 derived LinXE virus 
packaging cell line was maintained in DMEM supplemented with 10 % FCS, 2 mM 
glutamine, 0.5 U/ml penicillin, 0.5 pg/ml streptomycin and 75 pg/ml hygromycin 
(Calbiochem). All cell lines were maintained at 37°C with 5% C 0 2 unless otherwise 
stated.
2.2.4.2 -  Induction of apoptosis in Jurkat T cells
For apoptosis assays, cells were seeded at 1 - 2x l06 cells/ml and treated with 300 
ng/ml CH11 anti-Fas (Upstate Biotechnology), 25 pM etoposide or 1 pM 
staurosporine for up to 6 hours. After treatment, cells were harvested and washed 
with ice-cold PBS. One-fifth of the cells were analysed by flow cytometry by 
staining with Annexin V-PE (BD Pharmingen) and 7 A AD to measure apoptosis. The 
other four-fifths were pelleted and lysed in sample buffer for analysis by western blot.
2.2.4.3 -  Analysis of apoptotic cells by flow cytometry
Analysis of cells was measured by staining cells with 7AAD and with Annexin V-PE. 
Cells were resuspended in Annexin staining buffer which contains high calcium
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levels. Annexin V-PE was added at a dilution of 1:200. Samples were incubated at 
room temperature for 10 min. 7 A AD was then added to a final concentration of 10 
pg/ml. Samples were then analysed on a Beckman Coulter flow cytometer. For 
analysis of cells that had been infected with constructs containing an IRES-huCD2, 
cells were first stained with anti-huCD2-FITC for 5 min at a dilution of 1:200.
2.2.4.4 -  Preparation of Apoptotic lysate and in vitro assay for Mcl-1 
cleavage
Jurkat T cells were seeded at lxlO6 cells/ml and treated for 4 hours with or without 
CHI 1 anti-Fas (Upstate Biotechnology). Cell lysates were prepared as described in 
Sun et al. (1999). Briefly, 2x l07 cells were pelleted and washed in ice-cold PBS. 
Cells were then resuspended in PIPES buffer to a volume of 166 pl/108 cells. This 
was followed by three cycles of freezing in liquid nitrogen followed by thawing 
rapidly at 37°C. Samples were then spun in benchtop centrifuge for 30 mins at
16,000 x g. Supernatant was transferred to a fresh tube and spun at 100,000 x g for 
45 mins. The S100 fraction containing active caspases was collected and the protein 
concentration determined using Bio-Rad protein assay according to the manufacturers 
instructions. Aliquots were stored at - 80°C. Human and mouse HA-Mcl-1 were in 
vitro translated as per Section 2.1.2.5. Cell lysate was added to PIPES buffer to a 
final volume of 48 pi. For assays using recombinant active caspase-3 (BD 
Biosciences), active caspase-3 was added to a final volume of 48 pi with buffer used 
according to the manufacturers instructions. Caspase inhibitor zVAD-fmk (Enzyme 
System Products) or DMSO as a control was then added and incubated at 37°C for 15 
min. Finally 1.0 pi of the radiolabelled translated protein was added to the lysate, 
mixed by pippetting and incubated at 37°C for 2 hours. The reaction was terminated 
by the addition of 50 pi of 2x sample buffer. 20 pi of this was then resolved on a 12 
% SDS-PAGE gel (Section 2.1.2.1). Following this the gel was incubated in fixing 
solution for 15 min, vacuum dried onto 3MM filter paper and exposed to a 
phosphorimager screen overnight.
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2.2.4.5 -  Transfection of Jurkat T cells
The day before transfection Jurkat cells were seeded at 2x l05 cells/ml. The following 
day cells were washed in OptiMEM and constructs were co-transfected with GFP 
using Lipofectamine PLUS (Invitrogen) according to the manufacturers instructions. 
Generally 1.5 pg of DNA was transfected (Mcl-1 construct:GFP;9:1) per well of a six 
well plate. 24 hours after transfection cells were treated with either 300 ng/ml CHI 1 
anti-Fas or 25 pM etoposide for up to 6 hours as in Section 2.1.4.2 above. After 
treatment, cells were harvested and washed with ice-cold PBS. Cells were analysed 
by flow cytometry by staining with Annexin V-PE (BD Pharmingen) and 7AAD to 
measure apoptosis. For analysis, only GFP positive cells were examined, and of these 
only those that were both GFP positive and Annexin V positive were taken to be 
transfected and apoptotic.
2.2.4.6 -  Infection of FDCP-1 cells
Constructs for infection were first transfected into the LinXE packaging cell line 
using Lipofectamine (Invitrogen) according to the manufacturers instructions. 
Generally for each construct a 10 cm plate was transfected with 8 pg DNA. 24 hours 
after infection the media was replaced. Following incubation for an additional 24 
hours 10 ml viral supernatant was collected for each construct. FDCP-1 cells for 
infection counted and lxlO6 cells resuspended in 2 ml viral supernatant containing 8.0 
pg/ml polybrene to give a concentration of lxlO5 cells/ml. Cells were spun at 1800 
rpm for 45 mins at 32°C and then incubated at 32°C with 5% C 0 2 for 2 hours. Most 
of the supernatant was carefully removed and a further 2 ml viral supernatant 
containing polybrene added. The cells were spun as before and incubated at 32°C 
with 5% C 0 2 for a further 4 hours. The supernatant was again carefully removed and 
replaced with complete media and the cells incubated as normal overnight. The 
following morning media was removed from the cells and 4 ml viral supernatant 
containing polybrene was added and spun as before. Cells were incubated for 6 hours 
at 32°C with 5% C 0 2. Following this the media was replaced with complete media 
and the cells incubated as normal. The infected populations were expanded and 
infection efficiency was measured by flow cytometry using an anti-CD2-FITC
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antibody (clone RPA-2.10, eBioscience). Generally infection efficiency of 80% 
upwards was observed.
2.2A.7 -  Cycloheximide treatment of FDCP-1 cells
FDCP-1 cells were split to 2x l05 cells/ml the day before treatment. On the day of 
treatment 2 ml of cells at 5x l05 cells/ml were placed in wells of a 6-well plate. Cells 
were then treated for 0, 10, 20, 30, 60, 90, or 120 min with 30 p,g/ml cycloheximide 
(CHX), harvested and washed with ice-cold PBS before being lysed in Laemmli 
buffer. Samples were analysed by Western blotting and probed with anti-Mcl-1 or 
anti-HA antibodies. Blots were also probed with anti-a-tubulin to check for loading.
2.2.4.8 -  Growth Factor Withdrawal assays
FDCP-1 cells were prepared for growth factor withdrawal assays by first washing 
cells three times in RPMI-1640. Cells were then resuspended in media containing 
RPMI-1640 with 1% FCS, 2 mM glutamine, 0.5 U/ml penicillin, 0.5 p,g/ml 
streptomycin, 1 mM HEPES, and 0.0004% P-mercaptoethanol and maintained at 
37°C with 5% C 0 2. Apoptosis was measured by harvesting cells, resuspending in 
hypotonic buffer and addition of propidium iodide to examine DNA content of the 
cells. The percentage of sub-Gl cells was used as a measure of apoptosis.
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3 - Yeast Two-Hybrid
3.1 -  Introduction
3.1.1 -  BH3 only proteins and apoptosis
As outlined in Chapter 1, the Bcl-2 family of proteins are important regulators of 
apoptosis. Within this family the BH3 only proteins play an important role in 
responding to stimuli by sensitising (e.g. through Bad) or activating (e.g. through Bid 
and Bim) cells to apoptosis (Letai et al., 2002). We are interested in the “BH3 only” 
protein Bid. While its cleavage by caspase-8 is well characterised and it is well 
known that the truncated form of Bid (i.e. tBid) is the active form of the protein (Li et 
al., 1998; Luo et al., 1998) it is not clear how tBid is targeted to the mitochondria and 
how it regulates apoptosis in this setting.
We decided to use tBid as a bait protein in a yeast two-hybrid screen to identify novel 
interaction partners for the protein and to further clarify how this protein contributes 
to apoptosis.
3.1.2 -  Yeast two-hybrid
Protein-protein interactions are important for all biological systems. The yeast two- 
hybrid assay is a technique that was developed to examine and identify protein- 
protein interactions (Fields and Song, 1989). Yeast two-hybrid technology has 
proven to be particularly useful for analysis of proteins involved in apoptosis. A 
number of the Bcl-2 family of proteins were first identified using the yeast two-hybrid 
assay (Han et al., 1996; Yang et al., 1995), and much of the work characterising 
interaction between family members as well as the domains important for these 
interactions has been done using this technique (Sato et al., 1994; Sedlak et al., 1995; 
Wang et al., 1998). In order to further our understanding of the role of tBid in 
apoptosis, we have used tBid in this assay to screen a library for novel interaction
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partners. The principle behind this technology is reviewed in (Fields and Sternglanz, 
1994) and is summarised in Figure 3-1.
A number of different yeast two-hybrid systems have been established and all are 
based on a similar principal. We have used a GAL4 based system available from 
Clontech. The yeast that we have used for our screen is Y 190. This yeast strain is 
engineered to lack the genes TRP1, involved in tryptophan metabolism and LEU1 
involved in leucine metabolism. These genes are used to select for plasmids 
transformed into yeast. Y 190 also lacks a normal HIS3 gene involved in histidine 
metabolism but contains HIS3 and LacZ genes under the control of GAL4 upstream 
activation sequences (UAS) allowing selection of interacting proteins by nutrient 
deprivation (HIS3) and by blue/white selection (LacZ).
A known protein (tBid) is fused downstream of a DNA binding domain (the GAM  
DNA binding domain (GAL4-DBD)) and is known as the ‘bait’ protein (Fig. 3-1 A). 
This is expressed in Y 190 from a plasmid containing a tryptophan nutritional 
selection marker (Fig. 3-IB). At this stage it is important to ensure that the bait 
fusion protein does not activate the reporter genes alone (Fig. 3-1C). If this is the 
case the bait may be unsuitable for this assay. Alternatively, specific domains within 
the protein may be used as a bait, providing that they do not activate the reporters 
themselves. The library to be screened, generally a cDNA library, is fused 
downstream of a transcriptional activation domain (the G A M  activation domain 
(GAM-AD)) and is known as the ‘prey’ protein (Fig 3-ID). Our prey fusion-proteins 
are expressed in Y 190 from a plasmid containing a leucine nutritional selection 
marker. Co-transformation with these plasmids results in the expression of the TRP1 
and LEU1 gene products as well the GAM-fusion bait and prey proteins. This allows 
growth of Y 190 on dropout media lacking either tryptophan and/or leucine and 
potential activation of the reporter HIS3 and LacZ genes.
The GAM-DBD-bait vector is transformed into yeast (Fig. 3-IB), where the fusion 
protein is expressed and localises to the nucleus. Here it binds to the GAL4 UAS that 
controls reporter gene expression. The bait fusion protein should not be able to active 
transcription of the reporter genes itself. In Y 190 the HIS3 reporter gene is slightly
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leaky, therefore a specific inhibitor of the HIS3 gene product, 3-amino-1,2,4-triazole 
(3-AT), is incorporated into the media to inhibit this low level of HIS3 expression. 
Prior to screening, the amount of 3-AT incorporated into the media is optimised.
Once these conditions have been established the yeast containing bait is transformed 
with a GAL4-AD-prey vector containing the library (Fig. 3-ID). This fusion protein 
is also localised to the nucleus and here the bait and prey can interact with each other. 
Interaction of the bait and prey bring the GAL4-DBD and -A D  into close contact 
allowing transcription of the reporter genes. After transformation with a library, the 
yeast are plated out on a minimal dropout media and allowed to grow for up to 15 
days (Fig. 3-IF). Yeast containing a prey vector expressing a fusion protein that does 
not interact with the bait should not grow, while prey fusion proteins interacting with 
the bait protein switch on the reporters and grow successfully. Filter lift assays are 
used to check for LacZ expression on the colonies that grow successfully. The 
colonies that are blue are re-streaked and the prey vector isolated (Fig 3-1G). The 
library insert is sequenced to identify the gene and to confirm that it is in the correct 
open reading frame (ORF) downstream of the GAL4-AD in order to express a 
functional fusion gene (Fig 3-1H). This will refine the number of positives, as some 
of the constructs will not be in the correct ORF with the upstream GALA-AD. To 
confirm positive and true interactions, the isolated prey constructs are co-transformed 
into yeast with a vector containing a bait fusion protein or lacking the bait fusion, 
grown on minimal media and filter lift assays carried out again to show the interaction 
is reproducible and that the prey fusion protein is not able to switch on the reporters 
without the bait being present (Fig 3-11).
Once true positive interactions partners for the bait protein have been identified, these 
need to be confirmed outside of the yeast system. We have confirmed these 
interactions using a GST-pull down assay.
3.1 .3 -G S T  pull-downs
The GST pull-down assay is an in vitro assay that is used to characterise and show the 
ability of proteins to interact with one another. This assay can be a very sensitive and
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is often used in conjunction with other assays to independently confirm the ability of 
two proteins to interact with each other. This system is shown in Figure 3-2. 
Glutathione-S-transferase (GST) is a small protein of about 25 kDa that has a strong 
affinity for glutathione while having few non-specific interactions with other proteins. 
Bacterial systems are used to inducibly express GST fusion proteins that can be easily 
purified from lysed cells under non-denaturing conditions by absorption onto 
glutathione sepharose or agarose beads.
The system that we have used is a GST-fusion system that is commercially available 
from Amersham Biosciences. The genes of interest are fused to GST by cloning them 
downstream of and in frame with GST in a bacterial expression vector. The fusion 
gene produced is then incubated with a test protein to check for interaction. Using an 
in vitro translated bait protein labelled with [35S]-methionine gives a high degree of 
sensitivity and allows for accurate quantitation by phosphorimaging or densitometry.
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3.2 -  Results
3.2.1 -  Constructs for the yeast two-hybrid system
Mouse Bid and tBid were cloned by PCR from a mouse Bid cDNA that was a gift to 
us from Dr. Stanley Korsmeyer (Dana-Faber Cancer Institute, Boston, USA). The 
PCR products were then cloned into the bait vector pGBKT7 (Clontech) (Fig. 3-3A) 
in-frame with the upstream GAL4-DBD. The bait construct containing full-length 
Bid will be referred to as pGBid from here on, and the bait construct containing tBid 
will be referred to as pGtBid. A number of reports indicate that tBid can directly 
interact with Bax to induce a conformational change in the protein to result in its 
activation (Desagher et al., 1999; Eskes et al., 2000). Thus we decided to use Bax as 
a positive interacting prey for tBid in our yeast two-hybrid assay.
Mouse Bax was cloned by PCR from a mouse baxa cDNA construct that we have in 
our lab. This PCR product lacks the last 21 amino acids of Bax, which encodes for its 
transmembrane domain. The presence of the transmembrane domain may result in 
inappropriate localisation of the Gal4-AD-Bax fusion protein and its removal ensures 
its nuclear localisation. The ABax construct was cloned into pGADT7 (Clontech) 
(Fig. 3-3B) in-frame with the upstream GAL4-AD. This construct will referred to as 
pGABax from this point on.
A number of other vectors were used as positive controls for the yeast two-hybrid 
assay and are also commercially available from Clontech. These include pCL-1, 
containing a full open reading frame for the GAL4 protein (Fig. 3-4A); pVA3-l, a 
bait vector containing murine p53 protein (amino acids 72-390) fused to the GAL4- 
DBD (Fig. 3-4B); pTDl-1, a prey vector containing the SV40 large T-antigen (amino 
acids 87-708) fused to the GAL4-AD (Fig. 3-4C), and which interacts very strongly 
with the p53 region expressed from pVA3-l; and finally pLAM5'-l, which may be 
used as a false positive detection plasmid as it contains the human lamin C protein 
(amino acids 66-230) fused to the GAL4-DBD (Fig. 3-4D) and is relatively inert.
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Figure 3-4: Control vectors used in the yeast two-hybrid assay. (A) The pCLI vector contains a full GAL4 gene and allows 
expression of reporter constructs in Y 190. The pVA3-l bait vector (B) containing a fragment o f murine p53 and the pTDl-1 prey 
vector (C) containing a fragment o f the SV40 large T-antigen produce fusion proteins that interact with each other and activate 
transcription o f reporter genes when co-transformed into yeast. (D) The pLam5'-l vector contains human lamin C protein and 
may be used as a control to test for false positive interactions in the two-hybrid assay.
3.2.2 -  Expression of/Transform ation of the plasmids into the 
yeast Y190
Y190 yeast was used for all two-hybrid assays during this project. Competent yeast 
cells were prepared by the lithium acetate method already outlined in Chapter 2.2.3.1. 
Initial transformations with Y 190 used the control plasmids pCL-1, pVA3-l and 
pTDl-1. Fig. 3-5A outlines the transformations carried out. These transformations 
were plated out on appropriate dropout media (lacking tryptophan and leucine) and 
allowed to grow at 30°C for 2 to 3 days. Filter lift assays were carried out to check 
for expression of the LacZ reporter gene. As expected the pCL-1 plasmid 
transformed yeast expressed the LacZ reporter gene (Fig 3-5B). Co-transforming 
Y 190 with pVA3-l and an empty prey vector (Fig 3-5C), or pTDl-1 with an empty 
bait vector (Fig 3-5D) did not induce expression of the LacZ reporter. However, co­
transformation of pVA3-l with pTDl-1 resulted in the colonies turning blue when 
treated with the Z-Buffer (Fig 3-5E).
This confirmed that the Y190 was behaving as expected and that the LacZ reporter 
was working efficiently and did not appear to be leaky. We then tested our bait fusion 
proteins in the system.
The pGBid, pGtBid, pGABax plasmids were co-transformed with empty bait or prey 
vectors or with each other into Y 190 as outlined in Figure 3-6A. Western blots of 
total yeast extract were carried out to confirm expression of the fusion proteins within 
yeast. The western blots in Figure 3-7 each show untransformed Y190 (Lane 1),
Y190 transformed with empty vector (Lane 2), and two clones for each of pGBid, 
pGtBid and pGABax (Lanes 3 and 4). Antibodies raised against full-length murine 
Bid and Bax were used to detect both Bid and Bax respectively. The tBid fusion 
protein was undetectable using the antibody against full-length Bid. Instead we used 
an anti-Gal4 antibody to detect the fusion protein. This antibody also detects the 
Gal4-DBD in the vector only lane (Lane 2) of the tBid panel. These westerns show 
that all fusion proteins appear to be expressing correctly within the yeast two-hybrid 
system that we have used.
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A
Transform ation 
(i.e. Filter lift)
Bait Prey Blue
B pCL1 +
C PVA3-1 Empty vector -
D Empty vector pTD1-1 -
E pVA3-1 pTD1-1 +
B C
Figure 3-5: Control transformations in Y190. Transformations with the plasmids 
shown in Figure 3-4 are outlined in (A) above and the corresponding filter lift assays 
are shown in (B), (C), (D) and (E).
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A
Transform ation 
(i.e. Filter lift)
Bait Prey Blue
B pGBid Empty vector _
C pGtBid Empty vector -
D Empty vector pGABax -
E pGBid pGABax -
F pGtBid pGABax +
B \
E
5,'iJ
Figure 3-6: Transformation of Y190 with Bid and Bax fusion proteins. Plasmids 
containing Bid, tBid and Bax fusion proteins were transformed into Y 190 as outlined 
in (A). Filter lift assay results (B -  F) show the ability of tBid and Bax to interact and 
induce expression of the LacZ reporter gene in Y 190.
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Figure 3-7: Expressed fusion proteins in Y190. Expression of Gal4-DBD-Bid, 
-tBid and Gal4-AD-Bax in Y190 was detected by western blot. Anitbodies raised 
against full-length murine Bid and Bax were used to detect full-length Bid and Bax 
fusion proteins respectively. An anti-Gal-4 antibody was used to detect the tBid 
fusion protein as the Bid antibody was unable to detect the protein.
7 4
Filter lift assays on Y 190 transformed with bait or prey fusion constructs alone 
showed no induction of the LacZ reporter as expected (Fig 3-6B, C and D). 
Interestingly, the co-transformation of pGBid with pGABax was also negative for 
expression of the LacZ reporter (Fig. 3-6E), while co-transformation of pGtBid with 
pGABax gave a positive expression of the reporter (Fig. 3-6F). This suggests that 
tBid preferentially interacts with Bax and that the interaction between full length Bid 
and Bax, if any, is much weaker by comparison. On the basis of these results it was 
decided to use tBid as a bait for the yeast two-hybrid screen.
3.2.3 -  Titration with 3-amino-1,2,4-triazole (3-AT)
As mentioned in the introduction the Y 190 yeast strain contains a second reporter 
gene, the HIS3 gene, involved in histidine biosynthesis. Y 190 is unable to grow on 
media lacking HIS unless HIS3 expression is induced through interaction of a bait and 
prey fusion protein. This allows for greater stringency in identifying true interaction 
partners in the yeast two-hybrid system. However, this reporter is slightly leaky and 
unless this is controlled, yeast may be able to grow giving in a number of false 
positive results. To overcome the effect of this leaky expression from the HIS3 locus 
3-amino-1,2,4-triazole (3-AT) is incorporated into the media
3-AT is a specific inhibitor of the HIS3 gene product. This is added to the dropout 
media so as inhibit activity of any leaky HIS3 present in the cell. When the HIS3 
gene is switched on through interaction of bait and prey fusion proteins, so as the 
GAL4-DBD and GAL4-AD are brought into close proximity, the level of HIS3 
dramatically increases within the cell and overcomes the inhibitory effect of the 3-AT 
allowing the yeast to grow normally. Y190 expressing the tBid bait fusion was 
titrated with increasing amounts of 3-AT to determine the optimum amount to use in 
order to inhibit growth when the reporter is not switched on.
3-AT concentrations of 0 mM, 5 mM, 10 mM, 20 mM, 25 mM, 35 mM, 40 mM, 45 
mM, 50 mM and 60 mM were used in a dropout media lacking tryptophan and 
histidine. Y 190-tBid was grown in liquid culture over night and then plated onto 
dropout media containing 3-AT. These plates were incubated for 7 days at 30°C. 
Plates were initially examined for growth of colonies and subsequently filter lift
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assays carried out to check for auto-activation of the reporter genes. This also allows 
us to examine any possible mutagenic effect that the addition of 3-AT may have on 
reporter gene expression as well as general toxicity to the yeast.
The results of these assays summarised in Table 3.1. Growth of the Y 190-tBid yeast 
on a media containing 3-AT resulted in very little autoactivation of the reporter even 
at higher concentrations. There were a couple of large colonies that grew on plates at 
much higher concentrations of 3-AT (i.e. > 30 mM). However, concentrations of 15 
to 20 mM 3-AT were sufficient to minimise growth as a result of leaky expression of 
the HIS3 gene. Therefore it was decided to use a concentration of 20 mM 3-AT for 
the tBid yeast two-hybrid screen.
3.2.4 -  Apoptotic thymocyte library used for screen
The library used for the yeast two-hybrid screen was a cDNA library prepared from 
mouse primary thymocytes undergoing apoptosis and was a kind gift from Dr. Gabriel 
Gil-Gomez (IMIM, Barcelona). Mouse (FVB) thymocytes were irradiated with 5 Gy 
and cultured for 5 hours. RNA was prepared from these thymocytes and cDNA 
generated by a random priming method. The cDNA inserts were cloned into the 
EcoRl and Xbal sites of pAD-Gal4-2.1 (Stratagene). The library had over 90 % 
recombinants with an average insert size of 1.5 kb and contained approximately 1.6 x 
106 recombinant clones.
3.2.5 -  Large scale cDNA library transformation
Y 190 containing tBid was streaked on an agar plate containing appropriate dropout 
media. This was allowed to grow for 2 days at 30°C and then a single colony picked 
into 5 ml of similar dropout broth. This was grown overnight at 30°C with shaking 
and used to inoculate 500 ml of YPDA media the following morning such that the 
ODgoo was 0.28. This large culture volume was grown at 30°C with shaking and the 
cells harvested at O D ^  = 0.85. The cells were pelleted and made competent by 
washing in lithium acetate and were transformed with 240 p,g of the cDNA library as
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3-AT Cone. No. of Colonies Colony Size Comments LacZ +ives
0 mM Confluent Growth No colonies - complete confluent growth -
5 mM Confluent Growth . No colonies - complete confluent growth -
10 mM 200 - 300 colonies -0.5-1.0 mm These colonies look small - not growing well _
15 mM 100 - 200 colonies <0.5 mm Very small colonies - minimal growth -
20 mM -5 0  colonies tiny Very little background growth -
25 mM -  50 colonies tiny _ 1
30 mM 4-6 large 
-20  tiny
-1 .0  mm 
<0.5 mm
- -
35 mM 6-8 large 
10-20 tiny
-1 .0  mm 
<0.5 mm
- -
40 mM 3 to 4 <0.5 mm — _
45 mM 3 to 4 <0.5 mm _ _
50 mM 2 <0.5 mm -
60 mM 1 <0.5 mm - -
Table 3.1: Summary of results for titration of Y190-tBID with 3-amino 1,2,4-triazole
outlined in Chapter 2 (Section 2.2.3.2). After transformation the cell pellet was made 
up to 10 ml with sterile water and 1 ml was spread on each of 10 large square NUNC 
plates containing dropout media lacking tryptophan, leucine, histidine and containing 
20 mM 3-AT. Transformation efficiency was calculated by plating 1 pi and 5 pi 
aliquots from the large scale transformation on -Leu, -Trp dropout media. This allows 
for growth of yeast containing both plasmids. Colonies were counted on each plate 3 
days after transformation. The 1 pi plates contained 315 colonies, and the 5 pi plate 
contained approximately 1700 colonies. This gives a total number of transformants of 
between 3.1 to 3.4 x 106 (and a transformation efficiency of 1.3 to 1.4 x 104 cfu/pg 
DNA). Given that the total number of recombinants in the library is estimated to be 1 
x 106 every cDNA should be screened against tBid.
Library plates were incubated for 17 days at 30°C to allow recovery and growth of 
yeast. After incubation each plate had 5 to 10 large colonies of up to 10 mm in 
diameter. These had started to turn slightly pink, indicating a lack of adenine. There 
were also at least 10 to 20 colonies of ~ 5 -  10 mm in diameter, these were still quite 
pale. Finally there were lots of colonies about 1 - 2  mm diameter whose growth had 
been inhibited by the presence of 3-AT. Replica plates were made by taking filter 
lifts of each large plate and placing the filters on plates containing fresh dropout 
media lacking tryptophan, leucine, histidine and containing 20 mM 3-AT. The replica 
plates were incubated at 30°C for 2 -  3 days and the filters were then treated with 
liquid nitrogen and stained in Z-Buffer for 8 hours. After staining the filters were 
dried in a fume hood over-night. Filters are shown in Appendix I.
3.2.6 -  Yeast PCR and identification of interaction partners
Results of the yeast two-hybrid screen are summarised in Tables 3.2 and 3.3 and in 
Appendix II. The stained filters were used to identify colonies on the replica plates 
that were expressing the LacZ reporter gene. Once the colonies had started to grow 
on the replica plates prey inserts were picked using a p200 pipette tip and placed in 
two groups, strong blues or weak blues (Appendix II). A small amount of the yeast 
picked was used to inoculate a PCR reaction and the remainder used to streak an agar 
plate containing dropout media in order to generate a master plate.
78
Totals All Clones Positives Out of Frame No Insert No Match Misc.
Numbers 113 33 63 5 8 4
Percentages 100% 29% 56% 4% 7% 4%
Table 3-2: Summary of clones sequenced from yeast two-hybrid screen
Number Name Clones Identified
1 Nucleoside diphosphate kinase B 1, 2 , 4 ,  31,37, 56, 59, 62, 67, 
82, 97
2 EID-1 15, 17, 26,46, 66, 89
3 Activator of S-phase kinase (ASK) 6, 74, 99, 98, 103
4 CDC37 5, 7, 65
5 Mcl-1 31,45, 85
6 Bcl-2 29
7 Thymic dendritic cell derived factor 1 48
8 Hypothetical Protein from BRCA Region 87
9 CDC2L5 (isoform 2) 100
10 Rpl13a 112
Table 3-3: Summary of positive clones pulled out of yeast two-hybrid screen.
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The primers GADF1 and GADR1 were used to PCR all the prey inserts from the 
colonies picked as outlined in Chapter 2. PCR products were run out on a 1 % 
agarose gel and were cleaned up using a Qiagen PCR clean-up kit. Where possible 
these bands were sequenced directly using the GADF1 primer that had been used for 
PCR, and the sequence analysed. Prey cDNA sequences were identified using the 
BLAST tool to align the sequence to those available on the nucleotide database on the 
NCBI web site.
Five of the clones picked (4%) contained no cDNA insert. Of these 5 clones 4 were 
represented as strong blue colonies and 1 was represented by a weak blue colony 
(Appendix II). These were most likely to have had spontaneous mutations that 
allowed activation and expression of the reporter genes. Three of the clones 
contained 3'UTR sequences that would not normally be expressed as protein and one 
of the clones contained a cDNA sequence that had been inserted 3' - 5' (Table 3.2 and 
Appendix II). As a result these clones were eliminated as potential interaction 
partners. The open reading frame (ORF) of each cDNA pulled out of the screen was 
also checked to ensure that it was in-frame with the ORF of the upstream GAL4-AD. 
Of the 113 clones picked 63 (56%) of them were not in the same ORF as the upstream 
GAL4-AD (Table 3.2 and Appendix II) and these were automatically eliminated as a 
potential interaction partners. Eight of the clones (7%) matched no sequence in the 
database and translating the sequence in the same frame as the upstream GAL4-AD 
suggested that the fusion protein expressed was a nonsense protein. Ten potential 
interaction partners for tBid were identified from the remaining prey cDNA inserts 
analysed. These initial targets are outlined in Table 3.3.
Two of these ten potential partners for tBid were Bcl-2 family members. There was 
one clone containing a bcl-2 cDNA (clone 29), a protein that has already been 
reported to interact with tBid. The other Bcl-2 family member identified was Mcl-1, 
another anti-apoptotic protein. The three clones identifying Mcl-1 (Table 3.3) 
contained independent cDNA inserts that started in different regions of the cDNA 
(Figure 3-8). Nucleoside diphosphate kinase B (NDK-B) was identified in more 
clones (11) than any other cDNA (Table 3.3). However all these clones contained the 
same cDNA sequence and had 90 bp of 3'UTR upstream of the start codon. There
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Figure 3-8: Alignment of Mcl-1 prey fragments from yeast two-hybrid assay.
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were 4 clones identifying the protein activator of S-phase kinase (ASK) as interacting 
with tBid (Table 3.3). Three of the clones were represented by one cDNA while the 
fourth clone contained a different cDNA. Three clones were identified CDC37 
cDNA. As with NDPK-B, all the clones contained the same cDNA sequence.
Murine ElA-like inhibitor of differentiation-1 (EID-1) was identified in 6 clones 
(Table 3.3) and each of these clones contained independent cDNA inserts. There 
were also a number of other potential interaction partners that were represented by a 
single cDNA insert. These were murine thymic dendritic cell-derived factor 1, 
CDC2L5 (isoform 2), ribosomal protein LI3a, and a cDNA insert that matched to a 
sequence representing a hypothetical protein from the BRCA2 chromosomal region in 
humans.
3.2.7 -  Re-testing of potential interaction partners
Prey plasmids for the potential interaction partners were isolated from yeast as 
outlined in Chapter 2, Section 2.2.3.5. Restriction digestion analysis was used to 
confirm that all colonies contained the same cDNA insert. All prey inserts were again 
sequenced using the GADF1 primer to ensure that the correct insert was obtained.
Miniprep DNA was then used to co-transform Y 190 with either pGBKT7 (empty bait 
vector) or pGtBid. These were then plated out on appropriate dropout media and 
allowed to grow at 30°C for 2 to 3 days until colonies appeared. Filter lifts were then 
taken of each plate and tested for LacZ expression. Genuine interactions with tBid in 
yeast should result in no reporter activation in transformations with the pGBKT7 but 
expression of the LacZ reporter in transformations with pGtBid. If both 
transformations are blue on staining with Z-Buffer, this indicates a false positive as a 
result of direct activation of the reporter by the prey fusion protein or interaction with 
the GAL4-DBD. However if neither transformations are blue on staining with Z- 
Buffer this indicates a spontaneous mutation within the specific Y 190 clone originally 
identified allowing expression of the reporter genes, and not as a result of an 
interaction between the bait and prey fusion proteins.
Representative filter lift assays for the retest transformations are shown in Appendix 
III and summarised in Table 3.4. The retest assays identified NDK-B, CDC37, Bcl-2,
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Mcl-1 and EID-1 clones as interacting with the tBid bait in yeast. The ASK and 
CDC2L5 proteins were both able to activate the reporter genes in the absence of the 
bait protein tBid while the thymic dendritic cell factor 1, ribosomal protein LI3a and 
the hypothetical protein (from BRCA2 chromosomal region) did not appear to be able 
to switch on the reporters at all. This gave five true positives that interacted with the 
GAL4-DBD-tBid fusion protein in Y 190.
3.2.8 -  Constructs for the GST-pull down assay
Human cDNAs for each protein were obtained and cloned by PCR into pcDNA3.1- 
HA (Fig. 3-9A). This vector is pcDNA3.1 myc-HIS-(B) (Invitrogen) that has been 
engineered to contain a HA epitope tag that would be fused to the N-terminus of 
recombinant proteins. Details of the cloning procedure are outlined in Chapter 2, 
Section 2.2.2.2.
Human Bid and tBid were cloned by PCR into the pGEX-6P2 (Amersham) GST- 
fusion vector (Fig. 3-9B).
3.2.9 -  Preparation of GST fusion proteins
The pGEX-Bid and pGEX-tBid were used to transform the E. coli BL21 host strain. 
Cultures for GST-fusion protein expression were prepared and IPTG added to a final 
concentration of 100 pM to induce expression of the fusion proteins. Cultures were 
allowed to grow for 2 hours after addition of IPTG and were then harvested by 
centrifugation. Pellets were washed once and resuspended in ice-cold PBS. 
Sonication was used to break open the cells and the fusion proteins were purified 
using glutathione sepharose beads. The sepharose beads were resuspended in a final 
volume of 1 ml PBS and stored at 4°C. Bead fractions were run on an SDS-PAGE 
denaturing gel to determine efficiency of fusion protein production and to determine 
how much of the sepharose GST-fusion bead complex to use for pull-down assays. 
Gels were fixed and stained with Coomassie blue.
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Number Name Retest Result
1 Nucleoside diphosphate kinase B Positive
2 E1D-1 Positive
3 Activator of S-phase kinase (ASK) Auto-activation
4 CDC37 Positive
5 Mcl-1 Positive
6 Bcl-2 Weakly positive
7 Thymic dendritic cell derived factor 1 Negative
8 Hypothetical Protein from BRCA Region Negative
9 CDC2L5 (isoform 2) Auto-activation
10 Rpl13a Negative
Table 3-4: Summary of retest results for positive clones identified in the yeast two- 
hybrid assay. Corresponding filter lift assays are shown in Appendix III.
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Figure 3-9: Vectors used for GST pull-down assay. Prey cDNAs cloned into 
pcDNA3.1-HA (A) were used for in vitro translation while GST-fusion proteins were 
generated by cloning bait proteins down-stream of GST in pGEX-6P-2 (B).
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GST and the GST-fusion proteins GST-Bid and GST-tBid are shown in Figure 3- 
10A. Both GST and GST-Bid had very good induction in the BL-21 E. coli giving a 
high yield of protein (both are diluted 1:100) with little degradation of the fusion 
protein GST-Bid. The GST-tBid fusion construct however did not give as good a 
yield and also resulted in a number of degradation products. A similar SDS-PAGE 
gel was run and transferred to nitrocellulose membrane for Western blotting using an 
anti-Bid antibody (Fig. 3-1 OB). This identifies both the GST fusion proteins as 
containing the Bid protein and also confirms that the degradation products in the 
GST-tBid lane contain part of the Bid protein. These fusion proteins were used in 
pull-down assays to further determine if the tBid interaction partners identified in the 
yeast two-hybrid screen were true interaction partners for the protein.
3.2.10 -  The GST-pull down assay
Using the pcDNA3.1-HA constructs for the human proteins, detailed in section 3.2.8 
above, all potential interaction partners were in vitro translated in the presence of 
[35S]-Met using a T7 Quick-coupled in vitro translation kit from Promega. 
Radioactively labelling the proteins allows for sensitive detection of even weak 
interactions when using the GST-pull down assay. This procedure has already been 
previously outlined in Figure 3-2.
Sepharose beads containing GST alone, GST-Bid, and GST-tBid were incubated with 
2 pJ of in vitro translated product and mixed by rotation at 4°C for 2 hours. 
Complexes were then pelleted in a microfuge and washed 6 times with 1 ml ice-cold 
lysis buffer. After washing, beads were pelleted with as much of the supernatant and 
residue as possible removed. Sample buffer was added to each tube and then resolved 
on a SDS-PAGE gel. Gels were stained using Coomassie blue to check for equal 
loading and following drying were exposed to a phosphorimager screen overnight. 
Exposed screens were scanned the following day. Results are shown in Figure 3-11. 
The first lane in each image contains 10% of the in vitro translated prey protein used 
in the pull-down. The other lanes show the amount of prey protein pulled down by 
GST alone, GST-Bid fusion or GST-tBid fusion when the prey protein and fusion 
proteins are incubated together.
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Figure 3-10: GST-fusion proteins used for pull-down experiments. (A) A
Coomassie stained gel showing the loading of GST, GST-Bid and GST-tBid purified 
fusion proteins. (B) A Western blot corresponding to the gel shown in (A) using an 
anti-Bid antibody.
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Figure 3-11: GST pull-down assay using GST-Bid and GST-tBid. Prey 
constructs in vitro translated in the presence of [35S]-methionine were incubated with 
the GST fusion proteins to test for interaction between the bait and prey proteins.
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As expected both Bcl-2 and Mcl-1 interact with tBid, however it is interesting that 
they do not interact with full length Bid. The interaction between tBid and Mcl-1 also 
appears to be stronger than that between tBid and Bcl-2. EID-1 also shows an ability 
to interact specifically with tBid while the other two proteins, NDPK-B and CDC37, 
did not interact with either tBid or Bid in this assay.
In order to try and further strengthen the case for the interaction of both Mcl-1 and 
EID-1 with tBid we attempted to reverse the pull-down assay already by pulling down 
Bid or tBid with GST-Mcl-1 or GST-EID-1 fusion proteins.
Mcl-1 and EID-1 were cloned by PCR into the pGEX-6P2 vector and GST-fusion 
proteins prepared as before. Both GST-EID-1 and GST-Mcl-1 proved to be quite 
difficult to produce and both were also degraded during the preparation (Fig. 3-12A). 
Bid and tBid proteins were cloned into pcDNA3.1 and this was then used to generate 
in vitro translated protein labelled with [35S]-methionine. GST-alone, GST-Mcl-1 or 
GST-EID-1 proteins were used to pull down radioactively labelled Bid or tBid. In the 
case of both full-length Bid and tBid an input of 1% was used. This is much lower 
than the 10% input used in the pull-down assays shown in Figure 3-11. The [35S]-Bid 
appeared to come down in both the GST and GST-fusion lanes (Fig. 3-12B, top 
panels). To check if this is because of Bid binding to GST or to the glutathione 
sepharose beads a pull-down assay with beads alone or beads containing bound GST 
was carried out (Fig. 3-12C). This assay showed quite clearly that Bid appeared to 
bind non-specifically to the sepharose beads. For the pull-down assay with [35S]-tBid 
it was difficult to see tBid coming down with either GST or the GST-fusion proteins 
(Fig. 3-12B, bottom panels). The tBid protein did appear to be binding slightly to the 
GST beads and there appeared to be a slightly stronger band in the GST-fusion lane, 
although this result was difficult to reproduce. The tBid in general was difficult to see 
and may be as a result of weak binding or due to problems with the stability of the 
tBid protein in the assay.
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3.3 -  Discussion
We performed a yeast two-hybrid assay to identify novel interaction partners for the 
active form of the BH3-only protein Bid. We successfully identified a number of 
proteins that specifically interacted with tBid and which now need to be further 
characterised to establish functional significance for these interactions.
In setting up the yeast two-hybrid assay we looked for the ability of both Bid and tBid 
to interact with the pro-apoptotic protein Bax. It has previously been reported that 
full length Bid is capable of interacting with Bax (Wang et al., 1996), however we 
were unable to observe this interaction in our yeast two-hybrid assay. The reason for 
this is not clear. Western blots indicated that there did not appear to be a problem 
with expression of the protein in yeast and so it is possible that the interaction is not 
very strong and that the assay was not sensitive enough to allow reporters to be 
switched on. Another possibility is that fusing full length Bid to the GAL4-DBD 
results in a conformational change that is unfavorable for the Bid-Bax interaction to 
take place. However, tBid showed a strong interaction with Bax in this assay 
indicating that tBid rather than the full-length protein would be a more suitable bait in 
the assay. Titration with 3-AT to inhibit low levels of leaky HIS3 expression also 
showed tBid to be a favourable bait protein. There was little toxicity or spontaneous 
mutation observed when 3-AT was incorporated into the media and reasonably low 
levels of the compound inhibited growth due to leaky HIS3 expression.
The yeast two-hybrid screen itself identified 113 clones that contained prey cDNAs 
that induced expression of the reporter genes in Y 190. As the clones were picked 
they were divided into two groups. Those that gave a strong blue colour, indicating a 
strong interaction, and those that gave a weaker blue colour, indicating a weak 
interaction. There were 78 strong blue colonies picked and 35 weak blue colonies 
picked. Of the weak blue colonies only 15% (5 of 33) of cDNA constructs were in 
the same ORF as the upstream GAL4-AD compared with 36% (28 of 78) of the 
strong blue cDNA constructs that were in the same ORF as the upstream GAL4-AD. 
All prey plasmids containing a cDNA insert that was not in the same ORF as the 
upstream activation domain were automatically eliminated as potential interaction
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partners. A number of other clones could also be eliminated after initial sequence 
analysis. One of the clones contained no insert in the prey vector and probably a 
spontaneous mutation within the yeast to allowed activation of the reporters, while a 
number of other inserts contained only UTR sequence that is not normally expressed 
as protein in cells, hence these clones were automatically eliminated.
The 33 clones identified as possible interaction partners contained cDNAs that 
encoded 10 different proteins. Of these proteins five were pulled out of the screen 
only once. One of these cDNA inserts encoded the anti-apoptotic protein Bcl-2. This 
was the only one of these proteins to retest positive. The activator of S-phase kinase 
(ASK) protein was pulled out a number of times but was later identified as being able 
to activate the reporter genes in the absence of tBid. This resulted in the elimination 
of this protein as a potential interaction partner. The remaining prey cDNA constructs 
identified, NDPK-B, EID-1, CDC37 and Mcl-1, all retested positive in the yeast two- 
hybrid assay and were considered good candidates as potential novel interaction 
partners for tBid.
GST pull-down assays were used to confirm the interaction of the bait and prey 
proteins outside of yeast. GST-Bid and -tBid fusion proteins were generated in BL21 
E. coli and purified using glutathione sepharose beads. GST-Bid was relatively easy 
to produce while GST-tBid was more difficult and expression of this protein in the 
bacterial host strain resulted in some degradation of the fusion protein. Prey proteins 
were in vitro translated in the presence of [35S]-methionine and then incubated with 
the fusion proteins to check for interaction.
As Bcl-2 is a known interaction partner for tBid we used this as a positive control for 
our assay. We were successfully able to pull-down Bcl-2 with tBid in this assay, 
however there did not appear to be any interaction between Bcl-2 and full-length Bid. 
A similar result is seen in the case of Mcl-1. Again tBid is specifically able to pull­
down the Mcl-1 protein while the full-length Bid does not pull-down Mcl-1. It is 
interesting that in both the yeast two-hybrid and GST pull-down assays the interaction 
between tBid and Bcl-2 is much weaker than that between tBid and Mcl-1. This 
suggests that Mcl-1, rather than Bcl-2, is a preferred interaction partner for tBid. The
92
EID-1 protein was the only other protein that was seen to interact with tBid in both 
assays used. Again this interaction is specific for tBid. The fact that Bcl-2 does not 
interact with full-length Bid is surprising as this interaction has been reported 
previously using this assay. However tBid is the active form of the BH3-only protein 
and so should have a higher affinity for interaction with other Bcl-2 family members 
in this state.
Neither NDPK-B nor CDC37 appear to interact with the GST-Bid or -tBid fusion 
proteins in this assay. Although a number of clones identified both these proteins in 
the yeast two-hybrid assay, the cDNA insert identified was exactly the same for each 
case of NDPK-B and CDC37. In the case of NDPK-B, all cDNA inserts contained 
the last 90 bp of 5'UTR before the initiation codon. This adds an extra 30 amino acids 
to the N-terminus of the protein that may result in an altered confirmation and allow 
interaction with the tBid fusion protein and subsequent activation of the reporter 
genes in yeast. When these 30 amino acids are not present (as in the case with the 
GST pull-down assay) and the protein is in its normal conformation this interaction 
should not occur. Similarly with CDC37, as there was only one cDNA identified 
representing the protein, the interaction may be dependent on the confirmation 
achieved when only this exact part of the protein is fused to the GAL4-AD. In 
contrast, both for Mcl-1 and EID-1, all clones identified contained inserts starting at 
different regions in the mRNA resulting in slightly different fusion proteins that 
consistently interact with the bait.
It is worth noting however that at least in the case of CDC37 there maybe other 
reasons for its failure to interact outside of a cellular system. CDC37 has a number of 
different roles to play within the cell. One of these relates to its ability to act as a 
chaperone in a complex with a number of other proteins (Kimura et al., 1997). This 
protein complex involves amongst other proteins the heat-shock protein 90 (Hsp90) 
(Pratt et al., 1999). It has been shown in the literature that Hsp90 can be co- 
immunoprecipitated with Bid from NIH3T3 fibroblasts (Zhao and Wang, 2004).
Thus if CDC37 can interact with Bid or tBid it may interact as part of a complex with 
other proteins. Heat-shock proteins in yeast may be able to complex with the GAL4- 
AD-CDC37 fusion protein and binding to the bait protein and activation of the
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reporter genes. In the GST pull-down assay there are no other proteins present, thus 
CDC37 maybe unable to interact with Bid or tBid without some other chaperone 
complex proteins present.
We have identified two novel interaction partners for tBid. The anti-apoptotic Bcl-2 
family member Mcl-1, and the recently identified ElA-like inhibitor of differentiation 
(EID-1).
Although there is little published on the role of EID-1, there is no real evidence to 
suggest that it may have a role in apoptosis. Overexpression of EID-1 shows that it 
localises to both the cytoplasm and the nucleus (Bavner et al., 2002), and cells 
overexpressing the protein do not appear to have any alteration in cell-cycle and are 
not prone to apoptosis (MacLellan et al., 2000; Miyake et al., 2000). Its function to 
date has been described as being primarily nuclear, interacting with proteins such as 
pRb to maintain cells in a proliferate state, and downregulation of the protein appears 
to be required to allow for differentiation of fibroblasts to proceed (MacLellan et al., 
2000; Miyake et al., 2000).
Mcl-1 is a protein that is known to protect cells from apoptosis (Reynolds et al., 1994; 
Zhou et al., 1997). It is a Bcl-2 family member that is localised to the mitochondria 
(Akgul et al., 2000) and that has been shown to have an essential role in early 
development and in the differentiation and maintenance of haematopoietic cells 
(Opferman et al., 2003; Rinkenberger et al., 2000). However there is little work 
characterising Mcl-ls ability to interact with BH3-only members of the Bcl-2 family 
and this makes it an excellent candidate as a potential interaction partner for tBid.
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4 - Mcl-1 Cleavage
4.1 -  Introduction
Mcl-1 is a Bcl-2 family member that was first identified as an early response gene 
upregulated in ML-1 cells in response to the differentiation agent PMA (Kozopas et 
al., 1993). It has since been shown to have an important role early in development 
(Okita et al., 1998; Rinkenberger et al., 2000) as well as in differentiation and 
maintenance of haematopoietic cells (Opferman et al., 2003). It is thought that the 
role of Mcl-1 as an anti-apoptotic Bcl-2 family member is paramount to its function in 
differentiation and development (Craig, 2002).
4.1.1 -  Mcl-1 structure
As a Bcl-2 family member, Mcl-1 contains all BH-1, -2 and -3 homology domains 
(Kozopas et al., 1993). It is much larger than other Bcl-2 family members, containing 
a large N-terminal region consisting of two PEST sequences. PEST sequences are 
regions within proteins that are rich in the amino acids proline (P), glutamine (E), 
serine (S) and theronine (T) and are thought to target a protein for rapid proteasome 
mediated degradation within the cell (Rechsteiner and Rogers, 1996). Mcl-1 is 
known to have a short half-life (Akgul et al., 2000; Cuconati et al., 2003; Iglesias- 
Serret et al., 2003) and it has been assumed that these PEST regions are responsible 
for this short tm. Like many Bcl-2 family members Mcl-1 contains a transmembrane 
domain at its C-terminus. This localises the protein to membranes within the cell and 
in particular Mcl-1 appears to be localised to the mitochondrial membrane (Akgul et 
al., 2000). Here it can interact with other Bcl-2 family members and help prevent 
activation of pro-apoptotic proteins that result in release of mitochondrial proteins and 
subsequent progression of apoptosis.
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4.1.2 -  Mcl-1 and apoptosis
Since its discovery Mcl-1 has been shown to delay apoptosis in a number of cell types 
including CHO cells, and various haematopoietic cell types (Jourdan et al., 2003; 
Pedersen et al., 2002; Reynolds et al., 1996; Zhang et al., 2002; Zhou et al., 1997).
By comparison with Bcl-2 however M cl-l’s anti-apoptotic potential is not as potent 
(Reynolds et al., 1996), and until recently little was known as to how Mcl-1 functions 
in protecting cells from apoptosis. Early data on Mcl-1 showed a role for this protein 
in protecting haematopoietic cell types. Mcl-1 transgenic mice show reduced 
apoptosis within haematopoietic cell populations (Zhou et al., 2001), and Mcl-1 was 
shown to be the primary anti-apoptotic protein in neutrophils (Moulding et al., 2001). 
There is also much data detailing regulation of Mcl-1 expression in the presence or 
absence of cytokines including IL-6 and GM-CSF (Chao et al., 1998; Jourdan et al., 
2003; Puthier et al., 2001), and Mcl-1 appears to have a role to play in the 
pathogenesis of multiple myeloma (MM) (Derenne et al., 2002; Jourdan et al., 2003; 
Puthier et al., 2001; Zhang et al., 2002).
However, a number of papers published recently shed light on how Mcl-1 may 
function to protect cells from apoptosis. UV induced apoptosis of HeLa cells has 
been shown to require loss of Mcl-1 for apoptosis to proceed (Nijhawan et al., 2003). 
Overexpression of Mcl-1 in these cells results in complete inhibition of apoptosis.
This data also shows that Mcl-1 acts upstream of another anti-apoptotic Bcl-2 family 
member, Bcl-XL. Overexpression of Mcl-1 is able to prevent translocation of the pro- 
apoptotic Bax to the mitochondria. However, overexpression of Bcl-XL is unable to 
prevent this translocation, but does inhibit apoptosis by preventing Bax from forming 
large molecular weight homo-oligomers that are required for release of mitochondrial 
proteins involved in apoptosis. Thus once HeLa cells have been treated with UV 
radiation, translation of Mcl-1 is inhibited. The remaining Mcl-1 in the cell is 
degraded by the proteasome and this then allows pro-apoptotic Bcl-2 family members 
to translocate to the mitochondria (Nijhawan et al., 2003). Adenoviral-infected cells 
also result in destruction of Mcl-1, which again appears critical for apoptosis to 
proceed in this setting (Cuconati et al., 2003). This data shows that Bak interacts 
specifically with Mcl-1 in HeLa cells. It also suggests that the loss of Mcl-1 during 
infection is not just a consequence of apoptosis but a defining event in the initiation of
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Figure 4-1: Mcl-1 and apoptosis. As outlined in Section 4.1.2 Mcl-1 is degraded 
rapidly in response to DNA damage and appears to be an early event in this pathway. 
This can allow for activation of BH3-only family members although this activation 
may independent of Mcl-1 elimination. Overexpression of Mcl-1 (shown in bold 
italics) appears to prevent translocation of other Bcl-2 family members to the 
mitochondria. This activity of Mcl-1 is upstream of Bcl-XL activity, which cannot 
prevent translocation of Bcl-2 family such as Bax, but can prevent their ability to 
induce release of mitochondrial proteins through homo-oligomerisation.
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apoptosis as a result of infection, as a result of El A initiated DNA damage type 
response. Overall this suggests an important role for Mcl-1 in interacting with pro- 
apoptotic Bcl-2 family members, and also that elimination of Mcl-1 is an important 
primary event leading to the release of cytochrome c for apoptosis in response to 
DNA damage.
4.1.3 -  Mcl-1 and differentiation
It is now well established that Mcl-1 has an important role to play in differentiation. 
Rapid and strong up-regulation of Mcl-1 at the level of both mRNA and protein in 
haematopoetic cells in response to differentiation agents has been well documented. 
Anti-sense studies to knockdown Mcl-1 protein levels at this early stage in response 
to such differentiation agents results in rapid apoptosis and an inability to differentiate 
(Moulding et al., 2000). Initial attempts to develop an Mcl-1 knock-out mouse show 
that embryos fail to implant and die by between E4.0 and E5.0. A conditional Mcl-1 
knock-out mouse generated was used to knockout Mcl-1 out of B- and T-cell lineages 
(Opferman et al., 2003). This results in the complete abolition of both B- and T- 
lymphocytes. Knocking out the Mcl-1 gene in mature B- or T-lymphocytes also 
results in apoptosis of these cells. This indicates that Mcl-1 is required not only for 
normal haematopoetic development but for the maintenance of mature haematopoetic 
cells.
During differentiation cells undergo a vast metamorphosis in terms of gene expression 
that results in alterations to cellular structure, function, and morphology. In 
committing to differentiation these changes require a reorganisation of chromatin 
structure to alter gene expression. Recent data has shown that in addition to changes 
in gene expression, caspase activation may also play an important role in 
differentiation (Arama et al., 2003; Fernando et al., 2002; Pandey et al., 2000; Weil et 
al., 1999; Zermati et al., 2001). This can result in a large stress placed upon the cell 
that needs to be managed very carefully. Certainly part of the role of Mcl-1 in 
differentiation and development would appear to be linked to its function as an anti- 
apoptotic protein. Stabilisation and protection of cells from inappropriate apoptosis is 
essential during the commitment to differentiation. In particular Mcl-1’s apparent
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role in protecting from DNA damage may be also relevant for differentiating cells as 
they undergo vast changes in their gene expression profile.
Having identified Mcl-1 as a potential interaction partner for the BH3-only protein 
tBid as outlined in Chapter 3, we were interested in looking for any changes to Mcl-1 
during apoptosis. It is thought that Bid cleavage plays an important role in Fas 
mediated apoptosis of the Jurkat T-cell lymphoma cell line. By treating Jurkat cells 
with the Fas activating CH11 antibody we initially examined the effect of apoptosis 
on the Mcl-1 protein.
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4.2 -  Results
4.2.1 -  Mcl-1 is cleaved during apoptosis in Jurkat cells
We initially observed that Mcl-1 was cleaved in Jurkat cells in response to treatment 
with the anti-Fas monoclonal antibody CH11. As shown in Figure 4-2A, Mcl-1 was 
cleaved from its full length 42 kDa form to a lower band migrating at about 25 kDa as 
detected by Western blotting. This time course showed that Mcl-1 cleavage is 
observed at the same time as PARP cleavage (Fig. 4-2A). In order to establish if this 
cleavage was upstream or downstream of caspase activity Jurkat cells were incubated 
with 75 pM of the pan-caspase inhibitor zVAD-fmk for 30 minutes before inducing 
apoptosis. Both Mcl-1 and PARP cleavage was completely inhibited over the 6-hour 
time course (Fig. 4-2B). This indicated that caspase activity is required for Mcl-1 
cleavage. Inducing apoptosis with 1.0 pM staurosporine (Fig. 4-3A) or 25 pM 
etoposide (Fig. 4-3B) also resulted in a similar processing of Mcl-1.
4.2.2 -  Mcl-1 cleavage is mediated by caspases
An in vitro system was set up to examine the processing of Mcl-1 more closely. 
Human and mouse Mcl-1 cDNAs were cloned by PCR into the pcDNA3.1-HA (Fig.
3-9A) vector as outlined in Chapter 2, Section 2.2.2.3. Both human (Fig. 4-4A) and 
mouse (Fig. 4-4B) HA-Mcl-1 were in vitro translated in the presence of [35S]- 
methionine. The resulting radio labelled protein was incubated with a cytoplasmic 
lysate from untreated Jurkat cells or Jurkat cells treated with 300 ng/ml CHI 1 anti-Fas 
antibody for four hours. This lysate contains either inactive (i.e. non-apoptotic lysate) 
or active (i.e. apoptotic lysate) forms of caspases present in the cell. Treating the 
recombinant radiolabelled protein with increasing amounts of apoptotic lysate clearly 
showed the cleavage of both human and mouse Mcl-1 (Fig. 4-3 A and 4-3B).
Addition of 75 pM zVAD-fmk to the apoptotic lysate completely inhibited this 
cleavage as can be seen in the last lane in both Figures 4-4A and 4-4B.
These experiments show that human Mcl-1 is processed into three fragments while 
mouse Mcl-1 is processed into only two fragments. This suggests two cleavage sites
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Figure 4-2: Mcl-1 is cleaved during Fas-mediated apoptosis in Jurkat cells. (A)
Jurkat cells were treated with 300 ng/ml CHI 1 anti-Fas over a 6-hour time course. 
Western blots against Mcl-1 (top panel) of total cell lysate show cleavage of Mcl-1 
while blots against PARP (bottom panel) are used as a marker of apoptosis. Cells 
were stained with anti-Annexin-PE and analysed by flow cytometry to show the 
progression of apoptosis. The percentage of Annexin positive cells at each time point 
is shown below each lane. (B) Cells were treated with 75 pM zVAD-fmk for 30 
minutes prior to the addition of the CHI 1 anti-Fas antibody as outlined in (A). This 
shows complete inhibition of apoptosis and Mcl-1 cleavage.
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Figure 4-3: Mcl-1 cleavage is also mediated by staurosporine and etoposide 
treatment in Jurkat cells. Jurkat cells were treated with 1.0 pM staurosporine (A) or 
25 pM etoposide (B) to induce apoptosis over a similar time course to that carried out 
in Figure 4-1. Mcl-1 cleavage was observed by western blotting.
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Figure 4-4: Human and mouse Mcl-1 can be cleaved in to a number of 
fragments. In vitro [35S]-labelled human (A) and mouse (B) Mcl-1 were incubated 
with increasing amounts of apoptotic lysate for 2 hours at 37°C. Samples were 
resolved on an SDS-PAGE gel and exposed to a phosphorimager screen. The final 
lane in both gels shows that pre-incubating with 75 mM zVAD-fmk can abolish 
cleavage of the recombinant protein by apoptotic lysate, suggesting that caspases are 
responsible for the cleavage of Mcl-1.
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in the human protein and only one in the mouse protein. Incubating human HA-Mcl- 
1 with active caspase-3 resulted in the same cleavage pattern as for apoptotic lysate 
(Fig. 4-5), thus confirming that Mcl-1 can be directly cleaved by caspases and that the 
processing of Mcl-1 in Jurkat cells undergoing apoptosis is due to caspase cleavage of 
the protein. It is worth mentioning that although caspase-3 can cleave Mcl-1 in vitro, 
this may not be the primary or only caspase involved in Mcl-1 processing in vivo. We 
have also noted that there is a caspase cleavage consensus site (DXXD) present in the 
HA tag. This also appears to be cleaved in our in vitro assays and can be easily seen 
in Figure 4-5 by comparing the smallest fragments present on the gel. Active 
caspase-3 appears to cleave this site more efficiently than the apoptotic lysate and so 
this small fragment travels slightly faster in lane 3.
4.2.3 -  Mcl-1 is cleaved at Asp127 and Asp157
Analysis of the protein sequence of the human Mcl-1 protein did not identify any 
obvious or known caspase cleavage sites. All Asp residues were examined as part of 
a potential caspase cleavage site according to the three residues N-terminal to Asp and 
their homology to known caspase cleavage sites. A number of candidate cleavage 
sites were identified and the Asp residues were subsequently mutated by site directed 
mutagenesis to Ala residues. As shown in Figure 4-6A, mutation of D127A or 
D157A altered the cleavage pattern of the wild-type (wt) HA-Mcl-1 radiolabelled 
protein when treated with apoptotic lysate (compare lanes 3 and 4 to lane 2). 
Generation of a double mutant (D127A, D157A Mcl-1) resulted in the complete 
abolition of Mcl-1 cleavage (Fig. 4-6A, lane 5). An identical cleavage pattern was 
also observed by using active caspase-3 (Fig. 4-6B). Thus the three fragments 
generated by cleavage of the human Mcl-1 molecule are (i) an N-terminal fragment 
from amino acids 1 to 127, (ii) a long C-terminal fragment from amino acids 128 to 
350 (A127) and (iii) a shorter C-terminal fragment from amino acids 158 to 350 
(A 157) (Fig. 4-7).
Western blots using the Santa Cruz anti-Mcl-1 (S-19) antibody clearly show the A127 
fragment (Fig. 4-2 and 4-3) but do not allow us to observe the shorter A157-fragment. 
This is because the epitope used for the generation of this antibody is a short sequence
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Figure 4-5: The cleavage products of Mcl-1 are generated by caspase cleavage. 
In vitro translated HA-Mcl-1 was left untreated (lane 1) or treated with apoptotic 
lysate (lane 2) or active caspase-3 (lane 3). The cleavage products are indicated by 
Note the lowest band in lane 3 runs slightly faster than the corresponding band 
in lane 2. This is due to a caspase cleavage site in the HA epitope tag that is more 
efficiently cleaved by the active caspase-3.
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Figure 4-6: Human Mcl-1 is cleaved by caspases at D127 and D157. Aspartic 
acids at D127 and D157 were mutated to alanine by site-directed mutagenesis. The 
mutant proteins were treated with apoptotic lysate (A) or active caspase-3 (B). 
Mutating either D127 (A and B, lane 3) or D 157 (A and B, lane 4) alter the cleavage 
pattern. Cleavage is completely abolished when both resides are mutated (D127A, 
D157A) (A and B, lane 5). Both apoptotic lysate (A) and active caspase-3 (B) show 
the same pattern of cleavage.
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Figure 4-7: Mcl-1 cleavage fragments and double mutant (DblMut) Mcl-1. A schematic outlining the cleavage fragments 
generated by caspase cleavage o f the Mcl-1 protein. These fragments were cloned into expression vectors for further study. The 
diagram also shows a double mutant (DblMut) Mcl-1 molecule that was also used in these studies.
from amino acids 119 to 139 from the human protein, and is not present in the A157 
fragment.
4.2.4 -  Mcl-1 cleavage fragments protect Jurkat cells from 
apoptosis
To examine further the functional consequences of Mcl-1 cleavage each of the 
cleavage products were cloned into the mammalian expression vector pcDNA3.1-HA 
(Fig. 3-9A). These constructs were used to transiently co-transfect Jurkat cells with a 
pcDNA-3.1-GFP vector. Twenty to 24 hours after transfection, cells were treated 
with CHI 1 or etoposide for up to 6 hours. Transfection efficiencies of 25 -  30 % 
were routinely achieved as measured by cells positive for GFP. Apoptosis was 
measured by Annexin-V and 7AAD staining and analysed by flow cytometry. 
Transfected cells were specifically analysed by gating on the GFP positive 
population. Both Bcl-2 and Bid were used as controls. Bcl-2 should protect the cells 
from apoptosis while Bid should induce a stronger apoptotic phenotype.
As all other Bcl-2 family members known to be cleaved by caspases result in a pro- 
apoptotic signal, we thought that the generation of an Mcl-1 'Bax-like' fragment by 
caspase cleavage may also give a pro-apoptotic phenotype to the cleaved Mcl-1. 
However this did not appear to be the case. Overexpression of full length Mcl-1 did 
delay apoptosis in Jurkat cells. The anti-apoptotic effect of Mcl-1 in response to Fas 
stimulation with the CH11 antibody was not particularly strong (Fig. 4-8A) and Mcl-1 
appeared to have a stronger protective effect in response to etoposide (Fig 4-8B). It is 
also worth noting the protection conferred by Mcl-1 against both Fas and etoposide 
mediated apoptosis is weak when compared with that of Bcl-2 (Fig. 4-8, compare 
green bar (Bcl-2) with the orange bar (Mcl-1)). Unexpectedly, the C-terminal 
cleavage fragments behaved almost exactly as wild-type Mcl-1 when transfected cells 
were treated either anti-Fas or etoposide, and did not show any significant difference 
in their ability to protect or promote apoptosis when compared with the wild-type 
Mcl-1. The caspase cleavage resistant mutant Mcl-1 (DblMut-Mcl-1) was also tested 
in this system and again gave very similar results as for the wild-type Mcl-1 and the
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Figure 4-8: Mcl-1 and its cleavage products delay apoptosis in Jurkat cells.
Jurkat cells were co-transfected with Mcl-1 constructs indicated and GFP. Twenty to 
24 hours after transfection apoptosis was induced by treatment with 300 ng/ml CHI 1 
anti-Fas (A) or 25 pM etoposide (B). Apoptosis was measured by staining the cells 
with Annexin-PE and analysing by flow cytometry. By gating on GFP-positive cells 
transfected populations could be analysed. (A) Mcl-1 and its fragments slightly delay 
apoptosis induced by CHI 1 anti-Fas. (B) A greater delay in apoptosis is seen against 
treatment with etoposide. Note that protection by transfected Bcl-2 is much stronger 
than that by transfected Mcl-1.
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cleavage products. This suggested that at least in Jurkat cells Mcl-1 cleavage by 
caspases during apoptosis does not significantly alter the function of the Mcl-1 
protein.
Protection from apoptosis by Mcl-1 has been characterised in a number of cell types, 
including the murine IL-3 dependent haematopoetic cell line FDCP-1 (Zhou et al., 
1997). We decided to use these cells to further characterise the cleavage fragments 
and to examine the effect of the individual Mcl-1 cleavage products during growth 
factor withdrawal induced apoptosis.
4.2.5 -  The PEST regions in Mcl-1 do not regulate its stability
Mcl-1 cleavage products were cloned from pcDNA-3.1-HA into a pMSCV-IRES- 
huCD2-tailless (Fig. 4-9). This retroviral vector is a modified version of pMSCV- 
Neo (Clontech) that contains a human CD2 gene lacking most of its cytoplasmic tail 
under the control of an internal ribosome entry site (IRES), thus allowing for 
detection of transduced cells by the presence of human CD2 on the cell surface. 
FDCP-1 cells were transduced with constructs containing wild type and double 
mutant Mcl-1, Mcl-1 cleavage products and the empty vector as a control (Fig. 4-10). 
Infection efficiencies of 80 -  90 % were routinely achieved and overexpressed protein 
was detected by Western blot using an anti-HA antibody (Fig. 4-10). We found that 
fragments lacking part (i.e. A127) or all (i.e. A157) of the PEST region appeared to be 
much more abundant (Fig. 4-10, lanes 5 and 6) when compared with full length wild- 
type and DblMut-Mcl-1 proteins (Fig. 4-10, lanes 3 and 7). Alpha-tubulin was used 
as a loading control to confirm equal loading in each lane. Initially we thought that 
the higher levels of the A127 and A157 cleavage products may be as a result of 
increased protein stability, especially as the PEST regions in Mcl-1 are thought to be 
responsible for the rapid turnover of Mcl-1. To further assess the stability of full 
length Mcl-1 and the A127-Mcl-1 and A157-Mcl-1 cleavage fragments the mixed 
populations of transduced cells were treated with the translation inhibitor 
cyclohexamide (CHX) for 0, 10, 20, 30, 60, 90 or 120 minutes (Fig. 4-11). The 
Western blots in Figure 4-11 show that Mcl-1 and the two cleavage fragments are
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Figure 4-9: pMSCV-IRES-huCD2 tailless. The retroviral vector pMSCV-lRES-huCD2 tailless was used for retroviral infections of 
FDCP-1 cells. The vector is a modified version of the pMSCV-Neo vector that is commercially available from Clontech. The 
neomycin gene in pMSCV-Neo has been replaced with an internal ribosome entry sequence (IRES) that is followed by a human CD2 
construct that lacks most of its cytoplasmic tail. This allows for easy detection of infected cells by analysing for CD2 levels on the 
cell surface.
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Figure 4-10: Overexpression of Mcl-1 constructs in transduced FDCP-1 cells.
FDCP-1 cells were retrovirally infected with pMSCV-IRES-huCD2 constructs 
containing Mcl-1 and its cleavage products. CD2 on the cell surface was measured by 
flow cytometery and the percentage of infected cells expressing CD2 on their surface 
is shown below each lane. A western blot of total cell lysate was blotted using an 
anti-HA antibody to detect expression of the exogenous protein. The blot was 
stripped and probed using an anti-a-tubulin antibody to check for equal loading.
Much more protein was present for the A127- (lane 5) and A157-Mcl-1 (lane 6) 
constructs than for full length Mcl-1 proteins (lanes 3 and 7). This cannot be as a 
result of equal loading of protein or higher infection efficiency.
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Figure 4-11: PEST regions of Mcl-1 are not responsible for protein stability in 
FDCP-1 cells. FDCP-1 cells stably transduced with Mcl-1 constructs expressing full 
length HA-Mcl-1, HA-A127-Mcl-1 or HA-A157-Mcl-1 were incubated with 30 pg/ml 
cyclohexamide (CHX) for the times indicated to prevent translation of the exogenous 
proteins. Western blots on total cell lysate of samples were probed with an anti-Mcl-1 
antibody (HA-Mcl-1) or anti-HA antibody (for HA-A127-Mcl-1 and HA-A157-Mcl- 
1) and degradation of the protein observed over the time course indicated. The blots 
were also probed with an anti-a-tubulin antibody to check for equal loading. There 
appears to be no degradation of cx-tubulin over this time course, 
there to be no real difference in the rate of degradation between the protein products 
expressed from the constructs.
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surprisingly unstable, with an apparent half-life of < 30 min, while the levels of a- 
tubulin remain constant over the time course.
As protein stability could not account for the difference in protein levels in the 
transduced FDCP-1 cells we next examined levels of mRNA for each of the 
constructs. Figure 4-12 shows RT-PCR reactions to amplify a common C-terminal 
region in the overexpressed Mcl-1 and the cleavage fragments. RNA was prepared 
from four samples -  non-transduced FDCP-1 cells (Fig. 4-12A and B, lane 1) and 
FDCP-1 cells transduced with HA-Mcl-1 (Fig. 4-12A and B, lane 2), HA-A127-Mcl-1 
(Fig. 4-12A and B, lane 3), or HA-A157-Mcl-1 (Fig. 4-12A and B, lane4). cDNA was 
prepared from each of these samples and PCR reactions carried out to amplify a 
common region to all constructs. Products were analysed after 27 (Fig. 4-12A) and 
30 (Fig. 4-12B) cycles. The overall level of mRNA present for full length Mcl-1 
proved to be dramatically less than that for either A127-Mcl-1 or A157-Mcl-1 (Fig. 4- 
12A and B, compare lane 2 with lanes 3 and 4). Amplification of (3-actin by PCR was 
used to show equal amounts of cDNA were used for PCR reactions. As expected, 
non-transduced cells did not give any PCR product for exogenous Mcl-1 expression 
(Fig. 4-12A and B, lane 1). This large difference in the amount of mRNA present in 
the cells explains the difference in protein levels seen in Figure 4-10.
4.2.6 -  A157 fragment of Mcl-1 can still protect from apoptosis
We carried out apoptosis assays using the transduced FDCP-1 cells to investigate if 
the Mcl-1 cleavage products would promote apoptosis in this system. Apoptosis was 
induced by withdrawing growth factors withdrawal for a period of five days and 
monitored by measuring the percentage of sub-Gl cells each day using a flow 
cytometer. Contrary to previously published data (Zhou et al., 1997) Mcl-1 did not 
appear to delay apoptosis in these cells when compared to empty vector infected cells 
(Fig. 4-13A and B). Interestingly neither the A127- nor DblMut-Mcl-1 fragments 
appeared to have any pro-apoptotic function (Fig. 4-13A). In fact, only the A157 
fragment showed a significant difference when compared with empty vector control 
infected cells (Fig. 4-13B). The protection by A157-Mcl-1 appeared to be statistically 
significant at all time points with a p = 0.0036 at Day 5 (Fig. 4-13B).
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Figure 4-12: Relative mRNA levels of Mcl-1, A127-Mcl-1 and A157-Mcl-1 as 
determined by RT-PCR. cDNA was generated from FDCP-1 cells that had not been 
transduced (lane 1) or transduced with HA-Mcl-1 (lane 2), HA- A127-Mcl-1 (lane 3) 
or HA-A157-Mcl-1 (lane 4). PCR was carried out on each cDNA sample to amplify a 
region common to all constructs. Aliquots were taken from tubes after 27 cycles (A) 
and 30 cycles (B) and clearly show that the levels of Mcl-1 mRNA are lower than 
those of HA- A127-Mcl-1 and HA-A157-Mcl-1. PCR of P-actin was used to show 
that equal amounts of RNA had been used for each lane.
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Figure 4-13: A157-Mcl-1 can protect FDCP-1 cells from apoptosis induced by 
growth factor withdrawal. Apoptosis of FDCP-1 cells that had been stably 
transduced with Mcl-1 was induced by growth factor withdrawal. Neither Mcl-1, 
DblMut-Mcl-1, nor A127- Mcl-1 protected from apoptosis in this system (A). Neither 
did they promote apoptosis. However A157-Mcl-1 did show protection from growth 
factor withdrawal mediated apoptosis.
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Again, this fragment shows no pro-apoptotic potential but appears to retain the anti- 
apoptotic function of full-length Mcl-1, and can significantly delay apoptosis in 
FDCP-1 cells in response to withdrawal of growth factor.
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4.3 -  D iscussion
There are a number of Bcl-2 family members that are now known to be cleaved by 
caspases. The best characterised of these is Bid, the BH-3 only protein. Bid is a 
relatively inactive protein that exists as a p22 form within the cell. Cleavage of Bid 
by caspase-8 results in the generation of the potently apoptotic pl5 tBid fragment (Li 
et al., 1998; Luo et al., 1998). As outlined already this fragment translocates to the 
mitochondria where it plays an important role in apoptosis and has the ability to 
amplify apoptotic signals through stimulating the release of cytochrome-c from the 
mitochondria and subsequent activation of caspase-9. Bad and Bim are other BH-3 
only proteins that are cleaved by caspases (Chen and Zhou, 2004; Condorelli et al., 
2001). Bad is normally regulated through phosphorylation and sequestered by 14-4-3 
proteins in the cytoplasm (Datta et al., 2000; Zha et al., 1996). However it is known 
to be cleaved by caspases, and this cleavage results in a significant increase in its pro- 
apoptotic activity (Condorelli et al., 2001). Similarly, Bim is a sequestered to the 
microtubule-associated dynein motor complex within the cell, after release from the 
complex during early apoptosis BimEL can be cleaved by caspases induces a strong 
pro-apoptotic effect(Chen and Zhou, 2004). Cleavage of these proteins results in an 
increase to their already pro-apoptotic potential. The anti-apoptotic proteins Bcl-2 
and Bcl-XL are also known to be cleaved by caspases (Cheng et al., 1997; Fujita et al., 
1998). Cleavage of these proteins results in the removal of their BH-4 domain. This 
generates a ‘Bax-like’ fragment, containing BH-3, BH-1 and BH-2 domains. The 
result is that these previously anti-apoptotic proteins become quite potently pro- 
apoptotic.
In a similar fashion, we have shown here that Mcl-1 is cleaved by caspases to become 
a ‘Bax-like’ protein, lacking a BH-4 homology domain. However our experiments in 
both Jurkat-T cells and FDCP-1 cells show that overexpression of the cleavage 
fragments does not show any pro-apoptotic potential and that these fragments appear 
to retain an anti-apoptotic function. It is interesting to note that in these 
overexpression studies the cleavage fragments were much more abundant relative to
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full-length Mcl-1 fragments, suggesting that any anti-apoptotic potential these 
fragments may have is not as strong as the full length protein.
In the case of Jurkat-T cells, overexpression of the cleavage fragments showed a 
similar level of protection to that of the full-length Mcl-1 for both Fas and etoposide 
mediated apoptosis. In the case of Fas induced apoptosis there is a trend in which 
expression of these fragments may have the ability to delay apoptosis, although this is 
not a significant delay in apoptosis; while all fragments offer a better protection from 
etoposide induced apoptosis. This ability of Mcl-1 to protect better from etoposide 
induced apoptosis is consistent with the published role of Mcl-1 in apoptosis mediated 
through DNA damage (Cuconati et al., 2003; Nijhawan et al., 2003). What is 
interesting is that although the protein levels of the A127-Mcl-1 and A157-Mcl-1 are 
much higher than full-length Mcl-1 they do not appear to show an enhanced 
protective effect. This suggests that these fragments may not be as anti-apoptotic as 
full-length Mcl-1.
FDCP-1 cells were also used to examine protection by Mcl-1. These cells were stably 
transduced using a retroviral gene transfer system. Expression of both CD2-tailless 
and HA-tagged Mcl-1 constructs was well maintained over a period of weeks. This 
suggested that the overexpression of Mcl-1 caspase cleavage fragments did not have 
any seriously damaging effects on cell growth or proliferation. It has been previously 
published that wild-type full-length Mcl-1 can protect these cells from growth factor 
withdrawal induced apoptosis. However we were unable to detect any protective 
effect of Mcl-1 when compared with vector only control cells. It is unclear why this 
may be the case. FDCP-1 cells are murine myeloid progenitor cells that were 
originally generated from a population of murine bone-marrow cells, grown in the 
presence of IL-3 to generate IL-3 dependent cells (Dexter et al., 1980). There are a 
number of different populations of these cells - FDCP-Mix, FDCP-1 and FDCP-2 
cells, which were generated from the original IL-3 dependent population but have 
quite different characteristics. It is thought that many of these clones have diverged 
over the years resulting in a number of groups calling their cell lines FDCP-Mix, 
FDCP-1 or FDCP-2 cells when they may not be representative of the original cell 
populations that were characterised (Spooncer et al., 1993). We purchased our
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FDCP-1 cells directly from ATCC and they may not be exactly the same as those 
cells used in previously published data showing protection by Mcl-1. However, the 
A157-Mcl-1 fragment did delay apoptosis in these cells. This protection was 
consistent over a number of experiments and was statistically significant at all time 
points when compared with control cells. The reason for this increased protection 
may be in part as a result of the higher levels of A157-Mcl-1 protein. If this were the 
only reason for the increased protection of A157-Mcl-1 then A127-Mcl-1 should also 
offer increased protection as there is significantly more of this fragment compared 
with full length Mcl-1. This does not appear to be the case however.
Mcl-1 is known to have a rapid turnover within the cell and this has been thought to 
be as a result of two PEST regions within the protein. When we overexpressed the 
A127-Mcl-1 and A157-Mcl-1 fragments in both Jurkat-T cells and FDCP-1 cells, we 
initially assumed this to be as a result of the removal of the PEST regions from the 
protein. Investigation into Mcl-1 stability in FDCP-1 cells however showed that this 
was not the case, and that the real reason for lack of full-length Mcl-1 in the cells was 
lower mRNA levels. In fact our results showed that the stability of the Mcl-1 protein 
did not appear to be affected by removal of the PEST regions in FDCP-1 s. This 
confirms findings for Mcl-1 overexpressed in U937 cells (Akgul et al., 2000) and 
suggests that there is a region in the C-terminus of Mcl-1 that is responsible for the 
short half-life of Mcl-1. It also brings into question the functional significance of this 
large N-terminal region if it is not responsible for rapid turnover of Mcl-1 within the 
cell.
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5 - Discussion
The initial aim of this project was to identify novel interaction partners for the pro- 
apoptotic BH3-only protein tBid. We identified two novel interaction partners, EID-1 
and Mcl-1. During the course of this work we also observed that Mcl-1 was cleaved 
during apoptosis in the Jurkat T cell line. Consequently we characterised the cleavage 
of the Mcl-1 protein and attempted to determine the functional effects of the cleavage 
products.
There is little known about EID-1 and no evidence to suggest that EID-1 may play a 
role in apoptosis. Its published role relates to controlling gene expression in 
combination with histone deacetylases (HDACs) and histone acetyltransferases 
(HATs) (Bavner et al., 2002; MacLellan et al., 2000; Miyake et al., 2000). EID-1 is 
down regulated during differentiation of myoblasts and the haematopoetic cell line 
U937 and overexpression of the protein is able to block muscle specific gene 
expression and differentiation of C2C12 myoblasts (MacLellan et al., 2000; Miyake et 
al., 2000). Exogenous EID-1 appears to be localised to both the nucleus and 
cytoplasm (Bavner et al., 2002). Assuming that endogenous EID-1 has the same 
localisation pattern, it is possible that it may be able to interact with tBid during 
apoptosis. As well as the ability of EID-1 to interact with tBid, it may also interact 
with other Bcl-2 family members. Without evidence of a role for EID-1 during 
apoptosis it is difficult to see how this would have a functional significance for cell 
survival. For this reason we felt that that the interaction between Mcl-1 and tBid was 
a more relevant interaction and concentrated on experiments to determine the 
functional significance of this interaction.
Mcl-1 is an anti-apoptotic protein with a clear role in development and differentiation. 
As an anti-apoptotic Bcl-2 family member it is likely that Mcl-1 and tBid interact 
with each other in vivo. The next step in evaluating the interaction between these two 
Bcl-2 proteins is to show that this interaction occurs in vivo and to show that it has a 
functional significance. Co-immunoprecipitation of the proteins from cell lysates
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should confirm that Mcl-1 interacts with tBid. This, along with the yeast-two hybrid 
and GST data, would be very strong evidence for the interaction occurring in vivo. 
This interaction is most likely to occur via the BH domains of both proteins. Based 
on the yeast-two hybrid data presented in Chapter 3, we know that it is the C terminal 
region of Mcl-1 that is important for interaction with tBid and it is this region in Mcl- 
1 that contains the BH1, -2, and -3 domains. Mutation of these BH-domains should 
confirm if these domains are responsible for mediating the interaction between the 
proteins.
It has previously been shown that tBid can induce the release of cytochrome c from 
isolated mitochondria. We would predict that this tBid mediated cytochrome c 
release could be inhibited by the addition of exogenous Mcl-1. Any inhibition of 
cytochrome c release by Mcl-1 would be due to the ability of Mcl-1 to interact 
directly with tBid. In this situation Mcl-1 would act by sequestering tBid and 
preventing it from activating Bax or Bak (see Fig. 1-4). Thus by sequestering the 
‘activating ’ tBid, this would prevent oligomerisation of Bak and Bax. This can be 
readily examined using isolated mitochondria in vitro and inducing cytochrome c 
release by addition of exogenous tBid in the presence of Mcl-1. By generating Mcl-1 
overexpressing stable cell lines we can examine the protection offered by Mcl-1 in 
vivo in response to Bid mediated apoptosis.
It is interesting that in-depth analysis of the Bid null mice showed myeloid expansion, 
with an increased absolute neutrophil count (Zinkel et al., 2003). This myeloid 
hyperplasia leads to pre-leukaemic phenotype that progresses to a fatal clonal disorder 
that resembles human chronic myelomonocytic leukaemia (CMML) (Zinkel et al., 
2003). The authors of the study say that the myelomonocyte lineage of these Bid- 
deficient mice “is singularly dependent on Bid for physiologic cell death.” The Mcl-1 
protein also plays a vital role in survival of haematopoietic cells and myeloid cells in 
particular. In vitro culturing of cells from Mcl-1 transgenic mice show enhanced 
survival of haematopoietic cells in general with immortalisation of cells in the 
myeloid lineage (Zhou et al., 1998). In light of the results shown here, the fact that a 
lack of Bid or excess of Mcl-1 can provide cells of the myeloid lineage with a 
survival advantage suggests that these proteins co-operate to ensure proper
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homeostasis and maintenance of the myeloid lineage. Further study is required to 
determine the importance of Bid cleavage for its role in maintenance of myeloid 
homeostasis, as well as to examine whether the balance between Bid and Mcl-1 and 
the ability of these proteins to interact can influence normal myeloid homeostasis.
After identifying Mcl-1 as a novel interaction partner for tBid, we subsequently found 
it to be cleaved during apoptosis of Jurkat T cells. There have been a number of Bcl- 
2 family members that have been identified as targets for caspases (Chen and Zhou, 
2004; Cheng et al., 1997; Condorelli et al., 2001; Fujita et al., 1998; Li et al., 1998; 
Luo et al., 1998). In all cases to date, apart from Mcl-1, cleavage of Bcl-2 proteins by 
caspases results in the generation of a more potently apoptotic protein. We initially 
expected that this would also be case for Mcl-1. However experiments in both Jurkat 
T cells (where the cleavage was initially observed) and the IL-3 dependant FDCP-1 
cell line gave no indication that the cleavage products were pro-apoptotic. In fact, it 
is possible that one of the fragments may potentially retain some anti-apoptotic 
activity. Whether cleavage of Mcl-1 by caspases generates apoptotic fragments, 
neutralises the anti-apoptotic potential of the fragment, or has any effect on the 
function of Mcl-1 may depend on the context in which such fragments are generated.
A number of papers have detailed the roles of caspase proteins outside of apoptosis. 
Indeed the first caspase identified (caspase-1) was originally identified as an enzyme 
involved in the biosynthesis of interleukin-1-(3 (Thornberry, 1994). Since then other 
caspases have been implicated with roles in the maturation of other cytokines as well 
as being identified as having roles in differentiation (Abraham and Shaham, 2004).
This potential role of caspases in differentiation could have important implications for 
a role of Mcl-1 in differentiation. Caspase-3 has been shown to be activated in U937 
cells in response to differentiation with PMA (Pandey et al., 2000) and also to be 
activated during epidermal keratinocyte and erythroid differentiation (Weil et al., 
1999; Zermati et al., 2001). As caspase cleavage of Mcl-1 does not appear to alter its 
anti-apoptotic function dramatically, potential caspase activation during 
differentiation and possible cleavage of Mcl-1 during these events would make Mcl-1
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a much better protector under these circumstances than other anti-apoptotic Bcl-2 
proteins.
Cleavage of Mcl-1 can generates two main fragments, a larger C terminal fragment 
and a smaller N terminal fragment. The small fragment generated contains the PEST 
regions within the Mcl-1 protein. We speculated that this would generate more stable 
C terminal fragments, however this was not the case. In fact, the PEST regions do not 
appear to influence the stability of the protein and fragments lacking the PEST 
domains have a half-life similar to the full-length protein. This implies that the N 
terminal region of Mcl-1 may have a function that has yet to be determined.
This also raises an interesting question for the role of M cl-l’s BH-4 domain contained 
at the N terminus of the protein. Might its N-terminal region, containing the BH-4 
domain, influence differentiation and development, particularly as the PEST region 
does not appear to be responsible for the short half-life of Mcl-1? If Mcl-1 is cleaved 
during differentiation, this would release this region from the rest of the protein 
leaving it free to act elsewhere within the cell.
Interestingly the BH4 domains of other Bcl-2 family members have been implicated 
in determining cell fate during differentiation. It has been known for some time that 
Bcl-XL plays a role in erythroid differentiation. Part of this role may be independent 
of its anti-apoptotic function (Hafid-Medheb et al., 2003). In experiments with 
differentiating FDCP-Mix cells, Bcl-XL promotes differentiation to an erythroid 
lineage, while Bcl-2 promotes differentiation to a monocyte/macrophage lineage 
(Haughn et al., 2003). When the BH-4 domain of Bcl-2 was replaced with that of 
Bcl-XL, cells containing the modified Bcl-2 were no longer able to differentiate to 
monocytes/macrophages and instead gave erythroid cells. FDCP-Mix cells 
containing Bcl-2 showed lower levels of Raf-1, a protein known to influence 
erythropoiesis, while using the modified Bcl-2 restored levels of Raf-1 as seen in 
FDCP-Mix cells expressing Bcl-XL (Haughn et al., 2003). Perhaps the N terminal 
region of Mcl-1 may have similar properties that have yet to be identified.
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This thesis describes a number of interesting observations relating to the Bcl-2 family 
proteins Bid and Mcl-1. Based on the work presented here and data available in the 
literature we would hypothesise that these proteins have an important influence on 
each other that has not yet been acknowledged. Further work to characterise the 
interaction between tBid and Mcl-1 to determine its significance, as well as caspase 
cleavage of Mcl-1, may help elucidate the molecular mechanisms by which they 
influence apoptosis and clarify their physiological roles.
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Appendix I
Primers used for PCR reactions:
3'BaxA21-C7a I (5 '-CCATCGATTCACTGCCATGTGGG-3')
rCDCll-BamH  I (5'-CGGGATCCTCACACACTGACATCCTTCTCATCGC-3')
3'GST-Bid-X/io I (5'-CCGCTCGAGTCAGTCCATCCCATTTCTGGC-3')
3 'GST-Mcl-1 -EcoR I (5 '-CCGG A ATTCCT AT CTT ATT AG AT AT GCC-3') 
3'GST-EID-l- EcoR I (5 '-CCGG A ATTCCT ACT CT CT AT C A AT A ATC-3') 
3'hBid-£amH I (5 '-CGGG ATCCTCAGTCCATCCCATTTCTGGC-3') 
rhElD-l-BamU I (3 '-CGGG ATCCCT ACTCTCT AT CA AT A AT GT C-3')
3 'hNM23B-ZtamH I (5 '-CGGG ATCCTT ATT CAT AG ACCCAGT C-3') 
3'mBid-ZtamH I (5 '-CGGG ATCCT C AGT CC AT CT CGTTT CT A ACC A AG-3') 
3'Mcl-l-BamH I (5 '-GCGGATCCTCAGTCGCTGAA AACATGG-3') 
3'Mcl-127-R (5' -CGCGG ATCCCT AGT CC AGCT CCT CTT CGG-3') 
5'BaxA21-£coR I (5'-CCGGAATTCATGGACGGGTCCGG-3')
5 "GST-Bid-£coR I (5 '-CCGGAATTCCCATGGACTGTGAGGTCAACAACG-3') 
5'GST-EID-l- BamU I (5 '-CGCGGATCCCCAATGTCGGAAATGGC-3')
5 'GST-Mcl-1 -BamH I (5'-
CGCGG ATCCCC A AT GTTT GGCCT C A A A AG A A ACG-3')
5'GST-tBid-EcoR I (5'-CCGGAATTCCCGGCAACCGCAGCAGCCAC-3')
5'hBid-£coR I (5 '-CGGAATTCATGGACTGTGAGGTCAACAACG-3')
5'hCDC37-£coR I (5'-CGGAATTCATGGTGGACTACAGCCTGTGG-3')
5'hEID-l-£coR I (5 '-CGGAATTCATGTCGGAAATGGCTGAGTTGTCC-3')
5'hNM23B-£’coR I (5'-CGGAATTCATGGCCAACCTGGAGCGC-3'
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5'htBid-£coR I (5'-CGGAATTCACCATGGGCAACCGCAGCAGC-3') 
5'Mcl-A127-F (5 '-CCGG A ATTCGGGT ACG AGCCGG AGCCT CT CGG-3') 
5'Mcl-A157-F (5'-CCGGAATTCGGGTCACTACCCTCGACGC-3') 
5'M cl-l-£coR I (5 '-CGGAATTCATGTTGGCCTC-3')
5 mtBid-£coR I (5'-CCGGAATTCGGCAGCCAGGCCAGC-3')
Actin F3 (5'-GGCATCCACGAAACTACCTTCAA-3')
Actin B3 (5'-AACCGACTGCTGTCACCTTCAC-3')
D127A-F (5'-CATGTCGCCCG AAGAGGAGCT GGCCGGGT ACGAGC-3') 
D 127A-R (5 '-C AGCTCCTCTT AGGGCG ACATG ATGGCGTC AGC-3') 
D157A-F (5 '-GGT A AT A AC ACCAGT ACGGCCGGGTCACT ACCC-3') 
D157A-R (5'-CGTACTGGTGTTATTACCAGATTCCCCGACC-3') 
Mcl-l-3F(5'-TGCAGCGCAACCACGAGACCGG-3') 
pcDNA3.1-R (5'-AAAGCTTGGTACCGAGCTCGG-3')
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Appendix II
Yeast two-hybrid filters stained with Z-Buffer to identify interaction partners for tBid
Plate 1
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Plate 2
153
Plate 3
1 5 4
Plate 4
155
Plate 5
1 5 6
Plate 6
/
x
157
Plate 7
15 8
Plate 8
1 5 9
Plate 9
160
Plate 10
161
Appendix III
Table outlining all clones pulled out of yeast two-hybrid screen.
Plate
Number
Clone
Number
Strong
Blue
Weak
Blue
Possible
Interactant
Out of 
Frame
No
Match
Vector
only
Misc.
1 1
2
3
4
5
6 s
7 s
8 V
9 s
10
2 11 s s
12 s
13 s s
14 s s
15 s
16 s s
17 s
18 s y
19 s
20 s
3 21 s
22 s s
23 s s
24 s
25 s s
26 s
27 s s
4 28
29
30
31
32
33
s
y
s
s
s
s
s
5 34
35
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36
37
38
S
S
39 S S
40 S S
41 V
42 S
43 S
6 44 S S
45 S
46 S V
47 V
48 S V
49
50
51 V
52 S
53 S
54 S
55 S
7 56 S V
57 S y
58 V V
59 S
60 S V
61 S s
62 S
63 S s
64 V </
65 S
8 66 S S
67 V
68 S s
69 S s
70 V
71 V s
72 S s
73 S s
74 S
75 S s
76 V s
77 S s
78 V
79 V s
80 S s
81
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82
83
84
S
V
9 85 S
86
87
88
89 V
90
91
92 S
93 S
94 S s
95
96
97 S
98 V V
10 99 S V
100 S S
101 S V
102 S
103 S y
104 S
105 S
106 S
107 S
108 S
109 S V
110 S s
111 S
112 S
113 V
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Appendix IV
Summary of retest results for the yeast two-hybrid screen
'S (« )
NDPK
EID-1
tBID +tBID
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Mcl-1
-tBID +tBID
1 6 6
(Vi)
i '"I
e*-fcO
Be I-2
/
4*. 4
(vii) /«.•/ '>fas
Thymic
Factor
4I-J V*
(viii)
*
\
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S u m m a ry
M c l-1 is essential for no rm al haem atopoiesis, b e ing  req u ired  for lym phocyte 
d evelopm ent an d  m ain tenance. Its role in haem atopo ie tic  d iffe ren tia tion  and  
developm ent is associated w ith  its function  as an  an ti-ap o p to tic  m em b er o f  
th e  B d-2  fam ily o f  p ro te in s  a lthough  th e  und erlin in g  m echan ism  is poorly  
u n d e rs to o d . W e have characterized  caspase cleavage o f  th e  Mcl-1 p ro te in  
d u rin g  apoptosis. Caspase cleavage resu lted  in th e  rem oval o f  the  PEST 
regions fro m  th e  p ro te in  an d  g eneration  o f  a fragm ent co n ta in in g  the BH-1, 
-2 and  -3 hom ology  dom ains. Rem oval o f  the  PEST regions d id  no t appear to 
a lter M cl-1 stability, suggesting th a t these regions are n o t responsible for M cl- 
1’s sh o rt half-life. In  a d d itio n , unlike cleavage o f  Bcl-2 an d  Bcl-XL, which 
resu lted  in p ro -a p o p to tic  fragm ents, cleaved fo rm s o f  Mcl-1 were unab le  to  
in d u ce  apoptosis . This novel regulation  o f  Mcl-1 m ay have im p o rta n t 
im plications n o t on ly  fo r its role in apop tosis  b u t  also for the  essential role it 
plays in the  d iffe ren tia tion  and  developm ent o f  haem atopo ie tic  cells.
K eyw ords: apop tosis , M cl-1, caspase, Bcl-2, haem atopoiesis.
Mcl-1 was first identified as an  early response gene sw itched on 
in the h um an  m yeloid leukaem ia cell line M L-1, following 
trea tm en t w ith  the  d ifferentiation agent phorbo l 12-m yristate 
13-acetate (PM A) (K ozopas e t  a l ,  1993). It has since estab­
lished itself as an essential m olecule n o t on ly  early in 
developm ent (O kita e t  a l ,  1998; R inkenberger e t  a l ,  2000) 
bu t also fo r successful d ifferen tiation  o f  haem atopoietic  cell 
types (Craig, 2002; O pferm an e t  a l ,  2003). Mcl-1 has been 
show n to be absolutely required  for the successful developm ent 
and  m ain tenance o f  B an d  T  lym phocytes (O pferm an  e t  a l ,  
2003). C ond itional knock-ou t o f  m c l- 1  in B and  T  lym phocyte 
lineages results in  severe loss o f  m atu re  lym phocytes. In 
addition , knocking o u t the gene in m atu re  lym phocytes shows 
tha t m c l- 1  is also essential for the ir survival in response to  
cytokine signalling, m c l-1  transgenic m ice are highly suscept­
ible to  developing B-cell lym phom a (Z hou  e t  a l ,  2001) and  
there is a grow ing body o f  evidence to  support Mcl-1 as an 
essential survival pro tein  in  m ultip le m yelom a (M M ) (D er- 
enne e t  a l ,  2002; Z hang e t  a l ,  2002; Jou rdan  e t  a l ,  2003). Mcl-1 
is regulated by  a nu m b er o f  cytokines. Indeed  in terleukin  (IL)- 
7, and  to  a lesser extent IL-15, induce s trong  expression o f 
Mcl-1 in  p rim ary  thym ocytes tha t is im p o rtan t for their 
survival an d  m ain tenance (O pferm an e t  a l ,  2003). M any M M  
cell lines are dependan t on  1L-6 for survival th rough  upreg- 
ulation o f  m c l-1  expression. D ow nregulation  o f  the Mcl-1
pro te in  follow ing trea tm en t w ith  antisense has been show n to 
induce apoptosis in  these cells (Jou rdan  e t  a l ,  2003). T hus 
deregulation  o f  Mcl-1 can have a p ro fo u n d  effect on  cell 
g row th an d  survival.
As an an ti-ap o p to tic  m em ber o f  the  Bcl-2 family o f  p ro teins 
Mcl-1 also has a role in apoptosis an d  it is highly likely th a t its 
role in  haem atopoietic  d ifferentiation an d  developm ent is 
linked to  its func tion  as an an ti-ap o p to tic  p ro te in  (Craig, 
2002). T he ability o f  Mcl-1 to  p ro tec t cells from  death  is n o t 
very well understood . Like Bcl-2, it has all fou r Bcl-2 hom ology 
(BH) dom ains (K ozopas e t  a l ,  1993). It also has a C -term inal 
hydrophobic dom ain  tha t is responsible for the localization o f  
Mcl-1 to  m em branes w ith in  the cell, in  particu la r to  the 
m itochondrial m em brane (Yang e t  a l ,  1996; Akgul e t  a l ,  2000). 
W hile it appears th a t Mcl-1 m ay n o t b e  as po ten t a p ro tec to r 
against apoptosis as Bcl-2 (Reynolds e t  a l ,  1996), it does 
appear to  be the m ain  an ti-apop to tic  p ro te in  in som e cell types 
including neu troph ils (M ould ing  e t  a l ,  1998). U nlike o ther 
Bcl-2 family m em bers, Mcl-1 contains a large region consisting 
o f  tw o PEST sequences that have been th ough t to  target Mcl-1 
for rap id  degradation  w ith in  th e  cell. O u r results show ed that 
in FD C P-1 cells M cl-1 has a very rapid tu rnover, and  tha t C- 
term inal fragm ents lacking these PEST regions are ju st as labile 
as the full length w ild-type Mcl-1 in these cells. A lthough it is 
n o t clear exactly how  Mcl-1 functions as an  an ti-apop to tic
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pro te in , recent d a ta  places Mcl-1 upstream  o f  Bcl-XL in 
response to  ultraviolet (U V )-induced  apoptosis o f  H ela cells 
(N ijhaw an e t  a l ,  2003). O verexpression o f  M cl-1 prevents 
translocation  o f  Bax to  the m itochondria , an d  w hile Bcl-XL is 
unable to  prevent this translocation  it does inh ib it o ligom e­
riza tion  o f  translocated  Bax in  the m itochondria  (N ijhaw an 
e t  a l ,  2003).
T h e expression o f  M cl-1 can be regulated a t a transcrip tional 
as well as a post-transla tional level. Its expression is increased 
in  response to  signalling from  a n u m b er o f  different cytokines 
(C hao e t  a l ,  1998; M ould ing  e t  a l ,  1998; H uang  e t  a l ,  2000; 
P u th ie r e t  a l ,  2001; Pelletier e t  a l ,  2002; T u m an g  e t  a l ,  2002). A 
recent study  shows th a t M cl-1 is rapidly degraded  by  the 
p ro teasom e d u rin g  induction  o f  apoptosis by UV  irrad iation  
in  H ela cells (N ijhaw an e t  a l ,  2003). H ere w e re p o rt ano the r 
novel regula tion  o f  Mcl-1 at a  post-transla tional level, by 
caspase cleavage.
In m ost cases caspase activation is requ ired  fo r com plete 
apoptosis o f  the cell (B udihard jo  e t  a l ,  1999; Salvesen, 2002). 
Caspases exist as inactive pro-enzym es w ith in  the cell. U p o n  a 
death  signal, large signalling com plexes form  an d  activate 
in itia to r caspases. These in itia to r caspases cleave a large 
n u m b er o f  substrates as well as activating dow nstream  
executioner caspases. A nu m b er o f  Bcl-2 family m em bers are 
know n to  be cleaved by caspases. Bid, a  B H -3-only p ro te in , is 
activated upon cleavage by caspase-8 (Li e t  a l ,  1998; Luo e t  a l ,
1998), while Bcl-2, Bcl-XL, BimEL and Bad have also been 
show n to  be cleaved by  caspases (C heng e t  a l ,  1997; C lem  e t  a l ,  
1998; C ondorelli e t  a l ,  2001; Chen 8c Z h o u , 2004). Cleavage o f  
Bcl-2 and  Bcl-XL result in  the removal o f  the ir BH -4 dom ain  to  
generate Bax-like fragm ents tha t con ta in  BH -1, -2 and  -3 
hom ology dom ains. In all cases, cleavage o f  these p ro teins 
results in a stronger p ro -ap o p to tic  signal.
W e found  that cleavage o f  M cl-1 by caspases d id  no t result 
in an  apop to tic  signal. M ore im portan tly , caspase cleavage 
generated a fragm ent that, although  s tructura lly  sim ilar to  Bax, 
d id  n o t display p ro -ap o p to tic  activity. In add ition , we have 
found  the PEST regions in Mcl-1 d o  n o t appear to  be 
responsible for the sho rt half-life in FDCP-1 cells. These 
im p o rtan t observations m ay lead to  a b e tter u nders tand ing  o f  
how  the Mcl-1 pro tein  functions in preventing apoptosis and 
facilitating its role in  haem atopoietic  m aintenance.
M a te ria ls  a n d  m e th o d s
Reagents
All m edia and  cell cu ltu re reagents w ere ob tained  from  Gibco 
(Glasgow, UK). All o ther reagents were purchased from  Sigma 
(Poole, UK) unless otherw ise stated.
Cell lines and culture
Jurkat T-cells were grow n in Roswell Park  M em orial Institu te 
(R PM I) 1640 m edium  supplem ented  w ith  10% fetal calf serum
(FCS), 2 m mol/1 L-glutam ine, 0 5 U /m l penicillin  and 
0  5 pg/m ! strep tom ycin . FDCP-1 cells (A m erican Type C ulture 
Collection) were grow n in RPM I 1640 m ed ium  supplem ented  
w ith  10% FCS, 2 mmol/1 L-glutam ine, 0 5 U /m l penicillin, 
0-5 pg /m l strep tom ycin , 1 mmol/1 HEPES, 0 0004%  (5-merca- 
p toethano l an d  10% IL-3 cond itioned  m edia from  W EH I-3B  
cells. T he 293-derived LinXE virus packaging cell line was 
m ain tained  in  D ulbecco’s m odified Eagle’s m ed ium  (D M EM ) 
supplem ented  w ith  10% FCS, 2 m mol/1 L-glutam ine, 0-5 U /m l 
penicillin , 0 5 pg /m l strep tom ycin  and  75 pg/m l hygrom ycin 
(C albiochem , San Diego, CA, USA). All cell lines were 
m ain ta ined  a t 37°C w ith  5%  C O 2 unless otherw ise stated.
M cl-1 constructs a n d  p lasm ids
T he plasm id vector pcD N A 3T -H A  was used for all in  v i t r o  
assays an d  transien t transfection  experim ents. This was 
generated by  first annealing  the tw o oligos 5 '-TCGA G- 
ACCATGGCTTATCCTTA TG A CG TG CCTG A CTA TG CCA G - 
C C T G G -3 ' an d  5'-A ATTCCA GGCTGGCATAG TCA GGCAC- 
GTCATA AGGATA AGCCATGGTC-3'. T his d o u b le  stranded  
oligo was then  ligated in to  th e  X h o  I an d  EcoRI sites o f 
p cD N A 3T /m yc-H IS °(-) B (Inv itrogen , Paisley, U K ). Full 
length  h u m an  an d  m ouse m c l- 1  cD NAs w ere cloned  by 
polym erase chain  reaction  (PC R) in  fram e an d  dow nstream  
o f  the  HA tag  in to  the EcoRI an d  B a m  H I sites o f  pcD N A 31- 
HA. B oth h u m an  an d  m ouse  m c l- 1  cD NAs w ere am plified  by 
PCR using  the  p rim ers  5 'M C L -l- EcoRI (5'-CG G A A TT- 
C A TG TTG G C CTC -3') and  3 'M C L -l- B am H I (5 '- 
GCG G A TCCCTTCTTATTAG ATATGC-3'). M utan t m c l-1  
constructs D127A MCL-1 an d  D157A MCL-1 were generated 
by site d irected m utagenesis using the G eneT ailor™  Site- 
D irected M utagenesis System from  Invitrogen. T he p rim er 
pairs used for D127A-M CL-1 w ere D127A-F (5'-CA T- 
GTCGCCCGAAGAG GAGCTGGCCGGG TACGAGC-3') and 
D127A-R (5'-CAGCTCCTCTTAGGGCGA CA TGATGG CGT- 
CA G C-3'). T he p rim er pairs used for D157A-M CL-1 were 
D157A-F (5'-GGTAATAACACCAGTACGGCCGGGTCAC- 
TA C CC-3') an d  D157A-R (5 '-C G T  ACTGGTGTTAT
TA CCAGATTCCCCG ACC-3'). A doub le m u tan t molecule 
(D blM ut-M C L -1) was generated using the D127A-MCL-1 as a 
tem plate and  m uta ting  A sp157 to Ala using the p rim ers D157A-F 
an d  D157A-R as before. T he caspase cleavage fragm ents o f 
m c l-1  were cloned by PCR in to  the EcoRI and  B am H I sites o f  
pcD N A 3T-H A . 127-M CL-l was am plified using the prim er 
pair 5 'M cI-l- EcoRI and  M CL-127-R  (5 '-CG CGG ATCCCTA- 
G TC C A G CTCCTCTTCG G -3'), A127-MCL-1 was am plified 
using M CL-A127-F (5'-CCGGAATTCGGGTACGAGCCGGA- 
G C C TCTC G G -3') and  3 'M cl-l-  B am H I, and A157-MCL-1 
was am plified using M CL-A157-F (5'-CCGGA ATTCGGGT- 
CACTACCCTCGACGC-3') and  37M CL-1-Bam H I. For re tro ­
viral infection o f  F D C P-1 cells a m odified pM SCV neo vector, 
pM SCV-IRES-huCD 2 tailless (a gift from  D r Owen W illiams, 
In stitu te  o f  C hild H ealth) was used. This vector was generated 
by digesting the parental pM SCVneo w ith  EcoRI an d  Bam HI
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and inserting a linker PCR fragm ent containing an internal 
ribosom e entry site (IRES) followed by a hum an CD2 gene 
lacking m ost o f its cytoplasmic tail. This enables the detection 
o f  infected cells by expression o f  hum an  CD2 on  the surface o f  
infected cells. H A -M cU , H A -127-M d-l, H A -A l27-M d-1 , 
H A -A l57-M d-1  and  HA-DblM ut-M cl-1 were all d o n ed  by 
digesting the pcD N A 3-l-H A  constructs w ith Xbal, blunt 
ending, and  then  cloning in to  a b lunt ended EcoRI site o f 
pMSCV-IRES-huCD2.
Reverse transcription polymerase chain reaction (RT-PCR) 
analysis o f  mcl-1 constructs
T he RNA was prepared from  3 x  10* cells for each o f  no n ­
transduced FDCP-1 cells, o r  FDCP-1 cells transduced with 
pMSCV- H A -M d -1 -IRES-huCD2, pM SCV-HA-A 127-M CL-l- 
IRES-huCD2, o r pM SCV-HA-A I57-M CL-l-IRES-huCD2 
using a Quiagen RNeasy m ini k i t  Reverse transcrip tion  was 
carried o u t using an oligo-dT p rim er and  Superscript II reverse 
transcriptase (Invitrogen) according to  the m anufacturers 
instructions. The resulting cDNA was used for PCR to amplify 
(3-Actin using the prim er pair Actin F3 (5'-GGCATCCAC- 
GAAACTACCTTCAA-3') and Actin B3 (5'-AACCGACTGC- 
TGTCACCTTCAC-3'); while a C -term inal region from  
over-expressed M d - l  constructs w ere amplified using the 
p rim er pair M CL-1-3F (5'-TGCAGCGCAACCACGAGAC- 
CG G -3') and pcD N A 31-R  (5'-AAAGCTTGGTACCGAG- 
CTCG G-3').
Western blot analysis
Protein samples were prepared by lysing cells in  sample buffer. 
Sodium  dodecyl sulphate (SDS)-polyacrylamide gels (10-15% ) 
were prepared essentially as described (Laemmli, 1970). 
P roteins separated on th e  g d s were transferred to  either 
polyvinylidene difluoride (Im m obilon-P ; M illipore, W atford, 
UK) o r nitrocellulose filters (H ybond-C  pure; Am ersham, 
Bucks, UK). Filters were washed and stained w ith anti-mcl-1 
(S-19; Santa C ruz Biotechnology), anti-PARP (BD Pharm in- 
gen, Santa Cruz, CA, USA), anti-H A  (clone 3F10; Roche, 
Lewes, UK), o r an ti-a -tubu lin  (d o n e  YL1/2; Serotec, O xford, 
U K). H orseradish peroxidase (H RP) conjugated secondary 
antibodies were purchased from  Santa C ruz Biotechnology. 
Filters were developed using an enhanced chem ilum inescence 
(ECL) W estern blotting detection reagent (A mersham ).
Induction o f  apoptosis in Jurkat cells
For apoptosis assays cells were seeded at 1-2 X 106 cells/ml and 
treated w ith 300 ng/m l C H I 1 anti-Fas (U pstate Biotechnology, 
M ilton Keynes, UK), 25 pmol/1 etoposide o r 1 pmol/1 staurosp- 
orine for up  to  6 h. A fter treatm ent, cells were harvested and 
washed with ice-cold phosphate-buffered saline (PBS). One- 
fifth o f the cells were analysed using flow cytom etry by staining 
w ith Annexin V -phycoerythrin (PE) (BD Pharm ingen) and
7-am ino-actinom ycin D  (7AAD) to  m easure apoptosis. The 
o ther four-fifths were pelleted and lysed in sample buffer for 
analysis by W estern blot.
Preparation o f  apoptotic lysate and  in vitro assay fo r  Mcl-1 
cleavage
Jurkat T-cells were seeded a t 1 X 106 cells/ml and  treated for 
4 h  w ith o r  w ithout 300 ng/m l CH11 anti-Fas (U pstate 
Biotechnology). Cell lysates were prepared as described (Sun 
et al, 1999). Briefly, 2 x  107 cells were pelleted and washed in 
ice-cold PBS. Cells were then resuspended in PIPES (piper- 
azine-1, 4-bis 12-ethanesulfonic acid) buffer [50 mmol/1 
PIPES/KOH (pH  6-5), 2 mmol/1 ethylenediam inetetraacetic 
acid (EDTA), 0-1% (w/v) CHAPS and  one tablet o f  com plete 
inhibitors (Roche) per 10 m l lysis buffer) to  a volum e of 
166 p i/10* cells. This was followed by three cycles o f freezing in 
liquid nitrogen followed by thaw ing rapidly at 37°C. Samples 
were then spun in a bcnchtop centrifuge for 30 m ins at 
16 000 g. Supernatant was transferred to  a fresh tube and  spun 
a t 100 000 g  fo r 45 m ins. T he S100 fraction containing active 
caspases was collected and the p ro tein  concentration deter­
m ined using th e  Bio-Rad pro tein  assay. Aliquots were stored at 
-8 0 °C . H um an  and  m ouse H A -M d-1 were in vitro  translated 
using the TNT® T7 Q uick C oupled Transcription/Translation 
System from  Prom ega (M adison, W I, USA) in the presence o f 
[35S] -m ethionine (A m ersham ), according to the m anufac­
turers instructions. Cell lysate was added to  PIPES buffer to  a 
final volum e o f  48 pi. For assays using recom binant active 
caspase-3 (BD Biosciences, Cowley, U K), active caspase-3 was 
added to  a final volum e o f  48 p i w ith  buffer used according to  
the m anufacturers instructions. Caspase inh ib itor zVAD-fmk 
(Enzyme System Products), o r dim ethyl sulphoxide as a 
control, was then added and  incubated at 37°C fo r 15 m in. 
Finally 1-0 pi o f  translated p ro tein  was added to the lysate, 
m ixed by pipetting, and incubated at 37°C fo r 2 h. The 
reaction was term inated  by  the addition o f  50 pi o f  2 X sample 
buffer. Tw enty microlitres o f  this was then resolved by 12% 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Follow­
ing this the gel was fixed, dried  and  exposed to  a phosphoi- 
mager screen overnight.
Infection o f  FDCP-1 cells
Constructs fo r infection were first transfected in to  the LinXE 
packaging cell line using Lipofectam ine (Invitrogen) according 
to  the m anafacturers instructions. Generally 8 pg o f  each 
construct was transfected in to  a 10 cm  plate. Tw enty-four 
hours after infection, the m edia on  the cells was replaced by 
media used fo r the culture o f  FDCP-1 cells. Following 
incubation for an additional 24 h, 10 m l viral supernatant 
was collected fo r each construct. FDCP-1 cells for infection 
were counted  and  4 x  104 cells resuspended in 2 m l viral 
supernatan t containing 8-0 pg/m l polybrene to  give a concen­
tration o f  2 x  104 cells/ml. Cells were spun at 360 g  for
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45 m ins a t 32°C and  then incubated at 32°C w ith  5%  C 0 2 for 
2 h. M ost o f the supernatan t was carefully rem oved and a 
further 2 ml viral supernatan t containing polybrene was 
added. The cells were spun as before and  incubated at 32°C 
w ith 5% C 0 2 for a  further 4 h . T he supernatan t was again 
carefully removed and replaced w ith com plete media and  the 
cells incubated as norm al overnight. The following m orning 
m edia was removed from  the cells and 4 ml viral supernatant 
contain ing  polybrene was added and  spun as before. Cells were 
incubated for 6 h  a t 32°C w ith  5% C 0 2. Following this the 
m edia was replaced w ith com plete m edia and the cells 
incubated as norm al. The infected populations were expanded 
and infection efficiency was m easured by flow cytom etry using 
an  anti-CD 2-FITC antibody (eBioscience, San Diego, CA, 
USA). Generally, an infection efficiency o f  80% upw ards was 
observed.
Cycloheximide treatm ent o f  FDCP-1 cells and growth 
factor withdrawal assays
The FDCP-1 cells were split to  2 X 105 cells/ml the day before 
treatm ent. O n the day o f  trea tm ent 2 m l o f  cells at 
5 X 10s cells/ml were placed in wells o f  a 6-well plate. Cells
were then  treated for 0, 10, 20, 30, 60, 90, o r 120 m in  w ith 
30 pg/m l cycloheximide (CHX), harvested and  washed w ith 
ice-cold PBS before being lysed in Laemmli buffer. Samples 
were analysed by W estern blots and  probed w ith an ti-M d-1  o r 
anti-H A . Blots were also probed with an ti-a -tubu lin  to  check 
for loading. For grow th factor withdraw al assays, FDCP-1 cells 
were prepared by first w ashing cells three times in RPMI-1640 
m edium . Cells were then resuspended in m edia containing 
RPM I-1640 with 1% FCS, 2 mmol/1 L-glutam ine, 0-5 U /m l 
penicillin, 0-5 pg/m l streptom ycin, 1 mmol/1 HEPES, and  
0 0004% P-m ercptoethanol and m aintained at 37°C w ith 5% 
C 0 2. Apoptosis was m easured by harvesting cells, resuspend- 
ing in hypotonic buffer and addition o f  p ropid ium  iodide to 
exam ine DNA content o f  the cells. T he percentage o f  sub-G l 
cells was used as a m easure o f  apoptosis.
Results
Mcl-1 is cleaved during apoptosis in Jurkat cells
W e initially observed that Mcl-1 was cleaved in Jurkat cells in 
response to  treatm ent w ith the anti-Fas m onoclonal antibody 
CH11. As shown in Fig 1A, M d - l  was cleaved from  its full
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F ig 1. M d - l  is c leaved du rin g  ap op tosis  o f  Jurkat cells. Jurkat c ells w ere treated w ith  3 00  n g/m l CH 11 anti-F as (A  and  B), 1 0  pm ol/1 staurosporine  
(C ) or  25  0  pm ol/1 e top osid e  (D )  over  a 6 -h  tim e  course. A p op to s is  w as quantified by  flow  cytom etry  u sing  an ti-A nn exin  V -PE. Tota l cell lysate was 
resolved b y  SD S-PA G E and W estern b lo tted  w ith  an a n t i-M d -1 antib ody  (A , B, C  and  D ) and an anti-P A R P  antib ody (A  and B). P re-incubating w ith  
75 pm ol/1 o f  the pan -caspase in h ib itor  zV A D -fm k com p lete ly  abolished cleavage o f  M cl-1 or PARP in  response to C H U  (B ). Asterisks indicate  
c leavage products.
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length 42 kD a form  to a lower band m igrating at about 27 kDa 
as detected by W estern blotting. A tim e course study showed 
th at Mcl-1 cleavage occurred at the sam e tim e as PARP 
cleavage (Fig 1A). Inducing apoptosis w ith staurosporine 
(Fig 1C) o r etoposide (Fig ID ) also resulted in the processing 
o f  M d - l .  In o rde r to  establish if  this cleavage was upstream  or 
dow nstream  o f caspase activity, Jurkat cells were incubated 
w ith 75 pmol/1 o f  the pan-caspase inh ib itor zVAD-fmk for 
30 m in before inducing apoptosis. Both M cl-1 and PARP 
cleavage were com pletely inhibited over the 6-h  tim e course 
(Fig IB). This indicated that caspase activity was required for 
M d - l  cleavage.
Mcl-1 cleavage is m ediated by caspases
An in  v i t r o  system was set up  to  exam ine the processing o f 
M d -l  m ore dosely. H um an  (Fig 2A) o r  m ouse (Fig 2B) in  
v i t r o  translated [35S]-H A -M d-1 was incubated with a  cyto­
plasmic lysate from  untreated Jurkat cells o r Jurkat cells treated 
w ith CH11 anti-Fas an tibody fo r 4 h. This lysate contained 
either inactive (i.e. non-apopto tic  lysate) o r active (i.e. 
apoptotic lysate) forms o f  caspases present in the cell. T reating 
the pro tein  w ith  apopto tic lysate clearly showed the cleavage o f  
M d - l  (Fig 2A and  B). A ddition o f  zVAD-frnk to  the apopto tic 
lysate com pletely inhibited this cleavage.
H um an M d -l  was processed in to  three fragm ents while 
m ouse M d - l  was processed in to  only tw o fragments. This 
suggests two cleavage sites in the hum an  protein and  only one 
in the m ouse protein. Incubating hum an  M d -l w ith active 
caspase-3 resulted in the same cleavage pattern  as for apoptotic 
lysate (Fig 2C), thus confirm ing th a t M d -l  could be directly 
deaved by caspases and  that the processing o f  M d -l  in Jurkat 
cells undergoing apoptosis was because o f  caspase cleavage o f  
the protein. It is w orth  m entioning th a t although caspase-3 
deaved M d -l  in  v i t r o ,  this m ay no t be the prim ary o r only 
caspase involved in  M d - l  processing in  v iv o .  A caspase 
cleavage consensus site (DXXD) was also present in the HA 
tag, which also appeared to  be deaved in o u r in  v i t r o  assays and 
could be easily seen by com paring the smallest fragm ent 
present on  the gel (F ig2C ). Active caspase-3 appeared to  
deave this site m ore effidently than  the apopto tic lysate and  so 
this small fragm ent travelled slightly faster in this lane.
Analysis o f  the protein sequence o f  the hum an M d -l protein 
d id  no t identify any obvious o r know n caspase cleavage sites. 
All Asp residues were exam ined for a potential caspase cleavage 
site according to  the three residues N -term inal to  Asp and  their 
hom ology to  know n caspase cleavage sites. A num ber o f 
candidate cleavage sites were identified and the Asp residues 
were subsequently m utated  by site directed m utagenesis to  Ala 
residues. As shown in Fig 3A, m utation  o f  D127A o r D157A 
altered the cleavage pattern o f  the wild-type (w t) M d -l  protein 
w hen treated w ith apoptotic lysate (com pare lanes 3 and 4 to  
lane 2). Generation o f  a double m utan t (D127A, D157A M d -l)  
resulted in  the com plete abolition o f  Mcl-1 cleavage (Fig 3A, 
lane 5). The identical cleavage pattern was also observed by
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Fig 2 . H u m an and M ou se  M cl-1 can b e  c leaved in to  a nu m ber o f  
fragm ents b y  caspases. In vitro  [35S]-labelled  hu m an (A ) and m ou se  
(B ) H A -M d -1 w as in cu bated w ith  different am ou n ts o f  ap op to tic  
lysate for 2 h  a t 37°C . Sam ples w ere analysed by  reso lv ing  p rotein s 
w ith  SD S-PA G E . T h e gel w as dried and exposed  to  a  p h osp hoim ager  
screen . P re-incub ating  w ith  75  pm ol/1 zV A D -fm k (fina l lane in  b o th  A 
and B) for 15 m in  prior  to  the ad d ition  o f  a p op to tic  lysate prevented  
this cleavage. (C ) T reating hu m an H A -M cl-1  w ith  an ap op to tic  lysate 
or w ith  recom binant caspase-3 results in  the  sam e cleavage pattern. 
A sterisks indicate c leavage produ cts.
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F ig 3 . H u m a n  M d - l  is d eaved  by  caspases at D 1 2 7  and D 157 . A spartic a d d s  D 127  and D 157 were m utated  to  alan ine b y  site-d irected  m utagenesis. 
T h e  m utant pro te in s w ere treated w ith  ap op to tic  lysate (A ) or active  caspase-3 (B ) as in  Fig 2 . T h is  resulted in  an a lteration to  the deavage  pattern by  
b o th  ap op to tic  lysate and  recom b inan t caspase-3. C leavage w as com p lete ly  a b olish ed  w hen  b o th  resid ues w ere m utated  (D 1 2 7 A , D I5 7 A ). T he  
fragm ents that w ere c lon ed  for further analysis are d ep icted  in  (C ). T h e  pM SC V -lR E S -h uC D 2 ta illess vector  u sed  for retroviral in fection  is  o u tlin ed  in  
(D ) . A sterisks in d icate  deavage  produ cts.
using active caspase-3 (Fig 3B). Thus the three fragments 
generated by cleavage o f the hum an M cl-1 m olecule were (i) an 
N -term inal fragm ent from  am ino acids 1 to  127, (ii) a long 
C -term inal fragm ent from  am ino acids 128-350 (A127) and  
(iii) a sho rter C -term inal fragm ent from  am ino acids 158-350 
(A157) (Fig 3C). W estern blots using the Santa C ruz an ti-M d - 
1 (S -19) antibody clearly showed the A127 fragm ent (Fig 1) b u t 
n o t th e  shorter A 157-fragment. This was because the epitope 
used for the generation o f  this antibody was a short sequence 
no t present in  the A157 fragment.
T o  exam ine further the functional consequences o f  M d -l  
cleavage each o f  the cleavage products were cloned in to  the 
m am m alian expression vector pcD NA3-l-H A. These con­
structs were used to  transiently transfect Jurkat cells, which 
were then treated w ith C H U  o r etoposide for up  to  6 h. 
A poptosis was m easured by Annexin-V and 7AAD staining 
and  analysed by flow cytom etry. M d -l  did delay apoptosis, 
although it d id  no t protect as well as Bcl-2 (data not shown). 
The C -term inal cleavage fragm ents tested also protected from  
apoptosis b u t did n o t show  any significant difference in their 
ability to  protect o r prom ote apoptosis when com pared w ith 
th e  w ild-type M d - l  (data no t show n). A caspase cleavage
resistant m u tan t M d -l  was also tested in this system and gave 
very sim ilar results to  tha t o f  the wild-type M d -l  and  the 
deavage products.
Although we initially observed cleavage o f  Mcl-1 in Jurkat 
T-cells, its role in these cells is poorly characterized. Protection 
from  apoptosis by M d - 1 has been characterised in a num ber o f  
cell types, including the m urine IL-3 dependent haem atopoetic 
cell line FDCP-1 (Reynolds e t  a l ,  1996; Z hou e t  a l ,  1997; 
Pedersen e t  a l ,  2002). W e used these cells to  further charac­
terise the deavage fragments and to  exam ine the effect o f  the 
individual M d -l  cleavage products during grow th factor 
w ithdraw al-induced apoptosis.
The PEST regions in Mcl-1 do not regulate its stability
Mcl-1 deavage products were d o n ed  in to  a retroviral pMSCV 
vector modified to  contain a hum an CD2 gene lacking m ost o f 
its cytoplasmic tail under the control o f an IRES, thus enabling 
the detection o f  transduced cells by the presence o f hum an 
CD2 on  the cell surface (Fig 3D). FDCP-1 cells were 
transduced with constructs containing wild type and double 
m utan t M d - l ,  M d -l  cleavage products and the em pty vector
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Fig 4 . M cl-1 stability  is not regulated b y  its PEST regions in  FD CP-1 
cells. (A ) FDCP-1 cells w ere in fected w ith  pM SC V -IR E S-huC D 2 c o n ­
structs con ta in in g  w ild type H A -M cl-1  (lane 3 ) , H A -1 2 7 -M cl-l (lane  
4 ) , H A -A 127-M d -1  (lane 5 ), H A -A 157-M d -1  (lane  6 )  and  H A -D b l-  
M u t-M d -1  (lane 7). U n in fected  ceUs (lane  1) and vector  o n ly  contro l 
cells (lane 2) were also used. Sam ples w ere prepared by lysing  cell 
pellets in  Laem m li buffer and resolving protein s on  a SD S-PA G E gel. A  
W estern b lot was perform ed us in g  an an ti-H A  antib ody. T h e  m em ­
brane w as also probed w ith  an a n ti-a -tu b u lin  an tib ody to  check for 
load ing  and the percentage o f  cells expressing  the  h u m an  C D -2  antigen  
was taken as a m easure o f  in fection  efficiency. (B ) FD C P-1 cells 
transduced w ith  pM SC V -IR E S-huC D 2 vectors con ta in in g  H A -M cl-1  
( to p  p an els), H A -A 127-M d -1  (centre  pan els) or  H A -A l5 7 -M d -1  
(b o ttom  pan els) w ere treated w ith  30  n g /m l cycloh exim id e (C H X ) for 
the tim es indicated and sam ples analysed b y  W estern b lo ts  u s in g  anti- 
M d -1  or  anti-H A  an tib odies and  an a n ti-a -tu b u lin  an tib ody for 
load ing. (C ) R T-PCR  reactions to  assess th e  a m ou n t o f  R N A  present in 
transduced cells. R T-PtiR  reactions o n  R N A  from  non-transd uced  
FD CP-1 cells (lane 1), or  FD CP-1 cells transduced w ith  pM SC V -IR ES- 
hu C D 2 vectors con ta in in g  H A -M d -1  (lane  2 ) , H A -A l2 7 -M d -1  (lane  
3) or  H A -A 157-M d -1  (lane 4 ) after eith er  27  or  30  c y d e s  o f  am plifi­
cation .
as a control (Fig 4A). Infection efficiencies o f 80-90%  were 
routinely achieved and overexpressed protein was detected by 
W estern blo t using an anti-H A  antibody (Fig 4A). W e found
that fragments lacking part (i.e. A127) o r  all (i.e. A157) o f  the 
PEST region appeared to  be m uch m ore abundant (Fig 4A, 
lanes 5 and 6) when com pared w ith full length wild-type and 
D blM ut-M d-1 proteins (Fig 4A, lanes 3 and 7). Initially we 
thought that this was as a result o f  protein stability, especially 
as the PEST regions in M d -l  are thought to  be responsible for 
the rapid turnover o f  Mcl-1. T o  further assess the stability o f  
full length M d - l  and the A l27-M d-1  and A 157-M d-1 deavage 
fragments, the muted populations o f  transduced cells were 
treated w ith the translation inh ib itor cycloheximide (CHX) for 
0, 10, 20, 30, 60, 90 o r 120 m in (Fig 4B). The W estern blots 
(Fig 4B) showed that M d -l  and the tw o deavage fragments 
were surprisingly unstable, w ith a half-life o f  <30 m in, while 
the levels o f  a -tubu lin  rem ained constan t over the tim e course. 
The ra te o f  degradation o f  each fragm ent was calculated for 
each construct using a (Bio-Rad, Hercules, CA, USA) GS-800 
calibrated densitom eter and  Q uantity  O ne quantification 
software (data not show n). This analysis suggested that A 157- 
M cl-1 m ight be slightly m ore stable although this difference was 
not statistically significant, and suggested that the PEST region 
was n o t responsible for the rap id  turnover o f  Mcl-1.
As pro tein  stability could n o t account for the difference in 
pro tein  levels in the transduced FDCP-1 cells we next 
exam ined levels o f  mRNA for each o f  the constructs. Figure 4C 
shows RT-PCR reactions to  am plify a com m on C -term inal 
region present in  the overexpressed wild-type M d -l  and all o f 
deavage fragments. RNA was prepared from  four samples -  
non-transduced  FDCP-1 cells (Fig 4C, lane 1) and  FDCP-1 
cells transduced w ith H A -M d -l (Fig 4C, lane 2), HA-A127- 
Mcl-1 (Fig 4C, lane 3), o r H A -A l57-M d-1  (Fig 4C, lane4). 
The overall level o f  mRNA for full length M d -l  proved to  be 
dramatically less than  th a t for either A127-M d-1 o r  A157-M d- 
1 (Fig 4C, com pare lane 2 w ith lanes 3 and  4). Amplification o f 
P-actin by  PCR was used to  show  th at equal am ounts o f  cDNA 
were used for PCR. As expected, non-transduced  cells did no t 
give any PCR product. T hus the differences in the am oun t o f 
mRNA present in the cells were repeated in  the protein levels 
(Fig 4A).
Products o f caspase cleavage are not apoptotic
As the caspase cleavage o f  all o ther Bcl-2 family m em bers 
know n to undergo this process results in  a p ro-apopto tic  
signal, we thought that the generation o f  an  M d - l  Bax-like 
fragment by caspase cleavage, containing only BH-1, -2 and -3 
hom ology dom ains, m ay also give a pro-apopto tic  phenotype 
to  the M d - l  deavage products. W e carried o u t apoptosis 
assays using the transduced FDCP-1 cells to  investigate if  this 
was the case. Apoptosis was induced following grow th factor 
withdraw al for a period o f  5 d and m onitored  each day by 
measuring the percentage o f  sub -G l cells using a flow 
cytom eter. C ontrary to  previously published data (Zhou et al, 
1997), M d -l  d id  not appear to  delay apoptosis in these cells 
when com pared w ith em pty  vector infected cells. Interestingly 
the fragm ents did not appear to  have any pro-apopto tic
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Days afte r growth factor w ithdrawal
Fig 5 . C aspase cleavage p rodu cts d o  n o t  in d u ce  ap op tosis  in  F D C P -1 
cells. In fected F D C P -1 p op u la tion s w ere starved o f  grow th  factors over 
a per iod  o f  5  d . A p op tos is  w as m easured by  p rop id iu m  io d id e  sta in ing  
and  flow  cytom etery . R esu lts are expressed as percentages (m ean  o f  
three in depend en t experim en ts ±  standard dev ia tion ). O f  all the 
constru cts in fected , o n ly  H A -A l5 7 -M cl-1  sh ow ed  a sign ificant differ­
ence  to  vector  on ly  con tro l in fection s or  w ild  type H A -M d -l in fe c ­
tion s.
function. In  fact, the A157 fragm ent appeared to  show  a slight 
pro tec tion  from  grow th factor w ithdraw al-induced apoptosis 
w hen com pared w ith em pty vector contro l infected cells 
(P — 0 0036 at day 5) (Fig 5). This suggestion, that the 
cleavage products m ay also be able to  offer som e protection 
from  apoptosis, is a  unique and  novel finding for M d - l .
D iscussion
Various transgenic m odels involving Bcl-2 family m em bers 
have show n that these proteins have im portan t roles in growth, 
developm ent and haem atopoiesis. This role is linked w ith the 
ability o f  these pro teins to  influence apoptosis, although 
exactly how  they function  to  regulate apoptosis is not 
completely understood. For exam ple the p ro-apopto tic  p ro ­
teins Bax and Bak are essential fo r release o f  m itochondrial 
proteins required for apoptosis (W ei et al, 2001). U pon 
activation, these proteins translocate and  concentrate in  the 
ou ter m itochondrial m em brane and hom o-oligom erize to 
form  larger m olecular weight complexes (A ntonsson et al, 
2000; Eskes et al, 2000; W ei et al, 2000; A ntonsson et al, 2001) 
resulting in the release o f  m itochondrial proteins (Gross et al,
1999). O n the contrary, Bcl-2 is able to  inhibit release o f  these 
m itochondrial proteins. W hether it does this by sequestering 
BH3-only proteins, preventing them  from  activating Bax and 
Bak o r by inhibiting form ation o f  the activated Bax/Bak 
complexes is still unclear (Cheng et al, 2001). A recent study 
has show n that M d -1 appears to  function upstream  o f Bd-Xc 
in response to  UV -induced apoptosis, and com plete disap­
pearance o f  M d -l  is required before translocation o f  Bax to 
the m itochondria and  activation o f  pro-apopto tic  proteins
(N ijhaw an et al, 2003). They also report that a similar effect 
was observed when H ela cells were treated with etoposide.
O u r data show th at M d -l  in Jurkat cells was no t regulated 
in this m anner in response to  a num ber o f  different apoptosis- 
inducing agents, including etoposide. W e observed that there 
was no  change in Mcl-1 levels upon induction o f  apoptosis 
un til the caspases were activated. U pon activation o f  the 
caspases, Mcl-1 was deaved b u t did not appear to  be degraded 
p rio r to  caspase activation as is the case in UV-induced 
apoptosis in Hela cells (Nijhawan et al, 2003).
As previously outlined, M d - l  plays an im portan t role in 
development and com m itm ent to  differentiation particularly 
w ithin the haem atopoietic cell lineages (R inkenberger et al, 
2000; Craig, 2002; O pferm an et al, 2003). It is strongly 
upregulated in response to  differentiation signals and protein 
levels rapidly increase w ithin the cell (Kozopas et al, 1993; 
Yang e ta / ,  1996). Cellular differentiation and development 
require m ajor changes in gene expression profiles as well as 
substantial changes to  cellular m orphology and  structure. A 
num ber o f  recent publications have identified that caspase 
activity is required for the differentiation o f  a num ber o f  cell 
types including haem atopoetic cells (Eckhart et al, 2000; 
Pandey et al, 2000; Zerm ati et al, 2001; A ram a et al, 2003). 
These data show that activation o f  caspases play an im portan t 
role in successful differentiation o f  these cells. This caspase 
activity shows sdective cleavage o f  known substrates that are 
involved in  cellular organization. In such cases where caspase 
activity is required for successful differentiation it is possible 
that M d -l  deavage plays a  role in m aintaining cell viability, 
allowing reorganization and com m itm ent to  differentiation to 
proceed and  preventing the cell from p rem ature and inappro­
priate apoptosis.
H um an Mcl-1 is deaved at two sites in vitro, A sp127 and 
Asp157. M ouse Mcl-1 is only cleaved at one site and this is likely 
to  be at Asp108, as the region before this residue appears to  be 
conserved with the caspase cleavage site at A sp127 in hum an 
M d - l .  W e have show n that this deavage can be m ediated by 
recom binant caspase-3 o r  by apoptotic cell lysate although we 
have as yet been unable to  detect the shorter A 157-M d-1 
fragm ent in intact cells undergoing apoptosis by W estern blot. 
The Santa C ruz a n ti-M d -1 (S -19) antibody was raised against a 
peptide from  am ino acid 121-139 in hum an M d -l  and this 
only enables the detection o f  the larger A l2 7 -M d -I fragment. 
This epitope is lost in the A157-M d-1 fragm ent and therefore 
the antibody was unable to  detect this fragment.
Cleavage o f  M cl-1 by caspases results in the generation of 
fragm ents that lack the PEST regions at the N -term inus o f  the 
protein. PEST dom ains are associated w ith targeting proteins 
for rapid degredation by the proteasom e (Rechsteiner 8c 
Rogers, 1996) and M d -T s  PEST dom ains are thought to  be 
responsible for its short half-life (Kozopas et al, 1993; Yang 
et al, 1996). O ur results show that the half-life o f  M d -l  is 
surprisingly short in FD C P-1 cells. Interestingly, removing the 
PEST regions from  the protein, as was the case with the caspase 
cleavage fragments, did not significantly alter the turnover of
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the  pro te in . T hus full-length Mcl-1 an d  the  caspase cleavage 
fragm ents A l27-M cl-1 an d  A l57-M cl-1 all appear to  have 
s im ilar half-lives. This suggests tha t som e o th e r region existing 
w ith in  th e  C -term inus determ ines th e  half-life o f  M cl-1. This 
also raises questions as to  how  the P E ST -containing region 
con tribu tes to  Mcl-1 function  if it is n o t responsible for its 
rap id  turnover.
T he Bcl-2 family m em bers Bid, Bad, BimEL, Bcl-2 and  Bcl-XL 
are know n to  be cleaved by  caspases (C heng et al, 1997; Clem 
et al, 1998; Li et al, 1998; Luo et al, 1998; C ondorelli et al, 2001; 
C hen & Z hou, 2004). This cleavage is best characterized for Bid 
an d  is essential for its role as a p ro -ap o p to tic  p ro tein . H owever, 
the ro le o f  caspase cleavage o f  BimEL, Bad, Bcl-2 an d  Bcl-XL is 
less well unders to o d  although  caspase cleavage o f  these p ro teins 
does result in a  stronger ap o p to tic  effect (C heng et al, 1997; 
Clem  et al, 1998; C ondorelli et al, 2001; C hen 8c Z h o u , 2004). 
This change in  apop to tic  po ten tial o f  these pro teins can only 
result in  fu rthe r com m itting  the cell to  apoptosis. A lthough 
caspase cleavage o f  M cl-l generates a Bax-like fragm ent (i.e. 
con ta in ing  on ly  B H -1, -2  an d  -3) it does n o t appear to  have any 
p ro -apop to tic  activity.
As M cl-t has already been reported  to p ro tec t FDCP-1 cells 
from  apoptosis induced by grow th factor w ithdraw al (Z hou 
et al, 1997) w e overexpressed wild type o r m u ta ted  Mcl-1 as well 
as the cleavage fragm ents in these cells. In  con trast to  w hat has 
previously been reported , we found  n o  significant difference 
between con tro l infected cells an d  those infected w ith a w ild-type 
M cl-1 construct. W e repeated this experim ent a n u m b er o f  tim es 
an d  consistently  found this to  be the  case. It is possible tha t th is is 
partly  because o f  the fact tha t w e have used a m ixed popu lation  
o f  infected cells ra the r than  generating and  selecting for high 
expressing clones tha t m ay be m ore resistan t to  apoptosis.
It was surprising  that the caspase cleavage p roduc ts  showed 
n o  apop to tic  effect, given th a t all o th e r Bcl-2 family m em bers 
that are know n to be cleaved by caspases generate a stronger 
apopto tic  response. In fact, the sm aller A157-Mcl-1 C -term inal 
fragm ent appeared  to  p ro tec t FDCP-1 cells from  apoptosis. 
After 5 d approxim ate ly  55-60%  o f the A l57-M cl-1 infected 
cells were apopto tic  while apoptosis w ith in  the o th e r p o p u ­
lations o f  infected cells was m uch  h igher a t 85-90% . This 
un ique finding suggests tha t M cl-1, unlike o th e r Bcl-2 family 
pro teins, m ay have a role to  play in  con tinu ing  to  p ro tec t the 
cell even after caspase activation. W estern  b lo tting  analysis o f 
infected cells show ed that bo th  H A -A l27-M cl-1 and  HA- 
Al57-M cl-1 were in m uch  greater abundance than  full-length 
HA-M cl-1 m olecules, a lthough the  levels o f  infection were 
similar. This appeared to  be a result o f  higher mRN A levels in 
cells transduced  w ith  A l27-M cl-1 and  A l57-M cl-1 , w hich 
ultim ately results in m ore p ro te in  expressed. T he reason that 
A l57-M cl-1 has a s tronger protective effect on  the cells is 
probably partly  because o f  the fact th a t there is substantially  
m ore pro tein  present in  the cell. How ever, if this were the only 
reason then  the larger A l27-M cl-1 fragm ent should  also 
pro tec t to  a greater extent th an  w ild-type M cl-1, as it is also in 
m uch greater abundance. W e were unable to  detect any
significant increase in  p ro tec tion  by  the  A l27-M cl-1 fragm ent 
an d  so an  increased level o f  the  p ro te in  m ay only  be part o f  the 
reason for A l5 7 -M c M s  ability  to  delay apoptosis.
O u r results show  that the PEST regions in  M cl-1 d o  n o t affect 
its stability  in F D C P-l cells an d  th a t caspase cleavage o f  Mcl-1 
results in  the rem oval o f  these regions an d  generates a Bax-like 
fragm ent tha t can still p ro tec t cells from  apoptosis. H ow ever the 
function  o f  these caspase cleaved fragm ents is unclear. F urther 
investigations will address how  these cleavage fragm ents influ­
ence apoptosis an d  also dete rm ine  the im portance  o f  these 
fragm ents in  haem atopoietic  d ifferen tiation  an d  developm ent.
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